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Proteins that are secreted from the yeast, Saccharomyces cerevisiae, traverse a
pathway similiar to that found in mammalian cells: nascent polypeptides enter the
secretory pathway by translocation across the endoplasmic reticulum (ER)
membrane, after which they are sequentially transported through the Golgi complex,
where they are packaged into secretory vesicles which ultimately fuse with the
plasma membrane.
Many of the cellular functions which contribute to the secretion pathway have been
genetically defined, by the isolation of temperature-sensitive lethal mutants (sec)
which are deficient in protein secretion. At the restrictive temperature (37°C) sec
mutants exhibit an accumulation of secretory glycoproteins inside an organelle of the
secretory apparatus, ie either ER, Golgi, or secretory vesicles; but on return to a
permissive temperature accumulated material is secreted. Many of the sec mutants
are also incapable of fluid phase endocytosis at 37°C, indicating a general
requirement for SEC gene products during intracellular movement of membrane.
The sec1-1 mutation results in an accumulation of secretory vesicles and cessation
of endocytosis at 37°C. This thesis describes the isolation of a fragment of yeast
genomic DNA that complements the sec1-1 mutation. Transposon mutagenesis and
subcloning experiments have localised the gene responsible for complementation
within this fragment, and the nucleotide sequence spanning this region has been
determined. A single open reading frame of 1878 bp has been identified, which could
encode a polypeptide of 626 amino acids.
Previous genetic analyses mapped the SEC1 gene in a tightly linked cluster of genes
on chromosome IV, including SEC5, SEC7, and CDC37. Intriguingly, mutations in the
SEC5 gene, which is immediately adjacent to SEC1, result in a similiar phenotype to
that exhibited by a sec1-1 mutant. In this thesis I demonstrate that the yeast
genomic DNA fragment isolated from the genomic library also harbours a second
gene, independent of the SEC1 gene, which can complement a sec5-24 mutation.
Further genetic analysis has revealed a relationship between the two genes: at a
restrictive temperature of 33.5°C a sec5-24 mutant can be rescued by the
introduction of multiple copies of the SEC1 gene; this interaction is unidirectional
however, since a sec1-1 mutant cannot be rescued by multiple copies of the SEC5
gene. This phenotype is not due to sequence similarites in the two gene products,
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In this thesis I describe the characterisation of two genes from Saccharomyces
cerevisiae whose products are thought to participate in the late stages of secretion.
This introduction is therefore designed to provide the reader with a sound
understanding of protein secretion from yeast. The current model of protein
secretion, however, is largely derived from biochemical investigation of mammalian
systems; I have therefore reviewed this model since it provides a conceptual
framework in which investigations of the yeast secretory pathway can be
interpreted. Throughout this review I have chosen to highlight certain areas of
investigation that may be directly relevant to this project. Also, investigation of the
mammalian endocytic pathway has provided many insights into the mechanisms
employed during intracellular membrane transport. Recent biochemical and genetic
evidence indicates that the secretory pathway could share many of these
characteristics, I have therefore reviewed the endocytic pathway, again choosing
some aspects that I think may be relevant to this thesis.
1.1 SECRETION OF PROTEINS FROM MAMMALIAN CELLS: A BRIEF
OVERVIEW.
For eukaryotes, the generally accepted view is that soluble and membrane proteins
move from the endoplasmic reticulum (ER) to the Golgi complex, where they are
packaged into secretory vesicles and transported to the plasma membrane (See fig.
1.1, Palade 1975). Four classes of proteins traverse the secretory pathway; these
are proteins to be secreted, lysosomal proteins, plasma membrane proteins, and
proteins of the secretory apparatus itself - both soluble and membrane proteins. All
these different types of protein are synthesised on polysomes attached to the rough ER
(Siekevitz and Palade 1960). Simultaneous to their synthesis, these proteins are
translocated across the ER membrane, which ultimately allows the cell to segregate
metabolic pathways, communicate with other cells, and build new membrane.
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Figure 1.1 The mammalian secretory pathway.
This figure is a diagrammatic representation of a generalised mammalian secretory
pathway. Proteins enter the pathway by co-translational translocation across the ER
membrane, and are then transported to the Golgi complex, which they enter at the cis
face, and sequentially traverse the stacked cisternae until they reach the TGN where
they are packaged into vesicles for delivery to their destination. In this diagram the
Golgi complex is depicted as having two cis, two medial, and two trans cisternae, this
number is arbitrary and does vary. Transport between all the different
compartments of the secretory pathway is proposed to oocur by vesicular
translocation. During this journey proteins may be modified by addition of
oligosaccharide, formation of disulphide bonds, phosphorylation, sulphation, or
proteolytic cleavage (see text for further details). Proteins that are destined for
alternative locations in the cell, ie. soluble and membrane proteins of secretory
organelles and the lysosome, and proteins that are released by the regulated
secretory pathway are thought to be segregated from proteins that are constitutively
released during passage through the Golgi. See text for further details.
Regulated
secretion






1.1.1 Translocation of proteins across the ER membrane.
Proteins that are destined to be translocated into the secretory pathway possess a
specific signal sequence, which is usually located at the extreme amino-terminus of
the protein (Blobel and Dobberstein 1975). No consensus for a signal sequence
exists although the following features are commonly found: 1-3 positively charged
amino acids in the amino-terminal region of the signal peptide; followed by a long
hydrophobic sequence consisting of 14-20 amino acids; and finally a glycine or
alanine residue at the carboxy-terminus of the signal peptide (for review see
Duffaud et al., 1985). As the signal sequence emerges from the large subunit of the
ribosome it is recognised and bound by a cytoplasmic ribonucleoprotein complex (the
signal recoginition particle, SRP), which arrests further elongation of the
polypeptide chain. The ribosome-SRP-nascent chain complex is subsequently
directed to the membrane of the ER via a direct interaction between SRP and a
receptor protein (SRP receptor or docking protein). Following attachment to the
membrane both SRP and docking protein are released from the complex, and
elongation of the nascent polypeptide continues with the growing polypeptide being
directed across the membrane (for more details of translocation, SRP, and the SRP
receptor see review by Walter and Lingappa (1986) and references therein).
Proteins will usually pass completely through the membrane into the lumen of the
ER unless they possess a second hydrophobic sequence which can anchor the protein
in the membrane (for review see Rapoport and Weidmann 1985).
1.1.2 Modifications of proteins within the ER.
During translocation the polypeptide is modified in a variet of ways by enzymes
localised on the luminal side of the ER membrane. The signal peptide is usually
removed as it emerges through the membrane, by the enzyme signal peptidase (Baker
et al., 1986, Evans et al., 1986); oligosaccharide chains are added to selected
asparagine residues (see below and for review see Kornfeld and Kornfeld 1985), and
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oxidation of cysteine residues occurs to form disulphide bonds (Bergmann and Kuehl
1979, Peters and Davidson 1982).
Most secreted proteins become glycosylated by addition of sugar residues to the
polypeptide chain. The biochemical reactions involved in the addition of
oligosaccharides to asparagine residues have been elucidated, and are often used as
evidence for the progression of a polypeptide through the secretory pathway (see fig.
1.2). N-linked glycosylation is initiated in the ER: a core oligosaccharide chain
consisting of three glucose, nine mannose, and two N-acetylglucosamine molecules
(Glc3Man9GlcNAc2) is transferred from a lipid donor to the amide nitrogen of an
asparagine residue (hence the name N-linked glycosylation). Prior to exit from the
ER one mannose and the three glucose molecules are removed by the action of a
mannosidase and glucosidases respectively. More extensive modification of these
oligosaccharides takes place in the Golgi and is described below. The asparagine
residue to be glycosylated almost always occurs in the sequence Asn-X-Thr/Ser,
where X can be any amino acid except possibly proline and aspartic acid, but not all
Asn-X-Ser/Thr sequences are glycosylated.
Once within the lumen of the ER, nascent polypeptide chains must fold or assemble
into a competent structure prior to exit from the ER and transport to the Golgi;
proteins which fail to do so are prevented from leaving. In the few cases studied such
retained proteins are more often than not found in association with a resident ER
protein of molecular weight 78K, termed BiP or glucose regulated protein 78
(GRP78, Munro and Pelham 1986), whose synthesis is actually increased by the
presence in the ER of malfolded proteins (Kozutsumi et at., 1988). GRP78 was first
observed in myeloma cells in association with immunoglobulin heavy chains that
were being synthesised in cells which lacked light chains (Haas and Wable 1983),
but it has since been found in association with malfolded viral haemagglutinin
(Gething et at., 1986), factor VIII, von Willebrand factor, and tissue plasminogen
activator (Dorner et a!., 1987). Whether GRP78 actually helps in the folding of
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Figure 1.2 N-linked alvcosvlation.
This figure is a diagrammatic representation of N-linked glycosyaltion through the
secretory pathway. Newly synthesised proteins may be modified by addition of
oligosaccharides to the asparagine residue in the sequences Asn-X-Ser/Thr. During
translocation of the polypeptide across the membrane of the ER an oligosaccharide
moiety is transferred from dolicholpyrophosphate (Dol-P-P) by
oligosaccharyltransferase (1). This 'core' oligosaccharide is processed prior to
leaving the ER: three molecules of glucose and one of mannose are removed by the
sequential action of a-glucosidase I (2), a-glucosidase II (3), and ER 1,2
mannosidase (4). The oligosaccharide chain undergoes further sequential
modification during transit through the Golgi apparatus; each modification has been
demonstrated to occur in a particular cisterna, which is a major piece of evidence for
functional compartmentalisation of the Golgi:
cis cisternae: oligosaccharide side chains are trimmed by removal of four mannose
residues by Golgi a-mannosidase I (5).
medial cisternae: sequentially, a molecule of N-acetylglucosamine is added by
N-acetylglucosaminyltransferase I (6), followed by removal of one more mannose
residue by Golgi a-mannosidase I (7), and finally a second molecule of
N-acetylglucosamine and a molecule of fucose are added by
N-acetylglucosaminyltransferase II (8) and fucosyltransferase (9) respectively.
trans cisternae:two molecules of galactose are added by galactosyltransferase (10),




















normal proteins or only binds to proteins which are folded incorrectly is still
unknown, although recent evidence demonstrates that in vitro GRP78 is only found in
association with malfolded proteins (Kassenbrock et al., 1988).
1.1.3 The Golai complex.
The Golgi complex consists of 3-8 flattened cisternae which are grouped together in a
characteristic stack (for reviews see Rothman 1981, Farquhar 1985). One side of
this stack faces the ER and is termed the cis side, whereas the trans side faces
secretion granules or centrioles; cisternae which lie in between cis and trans are
sometimes called medial. Newly synthesised proteins enter at the cis cisterna and
traverse the subsequent cisternae in a unidirectional fashion.
Transfer of proteins from the ER to the Golgi is thought to be mediated by shuttling
vesicles. Specialised regions of the RER known as transitional elements, which lack
ribosomes, can often be seen to support many budding structures under the electron
microscope (EM). It has been difficult to prove however, if these vesicles represent
true intermediates in transport to the Golgi from ER, or whether they are delivering
material to the ER from another subcellular compartment. The biochemical
purification of these vesicles still remains elusive, although a possible candidate for
the vesicles has been detected in homogenates of HepG2 cells (Lodish et al., 1987).
The recent development of in vitro systems (Haselbeck and Schekman 1986, Batch et
al., 1987) and sem\-in vitro systems (Beckers et al., 1987) which faithfully
reproduce transport of material from ER to the Golgi complex will no doubt aid in
the characterisation of these vesicles and in the identification of molecules required
for transport.
Transport between adjacent cisternae of the Golgi complex is also thought to be
mediated by budding and fusion of vesicles (for review see Pfeffer and Rothman
1987). Cisternae are rarely seen to come into contact with each other, and therefore
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each individual cisterna represents a subcompartment of the Golgi. The pH, ionic
strength, and substrate concentrations can therefore be regulated and do vary
between the cis and trans sides of the stack. This heterogeneity and high degree of
compartmentalisation is also reflected in the wide variety of functions performed by
the Golgi complex, including: N-linked terminal glycosylation (for review see
Kornfeld and Kornfeld 1985); O-linked glycosylation (for review see Kornfeld and
Kornfeld 1985); sulphation (Huttner 1988); phosphorylation of lysosomal enzymes
(von Figura and Hasilik 1986); and proteolytic processing of prohormones (for
review see Thomas et al., 1988).
The processing of core oligosaccharide chains added to the polypeptide in the ER is one
of the main pieces of evidence for the functional compartmentalisation of the Golgi.
Briefly, the high mannose precursor chains are usually trimmed by mannosidases
and further modified by a series of glycosyltransferases. Five outer mannose
residues are removed and a triantennary structure (composed of GlcNAc, galactose,
and sialic acid) is constructed on the remaining core. Membrane fractionation studies
indicate that the various stages of the carbohydrate processing pathway is localised to
specific regions within the Golgi (see fig. 1.2), which provides a spatial and
temporal mechanism for control of the sequential maturation of the newly
synthesised glycoproteins.
Maturation of oligosaccharide side chains has been used as a biochemical marker of
transport through the Golgi during the development of an in vitro system (Fries and
Rothman 1980). In this system the G glycoprotein of vesicular stomatitis virus
(VSV) has been used as a model protein to follow transport (Balch et al., 1984a,b).
Donor membranes were prepared from a VSV-infected Chinese hamster ovary (CHO)
cell line that is deficient in N-acetylglucosamine transferase I activity, and is
therefore incapable of adding N-acetylglucosamine to the oligosaccharide chain (see
fig.1.2). The membranes were mixed with acceptor membranes prepared from
uninfected wild type cells in the presence of ATP, an ATP-generating system,
11
cytosolic proteins, and UDP-[3H]GlcNAc. Under these conditions radiolabeled
GlcNAc was incorporated into G glycoprotein from the donor membranes by the
enzyme located in the acceptor membranes. This is taken to represent transport of G
protein from the donor Golgi to the acceptor Golgi. This transport system has also
been reproduced in vivo : a VSV-infected CHO cell that was competent for the addition
of GlcNAc but not galactose to the oligosaccharide chain was fused with a second cell
that was deficient in the addition of GlcNAc but was able to add galactose. Following
cell fusion VSV G glycoprotein became correctly glycosylated (Rothman et al.,
1984a,b).
Reconstitution of inter-cisternal protein transport will ultimately allow the
identification of molecules that facilitate the process. Balch and Rothman (1985)
have reported that pretreatment with N-ethylmaleimide (NEM) of "donor" and
"acceptor" membranes in their in vitro system completely abolishes the transport
reaction, suggesting a requirement for an N-ethylmaleimide sensitive factor (NSF)
during secretion. Inhibition of transport does not occur however, if only "donor" or
"acceptor" membranes are pretreated; and moreover, transport can be restored if
donor membranes from uninfected cells (ie lacking G protein) are added to the
reaction. Taken together, this implies that NSF is periphally bound to membrane,
but can dissociate from this membrane under the conditions of the transport reaction
and replace endogenous NSF that has been inactivated with NEM. Subsequent
investigations have revealed that NSF has an approximate molecular weight of 100K
and is inactivated by boiling or trypsin treatment - consistent with it being
proteinaceous (Glick and Rothman 1987).
Much evidence suggests the Golgi to be the point within the secretory pathway where
different classes of protein are sorted in preparation for delivery to alternative
locations within the cell (for review see Farquhar 1985). The oligosaccharide
moieties on all the different types of protein are terminally modified, which must
mean that sorting occurs either in a trans Golgi cisternae or following exit from the
12
organelle. Griffiths and Simons (1986) propose the existence of a specialised
organelle on the trans side of the Golgi termed the "trans Golgi network" (TGN, see
fig.1.1), previously referred to as GERL, trans tubular network, and trans Golgi
reticulum, in which this segregation occurs. This hypothesis is based upon the
observation that, at 20°C, transport of newly synthesised viral glycoproteins from
the ER to the cell surface is blocked (Matlin and Simons 1983, Saraste and
Kuismanen 1984). Examination of accumulated material revealed that it was
terminally glycosylated (Fuller et at., 1985), and that it co-localised with an
enzyme marker specific for the TGN (acid phosphatase, Griffiths et at., 1985).
1.1.4 Transport of proteins to the cell surface and their release bv
exocytosis.
The contents of vesicles are released from the cell by an exocytotic mechanism.
However, Tartakoff and Vassali (1978) have shown that cells possess either a
constitutive and/or a regulated mode of vesicle release, and have thus defined cells in
a similiar manner. Regulated secretory cells are specialised to release, over a short
period of time, large amounts of protein at a much higher rate than the synthetic
rate. This is brought about by the storage of newly synthesised material in secretory
vesicles that, in the absence of stimulation, have a half life of several days, and
therefore become concentrated within the cytoplasm. Cells of the endocrine system
are known to concentrate secreted proteins by as much as 200-fold during their
passage from the trans Golgi to the mature vesicle (Salpeter and Farquhar 1981).
Fusion of these vesicles with the plasma membrane, and subsequent release of their
contents is determined by changes in the concentration of an intracellular message,
which is usually calcium. At present several investigations are directed at
determining the mechanism by which this occurs (see 1.1.5). In contrast,
constitutive secretory cells do not concentrate newly synthesised molecules - there
is no post Golgi storage pool and the transport vesicles move rapidly from the Golgi to
the plasma membrane, where fusion occurs constitutively.
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Direct evidence for the existence of two types of secretion within the same cell has
been obtained through studies of the endocrine cell line AtT-20. These cells
naturally secrete adrenocorticotrophic hormone (ACTH), but this particular cell
line also possesses an endogenous Murine leukaemia virus and therefore synthesises
a viral coat protein (gp70) which is transported to the plasma membrane prior to
viral budding. Gumbiner and Kelly (1982) have shown that secretory vesicles
which contain newly synthesised ACTH do not contain any newly synthesised gp70 and
vice-versa; and also found that only ACTH was stored within mature secretory
granules and subsequently released on exposure to an external stimulus. In the
absence of stimulation however, approximately 10% of the ACTH precursor
(proopromelanocortin, POMC) was "leaked" from cells with kinetics
indistinguishable from those of gp70. From these observations it was hypothesised
that POMC is stored in secretory vesicles in the regulated pathway, processed
proteolytically to mature ACTH and released only upon stimulation. In the
constitutive pathway POMC could be externalised in the absence of stimulation by the
same route that carries gp70 membrane protein.
Differences also exist between cells as to the sites chosen for exocytosis; cells can be
catagorised as being either polarised or non-polarised depending upon the
distribution of exocytotic events over the cell surface (for review see Kelly 1985).
Fibroblasts are excellent examples of non-polarised secretors, with secretion of
components of the extracellular matrix occuring anywhere over the entire cell
surface. In contrast, endocrine and exocrine cells are examples of polarised
secretory cells, localising the release of their products to a specialised domain of the
plasma membrane. A secretory cell can therefore be either regulated or constitutive,
and polarised or non-polarised.
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1.1.5 The chromaffin cell: an example of regulated secretion.
One of the best studied regulated secretory systems is the chromaffin cell of the
adrenal gland - a compound endocrine gland consisting of an inner medulla
surrounded by an outer cortex. Chromaffin cells are restricted to the medulla
region, and are specialised to secrete, upon stimulation, copious amounts of
catecholamines (adrenaline and noradrenaline), nucleotides, and soluble proteins, all
of which are packaged into secretory granules (referred to as chromaffin granules in
chromaffin cells; for review see Burgoyne 1984, Winkler et at., 1986)
Stimulation of the adrenal medulla is by the splanchic nerve of the sympathetic
nervous system, via release of acetylcholine over chromaffin cells (Elliot 1913,
Feldburg 1934). It is believed however, that acetylcholine initiates a chain of
events leading to a rise in intracellular calcium levels, which forms the signal for
secretion (Douglas et at., 1967).
Calcium may exert its effects through the ubiquitous calcium receptor protein,
calmodulin (Cheung 1980), since antagonists of calmodulin (e.g the phenothiazines,
Levine and Weiss 1977) or anti-calmodulin antibodies (Trifaro and Kenigsburg
1983) both perturb secretion of catecholamines from chromaffin cells (Wada et at.,
1983, Trifaro and Kenigsburg 1983). In fact, chromaffin granule membranes
possess binding sites for calmodulin (Burgoyne and Geisow 1981), which can be
classified as either calcium independent or dependent (Geisow et at., 1982):
calmodulin binds to polypeptides of molecular weight 22K and 25K in the presence of
EGTA (a chelator of calcium) and to polypeptides of molecular weight 50K and 69K in
the presence of 1mM calcium; consistent with an increase in the binding of
calmodulin to calcium dependent sites following calcium influx in stimulated cells
(Phillips 1974, Geisow and Burgoyne 1983) .
In addition to calmodulin, several more cytosolic proteins are recruited by the
chromaffin granule during calcium stimulation (Geisow and Burgoyne 1982, Creutz
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et al., 1983). Geisow and Burgoyne (1982) mixed purified chromaffin granules
with an adrenal medulla extract, in the presence of micromolar calcium, and
observed that proteins of molecular weight 33-37K and 70-77K became bound to
granules. Binding of these proteins was reversible since they were removed by
washing in EGTA buffer. Alternatively, Creutz et al., (1983) immobilised
chromaffin granule membranes onto a chromatography column, and then passed a
cytosolic fraction through this column in the presence of 2mM calcium. Bound
proteins were subsequently eluted from the column by step-wise washing in
solutions of decreasing calcium concentration. In total, twenty two "chromobindins"
were isolated by this method and can be classified, as shown in table 1.1, depending
upon whether: interaction is via phospholipid as opposed to an integral membrane
protein; whether recruitment to the membrane is ATP dependent; or whether they
can be found in tissues other than the adrenal medulla. These results should be
treated with caution however, since during stimulated secretion the concentration of
calcium rises from a resting state of approximately 0.1 pM to micromolar levels
only (Baker and Knight 1978, Knight and Baker 1982), and therefore the
significance of proteins which only bind to chromaffin granule membranes at calcium
concentrations no lower than 40|iM is uncertain.
Several of the proteins listed in table 1.1 have been further characterised. Space
does not permit discussion of each individual one, although specific examples will be
mentioned below. Three of the chromobindins: chromobindin XV (alternatively p70
or synhibin), chromobindin VIII (alternatively p36 or calpactin I), and
chromobindin IV (alternatively p32.5 or endonexin) have all been demonstrated to
cross react with antiserum to calelectrin (Geisow et al., 1986). Calelectrin is a
calcium binding protein, of molecular weight 34K, that was isolated from the
electroplax tissue of the ray Torpedo marmorata (a tissue very rich in cholinergic
synaptic membranes; Sudhof at al., 1984, Geisow et al., 1984). Geisow et al.,
(1986) cleaved calelectrin and chromobindins VIII and IV with either trypsin or
cyanogen bromide, purified the resulting peptide fragments, and sequenced those that
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Table 1.1 Characteristics of the chromaffin granule binding
proteins.
Protein Mol wt Isoelectric Ca2+a ATP5 Lipid0 Livi
point
Chromobindin I 19K 0.1 _ _ +
Chromobindin II 26K 5.7 40 - - +
Chromobindin III 26K 6.8 0.1 - PS, G +/-
Chromobindin IV 34K 5.8 0.1 - G ++
Chromobindin V 34K 5.2 40 - PS, G +
Chromobindin VI 35K 6.7 40 - PS, G +
Chromobindin VII 36K 5.1 40 - PS, G +/-
Chromobindin VIII 37K 7.9 0.1 - G +
Chromobindin IX 38K 6.9 40 - PS, G +
Chromobindin X 46K 5.6 40 - PS, G +
Chromobindin XI 47K 7.0 0.1 - PS, G +
Chromobindin XII 53K 6.8 40 + - +
Chromobindin XIII 55K 7.8 40 + - +
Chromobindin XIV 56K 5.9 40 + - +
Chromobindin XV 56.5K 6.2 40 + - +
Chromobindin XVI 57K 7.0 40 + - +
Chromobindin XVII 57.5K 5.7 0.1 - PS, G +
Chromobindin XVIII 58K 6.0 40 + - +
Chromobindin XIX 59K 7.0 40 + - +
Chromobindin XX 67K 6.1 0.1 - PS, G ++
Chromobindin XXI 66K 5.6 40 - PS, G +
Chromobindin XXII 0.1 - PS, G -
This table shows some characteristics of the twenty three chromobindins described
by Creutz et at., (1988). See text for details.
a. Calcium concentration at which the majority of each species elutes
from the affinity column. 40,40pM; 0.1, 0.1pM.
b. Dependence on ATP for binding. +, ATP required. ATP not required.
c. Ability to bind to liposome column. no binding; PS, binding to
phosphatidylserine; G, binding to granule lipids.
d. Indicates whether the protein was obtained from liver cytosol. +,
comparable yield to that from the medulla; ++, particulary abundant in
fractions obtained from the liver; +/- obtained in reduced yield relative
to medullary fractions.
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reacted with anti-calectrin antibodies. All fragments contained a consensus sequence
of seventeen residues, that occurs at least twice in each protein. The functional
significance of this repeat sequence is unknown at present, although since all the
proteins bind calcium but do not possess sequences previously correlated with
calcium binding (the EF hand, Kretsinger 1980) it is tempting to speculate that it
represents an alternative calcium binding domain. The discovery of this
immunological relationship has led to this class of proteins being given the generic
name "annexins" (for review see Geisow et al., 1987). Other functional
characteristics assigned to proteins in this group include the potential to bind
calcium independent of membrane, and their ability to promote aggregation of
chromaffin granules in the presence of calcium. The ability of annexins to bind
membrane is not influenced by pretreatment of membranes with trypsin, indicating
that the interaction may be with phospholipid (Geisow et at., 1987).
During stimulation, chromaffin granules move from intracellular sites to the plasma
membrane. This movememt could be diffusion but the rapidity of secretion has led to
the speculation that granules associate with the cytoskeletal system that, by analogy
to recent findings concerning the movement of vesicles during fast axonal transport,
is capable of generating motive force (for review see Vale 1987). In support of this
hypothesis, actin has been found in association with chromaffin granule membranes,
and may function as assembly sites for actin microfilaments (Burridge and Phillips
1975, Fowler and Pollard 1982, Wilkins and Lin 1981). The physiological
significance of this is uncertain however, since this is maximal at 0.1|iM calcium
and is inhibited at the higher calcium concentrations experienced during secretion.
Also, pretreatment of chromaffin cells with cytocholasin B, which promotes
dissassembly of actin filaments (Schneider et al., 1981, Knight and Baker 1982),
has only marginal effects on secretion; whereas a stabiliser of actin filaments,
phalloidin, inhibits secretion (Lelkes et al., 1986). These characteristics are
consistent with a model in which calcium influx causes generalised breakdown of
actin filaments and subsequent release of granules from the actin network; in this
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view the cytoskeleton prevents exocytosis. In support of this, secretion is inhibited
when antibodies directed against fodrin are introduced into permeabilised chromaffin
cells (Perrin et at., 1987). Fodrin, the non-erythrocyte counterpart of spectrin, is
found in the cytoplasm of all cells, but is usually localised to the under surface of the
plasma membrane, and membranes of secretory granules. Two previous
investigations assist in the interpretation of this result: Perrin and Aunis (1985)
reported that fodrin can bind to actin filaments, and proposed one of its functions to
be anchoring filaments to the plasma membrane; and Siman et at., (1985)
demonstrated that fodrin is highly susceptible to cleavage by a calcium activated
protease, which can be prevented by incubation of chromaffin cell membranes with
anti-fodrin antiserum. Thus one process that may occur during stimulation of
chromaffin cells is calcium activated proteolysis of fodrin, ultimately leading to
breakdown of the peripheral cytoskeletal network, allowing granules access to
exocytotic sites.
In relation to this, one of the proteins of molecular weight 70K observed to bind to
chromaffin granules in the presence of calcium (see above) has been identified by
immunological criteria to be caldesmon (Geisow and Burgoyne 1982, Burgoyne et
at., 1986) . This protein was originally identified in chicken smooth muscle as a
calmodulin regulated actin binding protein, but has since been found in a range of
tissues and cell types. In similiar fashion to fodrin, caldesmon is localised to the
periphery of the cell and has been implicated in the control of actin assembly. In the
absence of calcium, caldesmon stimulates assembly of actin and cross-linking of
actin filaments; both of these characteristics are inhibited by levels of calcium
similiar to those observed during secretion.
Two new concepts have emerged from investigations of the chromaffin cell: in the
absence of stimulation, secretory granules are prevented from interacting with
exocytotic sites on the plasma membrane, by a peripheral meshwork of the
cytoskeleton; and that secretory granules in unstimulated cells may not possess all
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the vital functions required for membrane fusion - these proteins are assembled onto
the granule during stimulation. Further investigation is required to ascertain if
these mechanisms are specific to the chromaffin cell, or regulated secretory cells in
general; but since several of the proteins described above have been identified in
numerous cell types, this system could be present in all cells that have regulated
secretory pathways.
1.1.6 The sorting problem-
The vast assortment of proteins that are present within the lumen and membrane of
the ER present the cell with a fundamental problem. In order to maintain the
integrity of the secretory pathway the cell must possess an efficient mechanism by
which it can recognise different classes of protein, and successfully segregate them to
their intended intracellular location.
Figure 1.3 represents the model proposed by Pfeffer and Rothman (1987) to explain
how the cell accomplishes this task. Transport between organelles is mediated by
budding and fusion of vesicles, and is unidirectional and energy dependent. Proteins
which are to establish an intracellular location within the pathway, ie luminal and
membrane proteins of the ER, Golgi, lysosomes, and secretory granules must possess
a targetting signal which is recognised by the cell and used to restrict their
distribution. Further proteins which do not possess a targetting signal will
successfully traverse the secretory pathway, eventually being released by
constitutive exocytosis.
An alternative model has been presented by Lodish and coworkers (1983). This
hypothesis was formulated in response to their observation that different proteins
are secreted at different rates: in hepatoma (HepG2) cells at 32°C the half time for
release of albumin and a 1-antitrypsin is 45 min, C3 complement and
ai-antichymotrypsin 85-90 min, and transferrin 140 min. Further investigation
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revealed that the rate-limiting step in the secretion of these proteins was their
release from the ER. The authors proposed the existence of specific receptors within
the ER to which secretory proteins must bind prior to transport to the Golgi. In this
view proteins which have a high affinity for such receptors would bind rapidly and
spend only a short time in the ER (e.g albumin and a1-antitrypsin), whereas slow
moving proteins such as transferrin would have low affinity and would move out of
the ER only at the speed of bulk flow.
Wieland et at., (1987) have presented evidence which supports the former model of
"secretion by default". They used the synthetic acyl tripeptide N acyl-Asn-Thr-Thr
(where N is a fatty acid with varying chain length of 2-10 carbon atoms), which is
capable of diffusion across membranes. Following diffusion into the ER however, the
polypeptide becomes glycosylated and can only then be released from the cell via the
secretory pathway. Since the tripeptide is so small it can be assumed to lack any
sorting signal and will therefore be conveyed by bulk flow. The observed kinetics of
release of the glycosylated tripeptide were at least equal to, in many cases more
rapid, than the secretion of any known protein suggesting that bulk flow is
sufficiently rapid to carry secretory proteins to the cell surface. Differences in the
length of time proteins remain within the ER, in this view, is probably attributable
to the time required to attain a suitable conformation prior to movement from the ER
through the secretory pathway (Wieland et al., 1987).
Further evidence in support of the "secretion by default" model has been obtained by
the identification of specific sorting signals on two different classes of protein.
Three resident proteins of the ER lumen - Bip/GRP78, GRP94, and protein
disulphide isomerase (PDI) all have the same tetrapeptide sequence (KDEL) at their
carboxy-terminus. The hypothesis that this represents a true retention signal was
tested by either deleting the tetrapeptide or by adding further amino acids to the
carboxy-terminus of GRP78. Both treatments resulted in the secretion of GRP78
(Munro and Pelham 1987). The tetrapeptide sequence is all that is needed for
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Figure 1.3 Signal mediated retention of proteins in the secretory
pathway.
This model has been proposed by Pfeffer and Rothman (1987). Transport from the
ER to the cell surface is accomplished in a number of stages ( | ) which are signal
independent and represent bulk flow. Alternatively, proteins that are located in
specific compartments of the secretory pathway, or proteins that are diverted to the
lysosome or secretory granules must possess a sorting signal that is recognised by
some mechanism, which operates to restrict the flow of these proteins along the










retention since when this is added to the carboxy-terminus of lysozyme, a secreted
protein under normal conditions, it becomes localised to the ER (Munro and Pelham
1987). Whether the signal acts by anchoring the protein to a second protein in the
ER, or as a signal for recapture following escape to the Golgi is still unknown
although recent evidence supports the latter (Pelham 1988, Cerriotti and Coleman
1988).
One signal which is used to segregate soluble proteins to the lysosome is also known
(for review see von Figura and Hasilik 1986). Upon arrival at the cis Golgi,
lysosomal hydrolases are modified by the combined action of a
GlcNAc-phosphotransferase and a GlcNAc-phosphodiesterase, which have the
combined effect of phosphorylating the sixth carbon position of certain mannose
(M-6-P) residues within the oligosaccharide side chains. This modification serves
as an address signal and is recognised by one of two M-6-P receptors of molecular
weight 215K and 46K. Conclusive evidence of where the hydrolase-receptor complex
is formed within the Golgi is still lacking.
1.2 ENPQCYTQSIS IN THE EUKARYQTIC CELL-
As described above, it is generally accepted that movement of proteins between
different compartments of the secretory apparatus is mediated by budding and fusion
of vesicles. Major insights into the mechanisms of intracellular vesicle movement
have been gained from investigations of endocytosis.
Endocytosis is almost certainly ubiquitous amongst eukaryotic cells. In general, the
process is one by which cells ingest extracellular materials by trapping them within
inward foldings of the plasma membrane which subsequently pinch off to form
intracellular vesicles. Two types of endocytosis have been described, namely: fluid
phase endocytosis, which involves material in the fluid phase becoming trapped in
the invagination during internalisation; and receptor-mediated endocytosis, during
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which there is an association of the intended ligand with a specific receptor on the
plasma membrane (for reviews see Goldstein et at., 1979, 1985). Both of these
routes are thought to be involved in several processes. Endocytosis provides a
mechanism by which animal cells obtain many micronutrients including iron,
cholesterol, and vitamin B12 (Hemmaplardh and Morgan 1976, Newmark et a/.,
1970, Anderson et at., 1977). It also provides a route into the cell for many
hormones, which enter the cell in hormone-receptor complexes (Goldstein et at.,
1976). In the context of this thesis, endocytosis performs a more relevant role in
what is loosely termed "membrane conservation". Many cells secrete high levels of
proteins by fusion of secretory vesicles with the plasma membrane, yet the cells are
not observed to increase in size. Therefore the cell must possess a mechanism by
which an amount of membrane can be recaptured which is equivalent to that supplied
during secretion. Endocytosis is thought to fulfill this function. In addition to these
vital roles, the endocytic pathway is subverted and used as a method of entry into the
cell for certain viruses (e.g influenza virus, Helenius et at., 1980) and toxins (e.g
diphtheria, Draper and Simon 1980).
Our understanding of the mechanism of endocytosis has largely been acquired through
studies, in mammalian systems, of the internalisation of individual proteins,
including epidermal growth factor (EGF), asialoglycoproteins (ASGP), and
transferrin; and small particles, e.g low density lipoprotein (LDL) - all of which
are taken up via a receptor-mediated pathway. The first event which must occur
during receptor-mediated endocytosis is the formation of a receptor-ligand complex
at the cell surface, after which such complexes become concentrated in specialised
regions of the plasma membrane termed coated pits (for review see Bretscher and
Pearse 1984). For the majority of ligands, e.g LDL (Anderson et at., 1982, Basu et
at., 1981), transferrin (Hopkins and Towbridge 1983, Hopkins 1985), a-2
macroglobulin (Hopkins 1982, Via et at., 1982), ASGP (Wall et at., 1980, Berg et
at., 1983), and insulin (Krupp and Lane 1982), the receptors are randomly
distributed over the cell surface but are able to spontaneously move into coated pits
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an enter cells continuously. In the case of EGF however, its receptors are randomly
distributed over the cell surface but they are unable to enter coated pits unless they
are in complex with ligand (Schlessinger 1980, Dunn and Hubbard 1984). Certain
gross features are common to the various receptors known to enter coated pits. Each
receptor comprises a large extracellular portion containing the ligand binding site, a
single helix spanning the membrane and a relatively small cytoplasmic portion. A
recent experiment demonstrates that the cytoplasmic tail may be of fundamental
importance during internalisation of the protein (Roth et al., 1986). The study
investigated the properties of two viral glycoproteins: the G glycoprotein of VSV
which cycles from the plasma membrane, and the haemagglutinin (HA) of influenza
virus which does not. Using genetic engineering the transmembrane and cytoplasmic
tail domains of HA were replaced with those of G protein. The resulting hybrid
protein was able to enter coated pits on the endocytic pathway. Despite the
significance of this result however, no common feature amongst the cytoplasmic tails
of different proteins has been recognised.
Once a full complement of material has been recruited into the coated pit, there is a
membrane fusion event at the neck of the invagination releasing a coated vesicle into
the cytoplasm. Within a very short period of time the vesicles are observed to lose
their coats, a reaction catalysed by a 70K "uncoating ATPase" (Chappell et al.,
1986, for review see Rothman and Schmid 1986). This event exposes the membrane
of the vesicles in preparation for fusion with membrane at its next destination. Naked
vesicles fuse with an organelle termed the endosome. This is almost certainly the
location at which internalised material is sorted prior to delivery to different
compartments within the cell (for review see Hopkins 1983). The endosome has an
acidic internal pH which is maintained by a membrane bound ATPase (Tycko and
Maxfield 1982, Golloway et al., 1983). All internalised material becomes exposed to
this acidic enviroment but the subsequent response that is initiated is specific to the
receptor-ligand complex (for review see Goldstein et al., 1985 and references
therein). In the cases of LDL and ASGP the ligands dissociate from their receptors
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and are ultimately delivered to the lysosomes, whilst the receptor molecules are
recycled to the cell surface to participate in further rounds of endocytosis.
Alternatively, both the ligand and receptor may be recycled back to the cell surface
thereby conserving both molecules - transferrin and its receptor follow such a
pathway. Where it is necessary for the cell to degrade both the ligand and receptor
both molecules are delivered to the lysosome: EGF is an excellent example of this.
Several biochemical investigations have produced results which indicate that the
secretory and endocytic pathways can pass through common organelles, and are
therefore interconnected. Snider and Rogers (1985) observed that a fraction of
internalised transferrin receptor (TfR) molecules cycle through the Golgi complex
prior to being re-exported to the cell surface. Using the enzyme neuraminidase, at
0°C, the workers were able to remove all sialic acid residues from exposed TfR
molecules on the cell surface; on return to 37°C in the presence of fresh growth
medium resialylated TfR was observed on the cell surface after 30min. This must
mean that some internalised TfR passed through the trans Golgi cisternae in which
sialyltransferase is located; in fact, further observations suggest that TfR can be
recycled as far as cis and medial cisternae (Snider and Rogers 1986, Woods et al„
1986). The physiological significance of this route remains to be determined,
although it has been suggested that molecules which pass down this pathway are in
need of repair (Farquhar 1981). In principal any biosynthetic event that normally
occurs in the Golgi complex including O-linked glycosylation, late stages of N-linked
glycosylation, sulphation, and proteolytic processing could occur in transit during
recycling as well as during the initial biosynthetic transport of newly synthesised
proteins through the Golgi.
1.2.1 Structure and composition of coated vesicles.
Coated vesicles were originally isolated from pig brain (Pearse 1975, and for
reviews see Pearse 1987, Pearse and Crowther 1987), but have since been isolated
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from numerous mammalian tissues (Pearse 1976), plant tissues (see Pearse and
Crowther 1987), and yeast (Mueller and Branton 1984). Examination of purified
material by SDS-PAGE reveals that their composition is very similiar, with the
major constituent invariably being a polypeptide of approximately molecular weight
180K, termed clathrin (Pearse 1976); but several additional species of molecular
weights 100-120K, 50-55K, and 32-36K are also present. Clathrin is a
non-glycosylated polypeptide which can account for up to 70% of the protein in a
vesicle coat, and is thought to play a fundamental role in the formation of coated pits
and vesicles. From its sensitivity to proteases and response to other mild treatments
(e.g high pH washing) it is known to reside on the cytoplasmic face of vesicles (see
Pearse 1987). When clathrin is dissociated from vesicles by mild treatment it is
more often than not found in a characteristic "triskelion" (Ungewickell and Branton
1981). Each leg of the triskelion is approximately 45nm long and is comprised of a
molecule of clathrin in association with a protein of approximate molecular weight
35K; because of this association the 180K molecular weight protein is called the
clathrin heavy chain and the 35K molecular weight protein the clathrin light chain.
Coated vesicles are heterogeneous in size, ranging from 50nm-150nm diameter, but
are remarkably similiar in shape. The vesicles have a surface lattice of hexagons
and pentagons, most are built from 12 pentagons in combination with a variable
number of hexagons, which determines the size of the vesicle (Heuser 1980, Nermut
1982). Depending upon the conditions of extraction, clathrin triskelions will
spontaneously assemble to form clathrin "cages", which resemble the polyhedral
structure of coated vesicles seen in vivo (Ungewickell and Branton 1982). This in
vitro reaction, and the association of ciathrin with developing coated pits in vivo, is
promoted by a family of proteins, of approximate molecular weight 100-11 OK,
which are also found in the coat of vesicles (Zaremba and Keen 1983, 1985).
Vesicle coats from bovine brain contain six proteins in this family which are usually
present in a ratio of approximately one 100K polypeptide per clathrin trimer.
Pearse (1985) observed that a receptor protein normally included in coated pits
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associated the 100-110Kd accessory proteins in vitro to produce small spherical
structures of diameter 30-1 OOnm, with an apparent stoichiometry of
approximately one receptor molecule per 100K polypeptide. When clathrin was
included in the assembly mixture these cores became encapsulated in clathrin cages.
These experiments provide a clue about the mechanism of coated pit and vesicle
formation: the 100-11 OK molecular weight proteins are thought to interact with the
membrane of the coated pit, perhaps by recognising the cytoplasmic tails of receptor
proteins, which in turn promotes crystallisation of clathrin on the membrane to
drive development of the vesicle. As there is a variety of 100-11 OK molecular
weight polypeptides the possibilty exists that the different molecules tend to occur on
different membranes in cells and that individual ones bind to specific groups of
membrane proteins in their respective membranes (Pearse 1985).
The cytoskeleton has been proposed to mediate intracellular movement of coated
vesicles throughout the cell (Lacy and Malaisse 1973, Reaven and Reaven 1980).
This is based upon morphological findings which suggest an association between
coated structures, microtubules, and actin filaments. In support of this hypothesis
two vesicle coat proteins of molecular weight 54K and 56K have been identified as
a-tubulin and 3-tubulin respectively by immunological criteria (Pfeffer et at.,
1983, Kelly et al., 1983). Association of coated membrane with cytoskeletal fibres
could also facilitate the formation of coated vesicles since contraction of such fibres
would effectively pull the coated membrane into the cytoplasm, thereby aiding
development of the coated pit.
1.2.2 Coated pits and vesicles in secretion.
Rothman and Fine (1980) presented evidence to support the existence of clathrin
coated vesicles which convey newly synthesised proteins from the ER to the Golgi, and
from the Golgi to the plasma membrane. Recent investigations however, have refuted
these observations; but moreover, indicate that clathrin does not play an important
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role in the movement of membrane during secretion. Morphological examination of
secretory cells reveal that secretory vesicles, coated with clathrin, can only be
detected budding from the trans Golgi network (Griffiths et al., 1985, Orci et al.,
1985). It is this compartment that holds centre stage in the sorting of proteins to
their alternative locations within the cell (Griffiths and Simons 1986). It has been
difficult to prove however, if these vesicles are delivering material to the organelle
from a different compartment, or if they are true carriers of biosynthetic material.
Compelling evidence is now available that argues against clathrin coated vesicle
participation in constitutive secretion. Using immunolabelling techniques, Griffiths
et al., (1985) and others (Wehland et al.,1982, Orci et al., 1986) failed to detect
VSV G glycoprotein in clathrin coated vesicles budding from the Golgi. In support of
these morphological studies, introduction of monoclonal antibodies, directed against
the clathrin heavy chain, into cells had no detrimental effect on the constitutive
release of proteins, but did severly inhibit endocytosis (Doxsey et al., 1987)
In an attempt to re-examine the transport of newly synthesised proteins through the
cisternae of the Golgi, Orci et al., (1986) observed a novel class of coated vesicle.
Using the in vitro system of Rothman and colleagues (see section 1.1.3), donor
membranes were seen to support many budding structures and complete vesicles
when incubated with cytosolic proteins in the presence of ATP. Both of these
structures appeared to possess cytoplasmic coats which were distinguishable from
clathrin coats: they did not adopt the characteristic polygonal configuration, and the
coats did not react with antibodies directed against clathrin heavy chain.
Confirmation that these vesicles act as biosynthetic carriers was obtained by
localising VSV G glycoprotein, by immunogold electron microscopy, to within
developing buds and vesicles that had these characteristic coats.
The role of clathrin in regulated secretion is less clear. Mouse AtT-20 cells exhibit
both constitutive and regulated secretion (Gumbiner and Kelly 1981, 1982);
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approximately 80% of the ACTH the cells produce is directed into the regulated
secretory pathway, being stored in secretory granules prior to release. Mature
secretory granules have never been observed to be coated or to obtain a coat during
stimulated secretion. However, newly synthesised ACTH can be detected in clathrin
coated vesicles budding from late Golgi cisternae (Tooze and Tooze 1986). It is
proposed that clathrin coated vesicles are intermediates in the formation of secretory
granules, which shuttle between the TGN and immature secretory granules,
delivering biosynthetic material and removing material that has been incorrectly
sorted to the granule (Tooze and Tooze 1986).
Coated vesicles have been isolated from yeast cells (Mueller and Branton 1984) and
clathrin triskelions purified. Examination of purified triskelions by electron
microscopy revealed that they are essentially identical to their mammalian
counterparts. The identification of clathrin in yeast allows powerful genetic analyses
to be undertaken, and the importance of clathrin during secretion to be determined.
Two groups have raised antibodies against purified clathrin triskelions, and used
these to isolate the gene encoding clathrin heavy chain (CHC1) (Payne and Schekman
1985, Lemon and Jones 1987). Both groups chose to test the importance of clathrin
in yeast metabolism by replacing the genomic CHC1 gene with a disrupted deleted
mutant chcl gene. Unfortunately the results obtained are contradictory: Payne and
Schekman (1985) reported that cells harbouring the mutant allele are viable, but
their growth is severly retarded and the cells are full of autophagic vacuoles,
diagnostic of sick cells. Further examination of these cells revealed that invertase is
secreted into the periplasm at rates comparible to wild type cells. In contrast Lemon
and Jones (1987) reported that strains which do not possess a functional CHC1 gene
are incapable of growth, and have argued that viability of the strains studied by
Payne and Schekman (1985) is due to the presence of a suppressor. Further
investigation is clearly required.
31
1.3 ANALYSIS OF THE PROTEIN SECRETION PATHWAY IN
SACCHAROMYCES CEREVISIAE.
Investigations into the secretion pathways of higher eukaryotes have yielded an
immense amount of information about the gross features of secretory organelles, and
the structure and covalent modifications of molecules that are transported through
these cellular organelles. It has been much more difficult however, to define cellular
functions involved in protein transport, and this difficulty has been fundamental in
provoking investigations into the secretory pathway of yeast. Many of the
components required for protein transport can be identified using a genetic approach,
to which S. cerevisiae is particulary amenable. In conjunction with the recent
revolution in yeast recombinant DNA methodology, this makes it an excellent system
in which to study secretion (Struhl 1983).
1.3.1 The isolation and characterisation of non-secretorv (sec)
mutants.
Strains of yeast that are deficient in the secretion of proteins were isolated from
cultures that had been subjected to chemical mutagenesis. Wild type yeast cells were
treated with ethyl methanesulfonate or nitrous acid to induce mutation, and then
tested for the ability to grow at 37°C; those strains that failed to grow were screened
for the ability to secrete acid phosphatase. From this initial mutant hunt only two
strains that are conditionally defective in protein secretion, designated sec1-1 and
sec2-2, were isolated (Novick and Schekman 1979).
Further investigation of the phenotype of sec1-1 mutant cells revealed that at 37°C
secretion of invertase and the incorporation of sulphate permease into the plasma
membrane were also blocked, which correlated with an intracellular accumulation of
these proteins. Much of the accumulated material however, was released from the
cell on the return to the permissive temperature of 24°C, even in the presence of
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cycloheximide, indicating that the sec1-1 mutation is reversible. At the
non-permissive temperature, sec1-1 and sec2-1 mutant cells cease to divide, but
in contrast to mutants of cell division (cdc, Hartwell et al., 1973) they do not
accumulate at a particular stage of the cell cycle. Biosynthesis of protein and
phospholipid continues in sec1-1 mutant cells at 37°C for at least 3 hours, which in
conjunction with the failure to increase net cell surface area leads to an increase in
cell density. Henry et al., (1977) observed a similiar situation during inositol
starvation of an auxotrophic strain, and demonstrated that under these conditions
starved cells could be separated completely from normal cells on a Ludox density
gradient. Using the same techniques Novick et al., (1980) observed that the 5%
increase in cell density of sec1-1 cells at 37°C allowed mutant cells to be separated
completely from a 100-fold larger population of wild type cells. This characteristic
proved invaluable since it provided a more efficient protocol for the isolation of
further sec mutants.
Mutagenised cultures were grown for several generations at 24°C and then
transferred to 37°C for 3 hours. Cells were then sedimented on a Ludox density
gradient, and the densest 1-2% of cells harvested. Mutants that were temperature
sensitive for growth were isolated from this population and screened for the ability
to secrete acid phosphatase and invertase at 24°C and 37°C. Conditional secretion
mutants were isolated at a frequency of 15%, a total of 485 being identified (Novick
et al.,1980). Two distinct classes of secretion mutant were identified amongst these,
dependent upon their characteristics at 37°C: class A sec mutants (187 in total)
showed an intracellular accumulation of active invertase at the non-permissive
temperature; whereas class B sec mutants showed no accumulation of active
invertase, despite protein synthesis proceeding at a high rate at 37°C.
Recent investigation of class B sec mutants has determined that these strains are
incapable of translocating secreted proteins across the membrane of the ER; nascent
polypeptides either accumulate in the cytoplasm or become lodged in the ER
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membrane. Since membrane translocation is not a central theme of this thesis I shall
not present further data on these mutants, but for more information the reader is
directed to Ferro-Novick et al., (1984a,b), Bernstein et al., (1985), Hibs and
Meyer (1988), and Kepes and Schekman (1988).
Using standard genetic techniques the 187 class A sec mutants were arranged into 23
complementation groups (see table 1.2, Novick et al., 1980). A representative
allele from each group was chosen and its phenotype characterised in more detail. All
sec mutations were recessive in heterozygous diploids, and all exhibited phenotypic
traits similiar to sec1-1, ie. at 37°C: a cessation in the secretion of acid phosphatase
and invertase, accompanied by an intracellular accumulation of these enzymes;
failure to incorporate sulphate permease into the plasma membrane; and prevention
of bud emergence, leading to an increase in cellular density; all of which are
thermoreversible.
Thermoreversible accumulation of intracellular acid phosphatase and invertase, and
the reduced incorporation of sulphate permease suggested that the sec mutants might
accumulate an organelle of the secretory apparatus. This hypothesis was confirmed
by EM analysis of thin sections of yeast cells (Novick et al., 1980). Wild type cells
grown at 26°C or 37°C, or sec mutants grown at 25°C displayed occasional
enrichment of vesicles in the bud, or short thin tubules of ER in close proximity to
the inner surface of the plasma membrane. Such cytological aberrations were much
more pronounced in mutant cells grown at 37°C, and indeed the mutants were
grouped in relation to which organelle they accumulated (see fig. 1.2). Novick et al.,
(1980) describe these organelles as being "intermediates in the secretory pathway
whose soluble contents are destined for secretion by exocytosis, and membranes for
incorporation into the plasma membrane by fusion". The most common class, with
10 members, accumulated membrane enclosed vesicles of diameter 80-1 OOnm,
which in contrast to wild type cells are not localised to the bud - these are proposed
to represent secretory vesicles. The second class, with 9 representatives, developed
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a more extensive network of ER than that seen in wild type cells. This was often seen
to line the inner surface of the plasma membrane and wind through the cytoplasm
where multiple connections with the nuclear membrane became visible. A subset of
mutant strains within this group (sed 7, sed 8, and sec23) also produced small
40nm vesicles which were often arranged in patches in the cytoplasm. Finally, the
third class of mutants accumulated an organelle with no obvious counterpart in
higher eukaryotic cells. This structure, termed the Berkeley body (Bb), varies in
form but seems to consist of two curved membranes with an electron transparent
lumen, is thought to represent the Golgi complex, perhaps fragmentated during
incubation at the restrictive temperature (Novick et at., 1980). Surprisingly, this
class of mutants has only 2 representatives (sec7 and sec14)\ if the complexity of
the Golgi in S. cerevisiae is similiar to that in mammalian cells this is a clear
underestimate of the functions required to maintain the integrity of the organelle.
Finally, two mutants could not be placed into the above classes: strains harbouring
mutations in the SEC 19 gene accumulated all three types of organelle at 37°C;
whereas sec11 mutant cells did not accumulate any organelles under restrictive
conditions.
Novick et a!., (1981) suggested that the organelles accumulated in sec mutants at
37°C represent distinct stages in the secretory pathway. They further postulated
that the secretory pathway is linear, and that double sec mutants constructed from
single sec mutants that block at phenotypically distinguishable stages would
accumulate the organelle corresponding to the earliest block. The possibility that the
gene products acted in independent pathways which contributed to the same process
would be indicated by the appearance of both phenotypes. As predicted, double
mutants carrying the sec18-1 mutation (an ER block) with the sec7-1 (Golgi) or
sec1-1 (SV) mutations all exhibited the sec18-1 phenotype at 37°C. Also,
mutations from all ten complementation groups that show accumulation of
80-1 OOnm SV were combined with the sec7-1 mutation, and in each case the mutant
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Table 1.2 The class A sec mutants.












sec11 12 No organelle accumulated
sec12 4 ER
sec13 4 ER
sec14 4 Berkeley bodies
sec15 2 SV
sec16 2 ER
sec17 1 ER, small vesicles
sec18 2 ER, small vesicles
sec19 1 ER, Berkely bodies, and SV
sec21 1 ER
sec22 4 ER, small vesicles
sec23 1 ER
Twenty three complementation groups have been identified by Novick eta/.,
(1980). Some of these groups have many representatives but others have only one;
this distribution suggests that there are other sec A complementation groups that
have not been discovered.
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accumulated Bb's at 37°C. Thus, the ER accumulating phenotype is epistatic to the
Golgi and SV accumulating phenotypes, and a Golgi accumulating mutant is epistatic to
all the vesicles accumulating mutants. This analysis however, could hide the
possibility that some gene products could be required at all stages in the secretory
pathway.
1.3.2. Biochemical investigation of the veast secretory pathway.
The development of a secretion model, derived from genetic studies, has greatly
facilitated biochemical investigations of the secretory pathway in S. cerevisiae.
Prior to the isolation of the sec mutants such studies were problematical due to the
low level of secretory organelles in the cell and the rapid transit time of proteins
through the pathway, e.g invertase takes only 5min or less to undergo complete
maturation and secretion - making the isolation of intracellular precursors
intrinsically difficult (Novick et at., 1981). The sec mutants however, accumulate
organelles of the secretory apparatus and secreted proteins at distinct stages in the
pathway, permitting the detection of intermediates in the biogenesis of certain
proteins, and the correlation between the appearance of these species and passage
through particular subcompartments. In this section I shall review studies of this
nature undertaken on invertase (a secreted periplasmic protein), a-factor (an
exported protein), and carboxypeptidase Y (a vacuolar enzyme); similiar
experiments have also been used to study the biogenesis of killer toxin (an exported
protein, Bussey et at., 1983). Referring to these studies I shall compare
glycoprotein maturation in yeast and mammalian cells, and also emphasize the




Invertase is a secreted enzyme, which remains associated with the cell wall. The
polypeptide is rapidly transported to the cell surface, with a half time of
approximately 5min, during which 9-10 N-linked oligosaccharides are added.
Esmon and colleagues (1981) have monitored maturation of the enzyme in several
sec mutants, and confirmed that N-linked oligosaccharides are assembled onto yeast
glycoproteins in at least two stages.
In yeast, N-linked glycosylation is initiated in similiar fashion to that in mammalian
cells: a core oligosaccharide is transferred from a lipid donor to the asparagine
residue, in the sequence Asn-X-Ser/Thr, during translocation into the lumen of the
ER (for review see Tanner and Lehle 1987). The lipid donor is charged with an
immature oligosaccharide unit on the cytoplasmic face of the ER membrane, and is
then translocated into the lumen of the ER where its assembly is completed (Lehle
1980). Transfer of core units to the polypeptide occurs co-translationally, and as
in mammalian cells, these are trimmed prior to exit from the ER by removal of 1
mannose and 3 glucose residues (Byrd et at., 1982, Esmon et at., 1984). No
extensive modification of core oligosaccharides occurs in yeast. Instead, many core
units are elongated during transit through the Golgi complex, to produce a structure
referred to as the outer chain, consisting of an a1-6 linked polymannose backbone to
which numerous mannoligomers (2-4 mannose residues in length) become attached
by a 1-3 linkages (for review see Ballou 1982).
Analysis of invertase molecules in sec mutants at 37°C confirms that addition of
oligosaccharides to the polypeptide is initiated in the ER, and completed during
passage through the Golgi (Esmon et al., 1981). Invertase accumulated in a sec18-1
(ER) strain contains oligosaccharide chains of the structure Man8GlcNAc2 (Esmon et
al., 1984); addition of outer chains is not detected until invertase molecules reach
the Golgi as defined by the sec7-1 mutant.
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Secretion of the mating Dheromone - alpha factor.
S. cerevisiae can exist as three cell types: haploid cells are either a or a, which can
mate together to form a/a diploids. Both haploid cell types produce mating
pheromones, a-factor and a-factor, which interact with cells of the opposite mating
type and prepare them for mating (for review see Herskowitz 1986).
The mating pheromone a-factor is a tridecapeptide that is encoded by two genes:
MFa1 and MFa2, both of which encode multiple copies of the a-factor peptide, MFa1
has four copies but MFa2 only two, which are initially synthesised as large
precursor polypeptides. Mature a-factor is generated by proteolytic processing of
these polypeptides as they traverse the secretory pathway. MFa1 encodes a
polypeptide precursor of 165 amino acids (prepro-a-factor), of molecular weight
18 580, which has the following features: a pre-region which comprises a 20 amino
acid signal sequence; a 60 amino acid pro-region which contains three consensus
sites for the additon of N-linked oligosaccharide; and a carboxy-terminal region
which encodes four copies of the mature a-factor peptide. The four repeat sequences
are separated by the spacer sequence LysArgGluAlaGluAla (See fig. 1.4, Kurjan and
Herskowitz 1982).
The biogenesis of this precursor, as shown in fig.1.4, was in part determined by
analysis of the protein in sec mutants (Julius et at., 1984a). The polypeptide is
directed into the secretory pathway by the amino-terminal signal sequence, which is
then removed by signal peptidase (Waters et at., 1988). The species of
pro-a-factor accumulated in a sect8-1 mutant (blocked in ER to Golgi transport)
has a molecular weight of approximately 25K. This increase in molecular weight is
consistent with the addition of three core oligosaccharides to the polypeptide, at
consensus sites in the pro-region. Analysis of a factor accumulated in a sec59-1
mutant (a class B sec mutation) under restrictive conditions supports this: the
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Fig 1.4 Biosynthesis of the mating pheromone rx-factor.
This diagram shows post-translational processing of the MFa1 gene product -
prepro-a-factor. This pathway has been elucidated by biochemical and
immunocytochemical identification of processing intermediates and by analysis of
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sec59-1 mutation prevents proteins from crossing the ER membrane, instead
nascent polypeptides become lodged in the membrane during translocation. Regions of
the proteins however, may protrude into the lumen of the ER and be used as
substrates for glycosylation. Four distinct species of pro-a-factor accumulate in
sec59-1 mutants at 37°C which only differ in the number of core oligosaccharides
that have been added to the polypeptide; these are thought to represent pro-a-factor
with either zero, one, two, or three core oligosaccharides.
Proteolytic processing of pro-a-factor is thought to occur during transit through the
Golgi, since no processing was detected in material accumulated by a sec18-1
mutant. The first cleavage of pro-a-factor is thought to be carried out by the Kex2
endoprotease, at the pairs of basic residues in the spacer peptides, to release the four
pheromone repeat units (see fig.1.4). The residual GluAla residues at the
amino-terminus of each peptide are removed by dipeptidylaminopeptidase-A, and the
carboxy-terminus LysArg residues by Kex1 exoprotease. This series of events must
be initiated after pro-a-factor has traversed the position at which SEC7 exerts its
effect, since material accumulated in a sec7-1 mutant at 37°C showed little evidence
of processing; and by similar argument must be completed by the time a-factor is
secreted since mature a-factor accumulates in a sec1-1 mutant under restrictive
conditions.
The three enzymes that are responsible for processing of pro-a-factor, ie. Kex2
endoprotease and, Kexland DPAP-A exoproteases have been identified, biochemically
characterised, and the structural gene for each enzyme isolated (see Bussey 1988
for review). A summary of part of this data is presented in table 1.3 along with key
references to which the reader is referred to for more information. This type of
proteolytic maturation of proteins is a general occurence in eukaryotic cells (for
review see Thomas et at., 1988), but the biosynthesis of a-factor provides the first
example of a eukaryotic protein in which all the biogenic precursors and the enzymes
responsible for processing have been identified.
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Table 1.3 Proteases that participate in the maturation of the mating
pheromone a-factor
PROTEASE ACTIVITY comments references
Kex2 Cleavage at the KEX2 The KEX2 gene has been cloned by
endoprotease C-terminal side complementation of the kex2 mutation.
of paired basic The DNA sequence of the gene predicts
residues (Lys- a polypeptide of 814 residues of approx
Arg). mol. wt. 90K. Hydrophobic residues are
are found at the N-terminus and between
resdiues 675-700, which could function
as a signal sequence and transmembrane
domain respectively. The amino terminal
675 residues of Kex2 protease contains
sequences that show homology to the
subtilisin family of bacterial serine
proteases, are sites for N-linked
and O-linked glycosylation, and
that are required for activation by
Ca2+. The enzyme is thought to be





Kex1 Removal of KEX1 A membrane associated carboxypeptidase
exoprotease Lys-Arg resi- B like activity that cleaves pairs of Lys-
dues from C- Arg residues from synthetic prptides has
terminus of been reported in yeast. The KEX1 gene is
peptides thought to encode this protein since the
released by activity is absent in kexl mutants.The KEX1
Kex2 cleavage gene has been cloned by complementation
of the kexl mutation. The DNA sequence of
the gene predicts a 729 residue protein of
mol. wt. 82K, which shows strong homology
to the serine protease CPY, infact Kexl
protease has a sequence identical to the
CPY active site (GDSYAG). The enzyme is






Dipeptidyl Removal of STE13 ste13 mutants secrete a mixture of non-
amino- Glu-Ala resi- functional, incompleltely processed forms
peptidase-A dues from N- of a factor, all of which possess residual
(DPAP-A) terminus of Glu-Ala residues from the spacer peptide
peptides at their amino terminus; ste13 mutants are
released by therefore incapable of mating (sterile). The
Kex2 cleavage STE13 gene has been cloned by complemen¬
tation of the ste13 mutation. DNA sequencing
predicts a polypeptide of 931 resdiues of
approx 90K. Cell fractionation studies
have shown that DPAPase-A is located in
separate compartment of the secretory
pathway to Kex2 protease, but it is not known
whether this compartment is another cisterna






Biogenesis of the vacuolar hydrolase- carboxvpeptidase Y.
The yeast vacuole contains a number of hydrolytic enzymes, and for this reason is
thought to be equivalent to the lysosome of mammalian cells (for review see Jones
1984). One vacuolar enzyme, the serine protease carboxypeptidase Y (CPY) has
been studied in detail. The gene encoding CPY, PRC1, has been isolated and sequenced
(Stevens et at., 1986, Vails et al., 1987). An open reading frame has been identified
that could encode a protein of 532 residues, with a molecular weight of 58K. By
reference to the known amino acid sequence the amino-terminus of mature CPY
begins at residue 112, indicating that CPY is synthesised as an immature precursor
(proCPY) containing a 111 residue pro-sequence (Martin et al., 1982, Svendson et
al., 1982, Breddam and Svendson 1984). Residues 3-18 of this propeptide are
hydrophobic and are thus thought to act as a signal sequence to direct the protein into
the secretory pathway. Maturation of the protein therefore, involves two proteolytic
cleavages: removal of the amino-terminal signal peptide by signal peptidase,
followed by removal of the pro-sequences to release active CPY. Conversion of
proCPY to CPY occurs in the vacuole and is dependent upon the PEP4 gene product
(proteinase A, Ammerer et al., 1986, Woolford et al., 1986): in pep4 mutants CPY
appears as an inactive protein of molecular weight 69K, of which 10K is N-linked
carbohydrate; whereas in wild type cells the pro-sequence is removed to produce a
protein of molecular weight 61K, of which 10K is also accountable to carbohydrate
(Hasilik and Tanner 1978).
In similar fashion to invertase, CPY also moves rapidly from its site of synthesis to
the vacuole, taking approximately 6 minutes, and thus detailed information about its
biogenesis has only been gained by analysis in sec mutants (Stevens et al., 1982).
Those mutants that accumulate ER at 37°C (e.g sect8-1) also accumulate an
immature form of CPY (pICPY) of molecular weight 67K, of which 8K is N-linked
oligosaccharide, consistent with the addition of core oligosaccharide units at four
positions in the mature protein. From the molecular weight of pICPY, it is not
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possible to resolve whether the amino-terminal signal peptide is cleaved in the ER,
although recent evidence supports this (Blachly-Dyson and Stevens 1987).
The two mutants that accumulate Golgi at 37°C (sec7 and sec14 ), exhibit different
responses to restrictive conditions: sec7-1 mutant cells accumulate pICPY,
identical to that seen in a sec18-1 mutant; whereas a sec14-3 mutant accumulates
two different proteins, pICPY and a second protein of molecular weight 69K
(p2CPY) in equal amounts. The difference in molecular weight of pICPY and p2CPY
is attributable to addition of outer chains to N-linked oligosaccharide during transit
through the Golgi. This clearly suggests that SEC7 and SEC14 gene products exert
their effects at different positions in the Golgi complex. Those sec mutants that
accumulate secretory vesicles (e.g sec1-1) block the pathway sometime after
proteins have traversed the Golgi, and do not prevent maturation of CPY into the
vacuole. In yeast therefore, a direct pathway exists from the Golgi to the vacuole,
similiar to that one described from the Golgi to the lysosome in mammalian cells.
Purification of secretory organelles from sec mutants.
The low abundance of secretory organelles makes their purification from wild type
cells problematical; the sec mutants however, provide an enriched supply of these
organelles thereby facilitating such experiments. Two groups have reported
purification of secretory vesicles from late blocking sec mutants at the
non-permissive temperature: Walworth and Novick (1987) utilised a sec6-4
mutant and Holcomb et al., (1988) a sec1-1 mutant. Examination of purified
vesicles by electron microscopy revealed that purified vesicles were not coated,
either by clathrin or some other protein which is entirely consistent with the
observation that secretion of invertase is not perturbed in chcl mutants (see section
1.1.8, Payne and Schekman 1985).
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Further analysis also demonstrated that plasma membrane proteins, e.g the plasma
membrane Na+/K+ ATPase, and soluble proteins, e.g acid phosphatase, are
transported to the cell surface in the same vesicles (Holcomb et al., 1988, Brada and
Schekman 1988); and also that vesicles accumulated in the two different sec
mutants have similiar polypeptide compositions. Walworth and Novick (1987)
analysed purified vesicles by SDS-PAGE, and observed three predominant protein
bands of approximately molecular weight 110K, 40-45K, and 18K when proteins
were visualised with Coomassie blue. The largest protein was specifically labelled
with [3H] mannose, and found to partition into the aqueous phase of Triton X114,
strongly suggesting it to be a soluble glycoprotein that forms part of the vesicle
cargo. The proteins of molecular weight 40-45K and 18K however, partition into
the detergent phase of Triton X114, and have cytoplasmic domains that are suseptible
to proteases. This is consistent with them being transmembrane proteins, but the
possibility remains that they are attached to the periphery of the vesicle in the same
fashion as Sec4p. Analysis of sec1-1 accumulated vesicles by SDS-PAGE resulted in
a very similiar polypeptide profile, raising the possibity that this pattern is
constant in the vesicles accumulated in any late sec mutant.
Many of the sec mutants are also defective in endocvtosis.
The biochemical evidence reviewed in section 1.2, supports the hypothesis that the
endocytic and secretory pathways pass through common organelles and are therefore
connected. In the text below I describe further genetic evidence, which implies that
several gene products that perform an essential role in secretion are also required
for endocytosis.
Riezman (1985) reported that S. cerevisiae has a functional endocytic pathway. He
used a synthetic dye, lucifer yellow carbohydrazide, that had previously been
exploited as a marker of fluid phase endocytosis in mammalian cells, and
demonstrated that it was internalised by actively growing yeast cells. The
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characteristics of internalisation are indicative of endocytic uptake, as opposed to
diffusion or directed transport across the plasma membrane: the accumulation of
lucifer yellow is temperature and energy dependent, and the amount of material
internalised is directly proportional to the external concentration of lucifer yellow
(ie it is not saturable). Using this as an assay the ability of the sec mutants to
endocytose lucifer yellow was determined (Riezman 1985). All 23 sec mutants
internalised lucifer yellow at the permissive temperature, although several
accumulate less than wild type. At 37°C however, many of the mutants are deficient
in endocytosis: the ten mutants that accumulate SV's are all defective for
accumulation of lucifer yellow in the vacuole; of the two mutants that accumulate
Golgi, sec7 is defective but sec14 is not; and of the nine mutants that accumulate
ER, sec18 and sec23 are also defective in endocytosis.
This is a clear implication of a broad overlap of functions required for movement of
membrane during both endocytosis and secretion, although the two processes are
seperate since mutants (end) that are defective in endocytosis but not secretion have
been isolated (Chvatchko et at., 1986). This could either be due to a simple
requirement for SEC gene products in endocytosis and secretion, or a more
complicated relationship where part of the endocytic pathway is obligatorily coupled
to certain stages in the secretory pathway.
1.3.3. R^sum^
The genetic and biochemical studies described above have led to the proposal of a
model of secretion that is fundamentally no different to that for the secretion of
proteins from mammalian cells (Schekman 1985, fig 1.5), in that it is a sequential
movement from the RER through the Golgi, to secretory vesicles which release their
contents by exocytosis. Entry into the secretory pathway is envisaged to occur by
cotranslational translocation, simiiiar to that previously described. Translocation of
proteins across the ER membrane in yeast is dependent upon an amino terminal
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signal peptide, although as yet no reports have appeared in the literature describing
SRP or SRP receptor. Following entry into the ER, proteins are transported to the
Golgi complex, via hypothetical vesicles.
The Golgi complex represents a branch point within the pathway: vacuolar
proenzymes are segregated and transported to the vacuole, whilst secreted and
exported proteins are packaged into vesicles for transport to the plasma membrane.
The yeast Golgi therefore seems to share many of the responsibilities of the
mammalian Golgi. Despite this central role however, the organelle remains
relatively "unexplored" in yeast: as yet there is no evidence for
compartmentalisation of the organelle into cis, medial, and trans cisternae, or some
other alternative morphology. Ultimately however, yeast must use mechanisms
similiar to those of mammalian cells to transport proteins through the Golgi, since a
yeast cytosolic fraction can substitute for its mammalian counterpart in the in vitro
system of Dunphy and colleagues (1986). Exit from the Golgi complex occurs by a
budding mechanism to yield secretory vesicles, which fuse with the plasma
membrane to release their contents. Histochemical staining of newly synthesised
acid phosphatase and invertase however, reveals that in actively growing yeast cells
secretion is polarised to the region of cell growth: exocytotic events are not randomly
distributed over the cell surface, but are localised to the developing bud (Tkacz and
Lampen 1972, Linnemans et al., 1977, Field and Schekman 1980).
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Fig 1.5 The veast secretory pathway.
Proteins that are secreted by S. cerevisiae are thought to traverse a pathway
similiar to that described for mammalian systems. Proteins enter the pathway by
co-translational translocation across the membrane of the ER, after which they are
carried from the ER to the Golgi and then to the plasma membrane; all transport is
thought to be mediated by vesicular translocation. Temperature sensitive mutations
(sec)have been isolated that block this pathway at a precise location, reflected by an
accumulation of an organelle of the secretory pathway under restrictive conditions.
The position at which the corresponding wild type gene products are thought to
function is shown. See text for further details. CW (cell wall), ER (endoplasmic












1-4 INVESTIGATIONS OF SEC ENCODED GENE PRODUCTS AND OTHER
PROTEINS THOUGHT TO BE INVOLVED IN SECRETION.
The isolation of the sec mutants has provided a foothold in the study of secretion in
yeast. Characterisation of mutant phenotypes, isolation of the corresponding wild
type gene, identification of suppressor mutations, and the development of cell free
systems will allow the functions that the SEC encoded proteins fulfill to be
elucidated. Several groups have decided to follow this pathway of investigation, and
have successfully isolated and characterised a number of SEC genes by
complementation of the corresponding sec mutant. These results are presented in
table 1.4.
1.4.1 The SEC4 gene encodes a GTP binding orotein that is found in
association with secretory vesicles and the plasma membrane.
Analysis of the SEC4 gene deserves special consideration since it has provided new
clues into some of the fundamental mechanisms that may be employed during
secretion. The SEC4 gene was originally isolated in an attempt to clone the SEC15
gene: a genomic library formed in the plasmid YCp50 (maintained at single copy,
Rose et at., 1987) was used to transform a sec 15-1 strain, with selection for
temperature resistant strains. Subsequent genetic analysis however, revealed that
the isolated fragment of genomic DNA did not correspond to the SEC15 locus. This is
most easily explained by an unlinked gene being isolated, whose product fulfills a
function similiar to the SEC 15 gene product, which when duplicated can suppress
the sec15-1 mutation. Further analysis revealed that the DNA fragment carried the
SEC4 gene.
During these studies some level of genetic interaction was also demonstrated between
the SEC4 gene and many other sec mutants (Salminen and Novick 1987).
Representatives of all the sec mutants were transformed with a YCp50 based
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SEC4 encodes a GTP binding protein
of mol wt 23K. Sec4p does not have
an N-terminal signal sequence, or
other internal hydrophobic domains,
but is found in strong association
with secretory vesicles and the





SEC7 Golgi like structure
(Berkeley Bodies)
An ORF of 2008 residues has
been identified by DNA sequencing
which could encode a protein of mol
wt 228K. Immunoprecipitation of
Sec7p identifies a polypeptide of this
size, which is phosphorylated and
distributed in both particulate and




SEC11 None At 37°C seel 1 cells accumulate Bohni ef al 1988
core glycosylated material in the
lumen of the ER; this material has
not been processed by signal peptidase.
The SEC11 gene encodes a protein of
167 residues, of mol wt 18 825, that
is predicted to be an integral membrane
protein. It is proposed that Sec11p is
a component of signal peptidase.
SEC15 Post-Golgi secretory DNA sequencing has identifed an ORF A. Salminen
vesicles sufficient in size to encode a protein of personal communication
approx mol wt 100K, but immunoprecip¬
itation of Sec15p suggests a mol wt of
115K; the reason for this discrepency is
not understood. Sec15p does not have any
hydrophobic sequences to direct it into a
membrane, but the protein is found
associated with the particulate fraction
of the cell. Immunofluorescence expts
show Sec15p distributed over the
peripheryof the cell in a punctate pattern.








The SEC12 gene encodes a polypeptide
of 471 residues, of approx mol wt 70K.
Sec12p is an integral membrane protein
that undergoes N-linked, and probably
O-linked glycosylation. Sub-cellular
fractionation and immunoelectron-
microscopy have localised Sec12p to






DNA sequencing has revealed that the
SEC18 gene encodes an polypeptide of
mol wt 83.9K; but in vitro transcription
and translation of SEC18 leads to the
synthesis of two polypeptides, of mol wt
84K and 82K. These two species are
thought to be the product of translation
initiation at different in-frame ATG
codons. Neither polypeptide has a N-
terminal signal sequence, yet some






The SEC23 gene encodes a protein of
approx mol wt 84K, that is found




Numerous SEC genes have been isolated by complementation of the corresponding
sec mutation, and subsequently analysed; this table summarises some of the results.
All the SEC genes studied so far have been found to encode proteins whose function is
absolutely requied for cell viability. Further details of the SEC4 and SEC15 gene
products are given in the text.
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plasmid, carrying the SEC4 gene, and tested for the ability to grow at 25°C, 33.5°C,
and 37°C. At 37°C duplication of the SEC4 gene was found to suppress the sec2-41
mutation, in addition to sec4-8 and sec15-1 mutations. When growth was tested at
the restrictive temperature of 33.5°C, the sec1-1, sec5-24, sec8-9, sed 0-2,
and sec19-1 mutations were also suppressed to some extent. With the exception of
sec19-1, all of these mutations block fusion of secretory vesicles with plasma
membrane, and thus fall into the same class as sec4-8. As yet it is unknown where
sec19-1 exerts its effects since sec19 mutants accumulate ER, Golgi, and SV's under
restrictive conditions (Novick et a!., 1980). It has also been demonstrated that
combination of the sec4-8 mutation with any of the above mutations, with the
exception of sec1-1, is lethal at the permissive temperature, providing further
evidence of strong genetic interaction between these components (Salminen and
Novick 1987).
The nucleotide sequence of the SEC4 gene has been determined (Salminen and Novick
1987), and predicts a protein of 215 amino acids (Sec4p), of molecular weight
23,479, which has significant similarity to all ras transforming proteins.
Similarity was strongest in the regions of the ras proteins that have been implicated
in GTP binding and hydrolysis, and indeed Sec4p possesses the three sequence motifs
that have been correlated with GTP binding function (McCormick et at., 1985,
Jurnak 1985). Using a TrpE-Sec4p fusion protein as an immunogen, antibodies
have been raised that specifically recognised a protein of molecular weight 23.5K in
a crude mixture of yeast proteins (Goud et al., 1988). It was possible to radiolabel
this protein with [32P]-GTP confirming its ability to bind GTP. Subcellular
fractionation experiments revealed that Sec4p exists in both the soluble and
particulate fractions of the cell - approximately 85% Sec4p sedimented with
membranes. In wild type cells 10-20% of the membrane bound Sec4p was found
associated with secretory vesicles, whilst the remaining Sec4p purified with plasma
membrane; when this distribution was analysed in sec6-4 (SV) mutant cells at
37°C the amount of Sec4p associated with secretory vesicles increased to 50%. Goud
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et al., (1988) propose that Sec4p initially associates with secretory vesicles and is
then transferred to plasma membrane as a result of exocytotic events.
Membrane associated Sec4p exhibits characteristics typical of integral membrane
proteins: Sec4p can not be washed off membranes by exposure to high pH, and in
partitioning experiments using the detergent Triton X114 the protein partitions into
the detergent phase (Bordier 1982, Goud et al., 1988). This is surprising since the
polypeptide does not possess an amino-terminal signal peptide, or internal
hydrophobic domains, that could direct translocation into a membrane. The protein
must therefore undergo some post translational modification or conformational
change in order to become attached to a membrane. In mammalian systems it is
thought that fatty acid acylation may mediate attachment of some proteins to
membrane (Magee and Schlessinger 1982), e.g for ras proteins, a palmitate moiety
is added in a thioester linkage to a cysteine located in the sequence Cys-A-A-X, where
A is any aliphatic amino acid and X the carboxy-terminus (Sefton et al., 1982, Buss
and Sefton 1986); Sec4p does not share this sequence but it does have the unusual
C-terminal sequence of SerAsnCysCys. Another yeast protein that may be involved in
secretion, Yptlp (see below) also has two cysteine residues at its carboxy-terminus
(GlyGlyCysCys); in this case the two cysteine residues are essential for function,
and mediate palmityolation of the protein, allowing its association with membrane
(Molenaar et al., 1988). It is tempting to speculate that Sec4p is attached to
membrane in similiar fashion, although attempts to radiolabel Sec4p with [3H]
palmitate however, have proven unsuccessful (Goud et al., 1988).
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1.4.2 The YPT1 gene is a ras homolooue and encodes a protein that mav
be invovled in secretion.
The protein that Sec4p resembles most closely is another yeast ras homologue -
Yptlp, product of the YPT1 gene. Yptlp is 206 amino acids in length and has 48%
identity to Sec4p. This high level of similarity is maintained throughout the protein,
including those regions responsible for binding of GTP. This homology is made even
more intriguing by recent reports that Yptlp may also perform an important
function during secretion. The YPT1 gene was originally identified as an open reading
frame located between the structural genes encoding actin (ACT1) and tubulin
(TUB2) on chromosome VI (Gallwitz et a!., 1983). The ORF is 618bp long,
sufficient to encode a polypeptide of 206 amino acids with a molecular weight of 23
213. As yet no function can be assigned to this protein, but as with Sec4p, Yptlp
bears significant resemblance to mammalian and viral ras proteins: over a region of
168 residues Yptlp shows 38% homology with the 189 residues of the human c-ras
gene products, suggesting that these proteins have similiar secondary and tertiary
structure, and perhaps function (Gallwitz et at., 1983). Consistent with Yptlp
being a ras protein the protein can bind and hydrolyse GTP (Wagner et at., 1987).
In an attempt to elucidate the function of Yptlp, two groups have undertaken genetic
analyses of the YPT1 gene (Schmitt et at., 1986, Segev and Botstein 1987). Both
groups confirm that theYPT1 gene is essential for cell viability since a ypt1 null
mutation is lethal. To further investigate the function of Yptlp, both groups chose to
examine the effects of depriving growing cells of functional Yptlp. To achieve this
Schmitt et at., (1986) replaced the chromosomal YPT1 gene with a YPT1 gene that
had been placed under the control of the GAL10 promoter, allowing high levels of
YPT1 expression by growth of yeast cells in media containing galactose as the sole
carbon source; or expression can be completely repressed by using glucose as a
carbon source. Alternatively, Segev and Botstein (1987) used site directed
mutagenesis to construct a cold sensitive mutant allele of YPT1, which was
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transplaced onto the chromosome in place of the wild type YPT1 gene. The ypt1-1
mutation is recessive and is lethal at the restrictive temperature of 14°C.
When exponentially growing cells were deprived of fuctional Yptlp, either by
repression of the GAL10 promoter or incubation of the ypt1-1 mutant at 14°C, many
phenotypic changes occurred. Cell growth ceased after several hours in the absence
of Yptlp; after 24hrs, examination of arrested cells revealed that they were
significantly larger than wild type cells, but in contrast to cdc mutants they had not
arrested with a unique morphology. However, Segev and Botstein (1987) observed
that arrested cells had replicated their DNA and thus contained two haploid units of
DNA per cell. They postulated therefore that Yptlp is required for cell division,
specifically after most of the nuclear DNA has been replicated, and proceded to
examine the effects of Yptlp deprivation in synchronous cultures. Unbudded ypt1-1
cells were collected from Ficoll gradients and then incubated at the restrictive
temperature (14°C) for several hours. Examination of arrested cells then revealed
that the majority had arrested with a unique morpholgy (mother cells with small
buds), consistent with Yptlp being involved in the cell cycle.
Recently, Segev et al., (1988) have published results that link Yptlp with the
secretory apparatus. Electron microscopy of the ypt1-1 mutant, revealed that at
the restrictive temperature (14°C), and to a lesser extent at the permissive
temperature (30°C), mutant cells experience an intracellular accumulation of
aberrant membranes. Two principal types of membrane were observed: long stacks
of cylindrical membranes that could represent abnormal ER, and large vesicles that
resembled the Berkeley bodies accumulated by sec7 and sec14 mutants. Consistent
with these findings, secretion of invertase from ypt1-1 cells is inhibited at 14°C,
resulting in an intracellular accumulation of enzyme, that was only partially
glycosylated. Invertase accumulated by ypt1-1 cells at 14°C migrates more slowly
by SDS-PAGE than invertase accumulated by a sec18-1 mutant at 37°C, but faster
than invertase from wild type cells, suggesting that the ypt1-1 mutant is defective
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either in the transfer of material from the ER to Golgi, or within the Golgi complex.
The subcellular location of Yptlp has been visualised by immunofluorescence using
anti-Ypt1p antibodies, and provides tantalising evidence that the protein is localised
to the Golgi complex. Wild type cells display a punctate pattern within the
cytoplasm, with intense staining also in the region of the bud. To test that this
pattern represents the distribution of a secretory organelle, immunofluorescence
was repeated in numerous sec mutants: the same punctate pattern was seen in
sec18-1 and sec1-1 mutant cells at both the permissive and restrictive
temperatures, but only at the permissive temperature in sec7-1 mutants. At the
restrictive temperature sec7-1 mutants displayed aggregated structures that
differed significantly from wild type cells, consistent with Yptlp being localised to
the Golgi complex (Segev et at., 1988).
1.4.3. A putative role for the cytoskeleton in secretion-
In S. cerevisiae, the first implication that the cytoskeleton was involved in secretion
came from investigations of actin. Actin is encoded by a single gene (ACT1) that has
been cloned, sequenced, and is essential for cell viability (Gallwitz and Seidel 1980,
Gallwitz and Sures 1980, Ng and Abelson 1980, Shortle et at., 1982). To study the
effects of actin deprivation on yeast cells three temperature sensitive mutations,
act1-1, act1-2, and act1-3 were constructed in vitro and then used to replace the
wild type ACT1 chromosomal gene (Shortle et al., 1984). Analysis of the phenotype
displayed by act1-1 and act1-2 mutant strains under restrictive conditions
revealed a defect in secretion: after thirty minutes at 37°C approximately 80% of
invertase was intracellular; this material was fully glycosylated consistent with a
late block of the secretory pathway. Examination of mutant strains by electron
microscopy also demonstrated an intracellular accumulation of post-Golgi secretory
vesicles similar to those seen in some of the sec mutants (Novick and Botstein
1985). The actin cytoskeleton could therefore mediate transport of post-Golgi
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secretory vesicles to the plasma membrane.
The YPT1 gene product may also exert its effect through the cytoskeleton. The fact
that the YPT1 and TUB2 genes are adjacent has led to speculation that Yptlp is a GTP
binding protein that interacts with tubulin during microtubule formation, which is
GTP dependent. In support of this hypothesis, cells that have been deprived of Yptlp
exhibit abnormal microtubule structure and distribution (Scmitt et al., 1986, Segev
and Botstein 1987). Microtubules have been visualised in wild type cells by
immunofluorescence and are seen to originate from two spindle pole bodies and extend
into the nucleus, where they either attach to the chromosomes or run from pole to
pole to form the spindle (Kilmartin and Adams 1984). In addition, other
microtubules extend into the cytoplasm and the developing bud, whose function is
thought to ensure correct orientation of the spindle before its elongation and
chromosome separation. Cells deprived of Yptlp however, show an abnormal
lengthening of cytoplasmic microtubules, accompanied by alterations of the spindle
which also appears to be of uneven thickness. Prolonged deprivation leads to large
scale breakdown of the mitotic spindle, and ultimate dispersion of nuclear material
throughout the cytoplasm. In many of these cells, several "rod"-like microtubules,
microtubules forming extensive loops, and amorphous pathches of aggregated tubulin
can also be seen.
The ypt1-1 mutation also has an effect on actin morphology (Segev and Botstein
1987): in unbudded wild type cells, actin appears as numerous dots or patches
distributed over the cell surface when visualised by immunofluorescence, whilst
budded cells are stained asymmetrically, ie extensive staining of the bud with faint
cables passing into the mother cell (Adams and Pringle 1984). The distribution of
actin in the bud changes as the bud matures: in very small buds actin is usually
localised to a cluster of individual spots, which increase in number as the bud grows;
but in fully developed buds actin becomes localised to the neck region. In ypt1-1
mutants that had been incubated at 14°C for 24hrs there was no evidence of
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asymmetrical staining in budded cells, instead actin spots were seen with equal
frequency in both the bud and mother cell.
Schmitt et al., (1988) argue that the pleiotropic effects resulting from Yptlp
deprivation (ie: inhibition of cell division, disorganisation of microtubules and actin
deposition, and accumulation of secretory organelles) is most probably due to a defect
in a protein that regulates a cellular component required for all these processes.
They postulate that this component is calcium because in certain eukaryotic cells
secretion is dependent on calcium (Burgoyne 1987, Howell et al., 1987), and
calcium is probably involved in regulating microtubule assembly (Schliwa et al.,
1981, Keith et al., 1983). In yeast, a calcium binding protein is required for
spindle pole body duplication (Baum et al., 1986), calcium controls actin assembly
(Greer and Schekman 1982), and calcium promotes the association of secretory
vesicles with plasma membrane (Henschke et al., 1983). In support of this
hypothesis mutant strains carrying a temperature sensitive ypt1ts allele, can be
rescued by increasing the extracellular levels of calcium, suggesting that Yptlp may
participate in modulating intracellular levels of calcium; but it is unclear how this
could be brought about since the major reservoir of calcium is the vacuole (Oshumi
and Anraku 1983, Eilam et al., 1985), yet the protein is localised to the Golgi
(Segev et al., 1988).
1.4.4 GTP binding proteins also function during protein transport in
mammalian cells.
The discovery that, in yeast, GTP binding proteins may perform an essential function
during secretion is an exciting new insight. Previously, only regulatory functions
have been ascribed to guanine-nucleotide binding proteins, such as signal
transduction in receptor systems and in growth control. This new role for GTP
binding proteins is probably not restricted to yeast, since proteins homologous to
Yptlp have been identified in mammalian systems (Touchot et al., 1987, Haubruck
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et al., 1987). The closest homologue, mouse ypt1, encodes a polypeptide of
molecular weight 23K, which has 71% of its residues identical to yeast Yptlp.
Moreover, anti-yeast Yptlp antibodies recognise a protein of the same approximate
molecular weight in mouse fibroblasts, that appears to be localised to the Golgi
complex since it fractionates with crude Golgi preparations, and also decorates an
internal organelle resembling the Golgi by immunofluorescence (Segev et al., 1988)
To assess the importance of GTP binding proteins in protein transport through the
Golgi complex, the in vitro transport system of Rothman and colleagues (see section
1.1.3) was subjected to GTP-yS and AIF4" (Melancon et al., 1987). Both of these
compounds are known activators of mammalian G proteins (see Gilman 1987), and
also GTPyS is a non hydrolysable analogue of GTP, such that GTP binding proteins
remain permanently activated. Both compounds inhibited transport of VSV G
glycoprotein from donor to acceptor membranes. Further analysis revealed that it is
probably some function of the acceptor membranes that is inhibited, since pre
treatment of only donor membranes or cytosol had marginal effect on transport.
Also, EM analysis of transport reactions that had been arrested, revealed an
accumulation of non-clathrin coated buds and vesicles, suggesting that transport is
inhibited due to an inability of donor vesicles to fuse with acceptor membrane. The
function which GTP binding proteins fulfill during protein secretion is unknown, but
consistent with all the data is a model in which GTP binding proteins mediate
interaction between proteins (address tags) on/in the membrane of a transport
vesicles with the appropriate acceptor membrane (Bourne 1988) (see fig. 1.6 and
legend for full description).
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Figure 1.6 Possible function of GTP-bindina proteins in vesicular
trgnslQcgt'Pn-
This model has been proposed by Bourne (1988) to explain the function of
GTP-binding proteins in intracellular membrane transport. A transport GTPase
(X) mediates vectoral transport of vesicles between different membrane
compartments: XGTP recognises a protein (Y) on/in the membrane of a budding
vesicle. The XGTpY complex directs interaction (via Y) with a docking protein (Z)
in/on the appropriate acceptor membrane, at which point GTP hydrolysis releases
Xqdp- leaving the vesicle-YZ complex in a position to initiate membrane fusion.
XGqp is then recycled by conversion to XGTP, a reaction catalysed by a guanine
nucleotide exchange protein (EP) located on the donor membrane. In this model
Bourne proposes that the GTP binding protein (X, ie. Sec4p or Yptlp) ensures that
vesicles tagged by an address label (Y) are delivered to the correct destination, tagged
by another address label. The hatched box represents the position at which events





1.5 OUTLINE OF THE PROJECT.
Mutant strains of yeast that are temperature sensitive for protein secretion provide
a foothold for investigations of the secretory pathway. These strains presumably
harbour a mutation in a gene whose product performs an essential function during
transport of proteins from the ER to the plasma membrane. Mutations in the SEC1
gene result in an intracellular accumulation of post-Golgi secretory vesicles under
restrictive conditions. This suggests that the SEC1 gene product is required in the
late stages of the secretory pathway where secretory vesicles fuse with the plasma
membrane. The aim of this project was to isolate and characterise the SEC1 gene and
its product. The SEC1 gene was chosen because the sec1-1 mutant is the best
characterised late-blocking sec mutant. It is hoped that the information gained from
these experiments will provide a framework for future biochemical investigations of








All chemicals were obtained from BDH chemicals, Sigma Chemical Co, or Fisons Ltd,
Loughborough.
Radiochemicals.
[35S]-dATP was obtained from either Amersham International pic (650Ci/mmol) or
New England Nuclear (500Ci/mmol). [35S] methionine (1115Ci/mmol) and
[32P]-dATP (>3000Ci/mmol) was from Amersham International pic. All
radiolabeled compounds were used as supplied by the manufacturer.
Enzymes.
All DNA modification enzymes including restriction endonucleases, phage T4 DNA
ligase, Bal31 exonuclease, and the Klenow fragment of DNA polymerase I were
obtained from Bethesda Research Laboratories (BRL). Zymolyase 100T was from the
Seikagaku Kogyo Co. Ltd; Japan. Lysozyme was from Sigma Chemical Co.
2.2 Bacterial and veast strains.
All the strains of E. coli and S. cerevisiae used in this work are listed in table 2.1,
with their relevant properties. Haploid MEY strains of S. cerevisae carrying mutant
sec alleles were constructed by crossing sec mutant strains, obtained from the Yeast
Genetic Stock centre, with either DBY746 or DBY747.
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Table 2.1 Bacterial and veast strains-
Bacterial Genotype Samsfi





E. coli 5K thi-1, thr-1, leuB6, lacYI,
hsdR, supE, tonA.




DBY746 MATa; Ieu2,3-112; his3-11,15; J. Hicks
trp1-289; ura3-52.
DBY747 MATa; Ieu2,3-112; his3-11,15; J. Hicks
trp1-289; ura3-52.
ABY12 MA Ta; sec 1-1; leu2-3,112; A. Boyd
his3-11,15.
MEY1 MATa; trp1-289; ura3-52. This study
MEY12 MATa; sec1-1; his3-11,15; Ieu2-3,112;
ura3-52.
MEY121 MATa/MATa; sec1-1/SEC1; trp1-289/TRP1 This study
leu2-3,112/LEU2; his3-11,15/HIS3;
ura3-52/ura3-52.
MEY230 MATa; sec2-56; his3-11; Ieu2-3,112; This study
Up 1-289.
MEY301 MATa; sec3-2; his3-11; Ieu2-3,112; This study
ura3-52.
MEY511 MATa; sec5-24; Ieu2-3,112. This study
MEY613 MATa; sec6-4; Ieu2-3,112; ura3-52. This study
MEY836 MATa; sec8-6; Ieu2-3,112; ura3-52. This study
MEY1007 MATa; sed0-2; his3-11; leu2-3,112; This study
trp1-289, ura3-52.
MEY1503 MATa; sec15-1, trp1-289; ura3-52. This study
RY26 MATa; ura3-1,3; ade-1; ade-2; tyr-1; J. Beggs
his7; canR; gal"; rna2-1.
FL100 MATa, gal" J. Beggs
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2.3 Media.
In general bacterial cultures were grown in complete medium (Luria broth, LB),
containing 1% (w/v) Bacto tryptone, 0.5% (w/v) Bacto yeast extract, and 0.5%
(w/v) NaCI. When appropriate the following antibiotics were added: ampicillin
(100{xg/ml), kanamycin (80(ig/ml), and tetracycline (20pg/ml). When solid
medium was required Bacto agar was added to the above media at a concentration of
1.5% (w/v). Bacterial strains were routinely stored on LB agar plates at 4°C,
except for E. coli NM522 which was grown on minimal medium to maintain selection
of the F' plasmid: this medium was 0.6% (w/v) Na2HP04, 0.3% (w/v) KH2P04,
0.05% (w/v) NaCI, 0.1% (w/v) NH4CI; this solution was autoclaved and on cooling
2ml 1M MgS04, 10ml 20% (w/v) glucose, 100pl 1M CaCI2 per litre were added.
Yeast were grown in complete medium (YPD), containing 1% (w/v) Bacto yeast
extract, 2% (w/v) Bacto peptone, and 2% (w/v) glucose; or minimal medium (SD),
0.67% (w/v) Bacto yeast nitrogen base without amino acids and 2% (w/v) glucose.
When required the following nutrients were added: histidine (20 pg/ml), leucine
(30 pg/ml), tryptophan (20 pg/ml), and uracil (20 |xg/ml). When solid medium
was required Bacto agar was added at a concentration of 2% (w/v).
2.4 Yeast genetic techniques.
Standard techniques were used in the construction and sporulation of diploids
(Sherman 1983). To test for complementation of sec mutations, the corresponding
sec mutant was transformed with plasmid DNA: transformants were selected on
minimal medium at 25°C, and then streaked out on minimal medium and tested for
the ability to form single colonies at restrictive temperatures (either 33.5°C or
37°C).
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2.5 General manipulations of DNA.
All standard techniques including restriction endonuclease cleavage, ligation,
extraction with phenol, and precipitation in ethanol were carried out as described by
Maniatis et al., (1982). Gel electrophoresis, for visualisation of DNA fragments,
was routinely carried out using 0.8% (w/v) agarose gels; the size of DNA fragments
was estimated by comparison with an EcoRI and Hind\\\ digest of phage X DNA (see fig
2.1)
2.6 Transformation of bacterial and veast cells.
DNA was transformed into bacterial cells previously treated with CaCI2 as described
by Maniatis et al., (1982). Yeast cells were made competent for transformation with
lithium acetate, following the protocol of Ito et al., (1983).
2.7 Recovery of plasmid DNA.
Plasmid DNA was recovered from bacterial cultures following the method of
Birnboim and Doly (1979). For recovery from yeast cells the following method was
used to prepare total DNA. A 5ml culture of transformed yeast cells was grown under
selection to stationary phase, cells were harvested by centrifugation (5000rpm in a
Beckman JA21 rotor for 5min) and resuspended in 0.5ml 1M sorbitol, 0.1 mM EDTA
pH7.5 and transferred to 1.5ml polypropylene microfuge tubes. To remove cell
walls, 200|xl Zymolyase 100T (2.5mg/ml) was added and the reaction incubated at
37°C for 60min. Sphaeroplasts were harvested by low speed centrifugation for
1min in a microfuge, and resuspended in 0.5ml 50mM Tris.HCI pH7.4, 20mM EDTA
pH8.5. Sphaeroplasts were lysed by addition of 50pl 10% (w/v) SDS and incubation
at 65°C for 30min after which 200jxl 5M potassium acetate was added and the tube
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Figure 2.1 Bacteriophage lambda DNA digested with EcoRI and Hindttl.
DNA fragments were routinely analysed by gel electrophoresis using 0.8% (w/v)
agarose gels. The size of DNA fragments was estimated by comparison to the
fragments of bacteriophage lambda DNA released in an EcoRI and HindIII digest. These




placed on ice for 60min. Precipitated material was removed by high speed
centrifugation in a microfuge, and the cleared supernatant decanted into a fresh
microfuge tube. An equal volume of isopropanol was added to this supernatant and the
tube incubated at room temperature for 5min. Precipitated nucleic acids were
collected by a 10sec high speed centrifugation in a microfuge, and were resuspended
in 20pl TE (10mM Tris, 0.1 mM EDTA pH 8.0) buffer. E. coli 5K cells were
transformed with approximately 500ng of this preparation, transformants being
selected on L agar plates, supplemented with antibiotics as described above.
2.8 Southern hybridisation.
Transfer of DNA fragments from agarose gels to nitrocellulose filters, and the
subsequent hybridisation of a-[32P]radiolabelled probes to the filter, were carried
out using the method of Southern (1975).
2.9 Northern hybridisations.
i) Extraction of RNA from S. cerevisiae:
Total RNA was prepared from DBY746 transformed with pEDB16. A 200ml culture
was grown under selection to a cell density of 2x107 cells per ml (mid-log phase),
at which point the cells were harvested by centrifugation (5000rpm in a Beckman
JA21 rotor for 5min) at 4°C, and washed in one tenth volume of sterile water that
had been previously treated with DEPC. The cells were again harvested by
centrifugation (as above) and resuspended in 4ml guanadinium thiocyanate solution
(4M guanadinium thiocyanate, 0.5% (w/v) sodium N-laurylsarcosinate, 25mM
sodium citrate pH7.0, and 0.1 M 6-mercaptoethanol) and transferred to a 30ml
siliconised glass tube. Cells were broken by vigorous vortexing for 30sec followed
by cooling on ice for 30sec; this cycle was repeated five times. Protein was
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extracted from the cell debris by several phenol-chloroform treatments, until no
residual material appeared at the interface following centrifugation. RNA was
precipitated from the aqueous phase at -20°C, by the addition of 0.025 volumes 1M
acetic acid and 0.75 volumes ethanol. The precipitate was collected by high speed
centrifugation in a microfuge, resuspended in 0.4ml DEPC-water, and extracted once
more with phenol-chloroform. Re-precipitated RNA was finally resuspended in
DEPC-water at a concentration of 3-5mg/ml. This method of extraction yielded
approximately 1mg RNA.
ii) Electrophoresis and blotting of RNA.
RNA samples were fractionated by electrophoresis through formaldehyde denaturing
agarose gels. 3g of agarose were dissolved in 130ml DEPC-water by heating; on
cooling to 70°C, 40ml 5x MOPS (in 11: 20.9g MOPS, 3.4g Na0Ac.3H20, 0.95g EDTA,
and adjusted to pH7.0) and 33.5ml 40% (v/v) formaldehyde were added and the gel
poured immediately. To prevent loss of formaldehyde, the gel was not submerged into
running buffer until immediately prior to use.
Prior to loading, 4.5pl of sample (approximately 20pg) was diluted to 20|xl by the
addition of 2jxl 5xMOPS, 10jxl deionised formamide, and 3.5pl 40% (v/v)
formaldehyde; and then placed at 65°C for 10min to destroy RNA secondary
structure. 3p.l sterile loading buffer (50% (v/v) glycerol, 1mM EDTA, 0.4%
(w/v) bromophenol blue, 0.4% (w/v) xylene cyanol) was added and the samples
applied to the gel immediately. Electrophoresis was carried out in IxMOPS running
buffer, at 100V for 4hr.
RNA was transferred to "Genescreen" transfer membrane (supplied by New England
Nuclear) by capillary action using 20x SSC (3M NaCI, 0.3M C6H5Na307.2H20), and
crosslinked to the membrane by baking at 80°C in a vacuum oven for at least 2hr.
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Filters were prehybridised in 20ml 50% (v/v) deionised formamide, 1M NaCI, 1x
"P" buffer (0.2% (w/v) BSA, 0.2% (w/v) PVP, 0.2% (w/v) Ficoll, 50mM
Tris.HCI pH7.5, 0.1% (w/v) Na2P407.10H2O, 1% (w/v) SDS), and 100pg
denatured salmon sperm DNA, at 42°C for 12-18hr. The probe (in a volume no
more than 500p.l) was boiled and added directly to the prehybridisation mix and
allowed to hybridise for 16-48hr. Following hybridisation, the filter was removed
and washed as follows: 2x 5min at room temperature in 2x SSC; followed by 2x
30min. at 65°C in 2x SSC, 0.5% (w/v) SDS; and finally 2x 30 min. at room
temperature in 0.1 x SSC. Filters were subsequently exposed at -70°C with
intensifying screens, using Kodak X-OMAT film.
2.10 Preparation of radiolabeled DNA fragments.
Two methods of radiolabelling DNA fragments were routinely used in this work The
4.3kb Hind\\\-BamH\ fragment of pEDB1 and the 1.1 kb Hind\\\ fragment of Ylp30
carrying the URA3 gene (Botstein et at., 1979) were purified from agarose gels
following the method described by Maniatis et at., (1982). 25ng of purified
material was radiolabeled following the method of Feinberg and Vogelstein (1982):
DNA synthesis was primed on denatured DNA by random hexadeoxynucleotides
(obtained from Pharmacia) in the presence of the Klenow fragment of E. coli DNA
polymerase I and a[32P]-dATP. Under these conditions DNA was labelled to
approximately 2x109 cpm/p.g.
Alternatively, the 2.9kb Hind\\\-Xho\ of pYI51 was cloned into the Hind\\\-Sal\
restriction sites of bacteriophage M13mp18 and M13mp19 to form pHX18 and
pHX19 respectively. Single stranded DNA was prepared as for DNA sequencing
(described below), and DNA synthesis primed by "hybridisation probe" primer
(obtained from Pharmacia) in the presence of the Klenow fragment of E. coli DNA
polymerase I and a[32P]-dATP, following the protocol of Hu and Messing (1982).
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2.11 Transposon mutagenesis.
The transposon Tn5 used in this study is carried by a phage lambda vector. The phage
carries mutations in the cl, O, P, and rex genes (Lb22p Oam, Pam, cl857, rex::Tn5)
which prevent it from either replicating or lysogenising when present in a sup0
background. In such a cell the phage lies dormant, and thus any kanamycin resistant
colonies isolated represent transposition of a Tn5 molecule; transposon mutagenesis
experiments were therefore carried out using E. coli strain 159 as a host.
i) Preparation of phage lysate.
A 5ml culture of E. coli 5K was grown for 18hr in BBL broth (1% (w/v) BBL
trypticase, 0.5% (w/v) NaCI), 1% (w/v) maltose, and 10mM MgCI2-
Approximately IOOp.1 of this was mixed with 100pl X::Tn5 (102-103 pfu/ml) and
incubated at room temperature for 10min. Following this, 6ml of "top" BBL agar (as
BBL broth plus 0.65% (w/v) agar) was added and the mixture was overlayed onto a
BBL plate (as BBL broth plus 1.5% agar). Plaques were observed after overnight
incubation at 37°C. A single plaque was removed and added to 200pl phage buffer and
5pl chloroform. This mixture was shaken at 37°C for 30min to remove chloroform.
A fresh culture of E. coli 5K was infected and plated as above, although incubation at
37°C was only allowed for 5hr. The "top" agar containing the phage was broken and
collected in a tube, and subsequently centrifuged (6000rpm in a Beckman JA21
rotor for 20min.). The supernatant was removed and mixed with 200|il chloroform,
to remove surviving bacteria. The phage titre was determined by an infection of E.
coli 5K, a titre above 1010 pfu/ml being sufficient for use. Prior to use the
supernatant was shaken at 37°C for 2hr to remove the chloroform.
75
ii) Tn5 directed mutagenesis.
E. coli 159 was transformed to ApR with pEDB16. A 5ml culture of this strain was
grown under selection, in the presence of 0.2% (w/v) maltose, to mid log phase
(A600"°-5)- The cel,s were harvested by centrifugation (5000rpm in a Beckman
JA21 rotor for 5min) and resuspended in 2.5ml phage buffer (2mM KH2P04, 5mM
Na2HP04, 8.5mM NaCI; this solution was autoclaved and on cooling 100pl 1M
MgS04, 10|xl 1MCaCI2, 100|xl 1% (v/v) Gelatine per 500ml was added). After
removing chloroform from the phage lysate, 1ml was mixed with 1ml bacterial
cells, to produce a multiplicity of infection of approximately 10. The infection was
allowed to proceed for 10min at room temperature, after which 4ml of LB was added
and the mixture incubated at 42°C for a further 10min. The cells were harvested by
centrifugation (5000rpm in a Beckman JA21 rotor for 5min) and resuspended in
100(il LB, and then plated onto L agar plates containing ampicillin and kanamycin.
Many colonies were observed following overnight incubation at 37°C, which were
washed of the plates, and the resulting cell suspension used to inoculate a 50ml
culture. This culture was grown under selective conditions to stationary phase and
plasmid DNA extracted; approximately 2pg of this preparation was used to transform
E. coli 5K to KmR. Plasmid DNA from individual transformants was screened for the
nature of the Tn5 insertion they contained, using restriction endonuclease digests.
2.12 DNA sequence analysis.
i) Construction of a set of Bal31 generated deletions in the SEC1 gene.
The 5.6kb Hind\\\-Pst\ fragment of pYI51 was cloned into the Hind\\\-Pst\ sites of
Bluescribe M13+ (see Stratagene catalogue 1988) to form plasmid pME1.
Approximately 20pg of pME1 was linearised by cleavage at the Xho\ site and then
treated with Ba/31 exonuclease using standard buffers and conditions (Maniatis et
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a/., 1982) Linearised pME1 (20|ig) was resuspended in 10Ofxl water to which
10OpI "Bal31 reaction buffer" (40mM Tris.HCI pH8.0, 1.2M NaCI, 24mM MgCI2.
24mM CaCI2, 2mM EDTA) and 15 units Bat31 exonuclease were added; the reaction
was incubated at 30°C. To obtain a number of different deletion endpoints, aliquots
(20|il) were removed at different time points (T= 0,2,4,6,8,10,15,25, and
30min) and the reactions terminated by addition of 4pl 0.5M EGTA pH7.5. Using
these conditions approximately 70bp were deleted from each end of the DNA
molecules per minute. The different aliquots were pooled and subjected to a
filling-in reaction using the Klenow fragment of DNA-polymerase I to ensure that
the ends of DNA molecules were flush. Finally, DNA was cleaved with Sma\ and the
resulting fragments religated together. This DNA was used to transform E. coli
NM522 to ApR, and then individual transformants screened for the nature of the
plasmid they contained. The various deleted derivatives that were isolated are shown
in fig 2.2. For sequencing, each deletion was transferred to bacteriophage M13mp19
(Messing 1983) as a Hind\\\-EcoR\ fragment, or in the case of pMEAO as an
Hind\\\-Xho\ fragment ligated into the Hind\\\-Xho\ restriction sites.
ii) Preparation of single stranded DNA.
A single plaque was used to infect 20p.l of exponentially growing E. coli NM522 cells,
in a 30ml polypropylene tube. After 5min at room temperature, 1.5ml of 2x TY
(1.6% (w/v) Bacto tryptone, 1% (w/v) Bacto yeast extract, 0.5% (w/v) NaCI)
growth medium was added and the cultures incubated at 37°C for 8-18 hr. During
incubation the cultures were shaken vigourously to provide adequate aeration.
The cultures were transferred to 1.5ml polypropylene microfuge tubes, and the cells
harvested by high speed centrifugation in a microfuge. Supernatants were decanted
into fresh microfuge tubes and single stranded DNA prepared from these stocks. DNA
was precipitated by addition of 200pl 20% (w/v) PEG6000, 2.5M NaCI solution to
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Diagram showing Bal31 deletion endpoints, see text for further details.
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900|xl supernatant. After 60min at room temperature the DNA precipitate was
collected by high speed centrifugation in a microfuge, and the pellet resuspended in
200(j.l TE buffer. This was extracted two times by the addition of an equal volume of
a 1:1 phenol-chloroform solution, after which DNA was precipitated out of the
aqueous phase in the presence of one tenth volume 3M NaOAc pH5.5 and two volumes
ethanol at -20°C. Precipitated DNA was collected by centrifugation and resuspended
in 20|il TE buffer, 5pJ of which was used in a typical sequencing experiment.
iii) Sequencing of DNA: DNA molecules were sequenced using the dideoxy chain
termination protocol of Sanger et al.,(1977), in the presence of [35S]-dATP
(Williams et al.,. 1986). Sequencing reactions were electrophoresed on 6%
acrylamide gels (0.4mm thickness) containing 8M urea.
2.13 Coupled in vitro transcription and translation of DNA molecules.
Plasmid DNA was extracted from bacterial cells by the method of Birnboim and Doly
(1979), and further purified by centrifugation in a CsCI density gradient as
described by Maniatis et al., (1982). Approximately 5pg of DNA was transcribed
and translated in vitro by introduction into a bacterial cell-free system following the
protocol of Zubay (1973), using a kit obtained from Amersham International pic.
During the reaction, newly synthesised proteins were radiolabeled by incorporation
of [35S]-methionine, and were then visualised by gel electrophoresis and
fluorography as described below.
2.14 Gel electrophoresis of proteins.
Proteins were electrophoresed through polyacrylamide gels following the basic
procedures and buffer system of Laemmli (1970). The constitution of the various
buffers and solutions is given in table 2.2; 10% (w/v) acrylamide separating gels
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with a 5% (w/v) acrylamide stacking gel were routinely used. Electrophoresis was
usually carried out using the Hoeffer "mighty small" apparatus. Gels were cast
between a glass plate and an alumina back plate (10x8cm), seperated by two PVC
vertical spacers, held together by clips and sealed with 1% (w/v) molten agarose.
Proteins were electrophoresed at a constant current of 40mA, with the cooling
system in operation. Alternatively, larger slab gels (18x14cm) were used, which
were electrophoresed at a constant current of 10mA for 18hr.
When the dye front had reached the bottom of the gel the power supply was
disconnected and the gel removed. For visualisation, the gel was first immersed in
fixing solution (1% (v/v) acetic acid, 20% (v/v) methanol) for 30min with gentle
agitation. Protein bands were then stained with 0.25% Coomassie Brilliant Blue
P250 dissolved in 50% (v/v) methanol, 7.5% (v/v) acetic acid for 10min. Gels
were destained by agitation in 10% (v/v) methanol, 7% (v/v) acetic acid, with a
piece of polyurethane foam to absorb free dye.
For fluorography, radioactive gels were dehydrated by successive washes in
dimethylsulphoxide, followed by impregnation with PPO exactly as described by
Bonner and Laskey (1974). Gels were then dried onto a sheet of Whatman 3MM
chromatography paper, and exposed at -70°C using Kodak X-OMAT film.
2.15 Purification of a cro-B-aalactosidase-SEClp fusion protein.
A 11 culture of E. coli NF1, transformed to ApR by pEXS1 was grown at 30°C to
A600=°-3- The culture was then incubated at 42°C for a further 5hr to induce
expression of the fusion protein. Cells were harvested by centrifugation and washed
in 300ml 0.1 M Tris.HCI pH7.5, and then resuspended in 10ml 0.1 M Tris.HCI pH7.5
per g wet weight of cells. Cells were lysed by addition of lysozyme to this suspension,
to a final concentration of 1mg/ml. The cell suspension was incubated on ice for
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Table 2.2 Solutions and buffers used in polyacrylamide gel
electrophoresis.
A. Seperating gel buffer:
0.75M Tris.HCI pH8.8, 0.2% (w/v) SDS
B. Stacking gel buffer:
0.25M Tris.HCI pH6.8, 0.2% (w/v) SDS
C. Acrylamide solution:
44% (w/v) acrylamide, 0.8% (w/v) N;N'-methylene-bis-acrylamide
(bis)
D. Electrophoresis buffer:
0.125M Tris, 0.192M glycine, 0.1% (w/v) SDS
(gives pH8.3 without adjustment)
E. Sample buffer:
0.0625M Tris.HCI pH6.8, 20% (w/v) glycerol, 4% (w/v) SDS, 5%
(w/v) R-mercaptoethanol
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20min, and then sonicated for four periods of 30sec using a large sonication probe.
Throughout sonication the sample was kept on ice to prevent excess warming. Cell
debris was removed by centrifugation (1000rpm in a Beckman JA21 rotor for
5min), and inclusion bodies harvested from the supernatant by further
centrifugation (15000rpm in a Beckman JA21 rotor for 20min). Purified
inclusion bodies were washed twice in 25ml 0.1 M Tris.HCI pH7.5, 0.1% (v/v)
Triton X-100; and finally resuspended in 1ml per g cells 100mM Tris.HCI pH8.0,
150mM NaCI, 6mM B-mercaptoethanol, 1% (w/v) SDS, 1% (v/v) Triton X-100.
Some difficulty was encountered in getting all the material to dissolve, which was
overcome by a 10min. incubation at 65°C. A sample of this material (approximately
one third) was further purified by passage over a 100ml G150 Sephadex column, in
100mM Tris.HCI pH8.0, 150mM NaCI, 6mM R-mercaptoethanol buffer. Fractions
from this column were analysed by SDS-PAGE, and the desired fractions pooled and
stored at 4°C.
2.16 Immunisation of rabbits with purified fusion protein.
Approximately 300|ig of purified inclusion bodies were emulsified with an equal
volume of complete Freund's adjuvant, using a Sorvall omni-mixer with a
microattachment. Emulsified material was taken up into a 1ml syringe, avoiding air
bubbles, and injected into rabbits with a 19 gauge sterile needle. Two young female
New Zealand White rabbits were each immunised with this amount of material by
sub-cutaneous injection, into at least 8 different sites over the back of the rabbit.
This was followed 5 weeks later by a subcutaneous booster of 250pg of protein
emulsified with incomplete Freund's adjuvant as described above. Both rabbits were
boosted 3 times, at intervals of 2 weeks. On the seventh day following each boost, a
30ml sample of blood was taken from each animal, and a clot allowed to form by
standing the blood at room temperature for 2hr and then at 4°C for a further 18hr.
The serum was decanted and centrifuged at 5000rpm in a Beckman rotor (type
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JA21) for 10min, and then filter sterilised by passage through a 0.22p.m millipore
filter and stored at 4°C.
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Chapter Three.
Isolation of a fragment of yeast genomic DNA
the can complement the sec1-1 mutation.
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3.1 Introduction.
The studies presented in this chapter describe the isolation of a genomic DNA
fragment that is capable of complementing the sec1-1 mutation at 37°C. A library of
random S. cerevisiae genomic DNA fragments was obtained from J. Hicks (Nasmyth
and Tatchell 1980). A detailed protocol describing the formation of this gene bank
can be found in the above reference but briefly, genomic DNA was cleaved with Sau3A
under conditions that resulted in partial digestion. DNA fragments with an
approximate size of 10kb were purified and cloned into the BamH1 site of YEp13
(see fig1.1, Broach et al., 1979). For propagation in bacterial strains the plasmid
has both a bacterial origin of replication and genes conferring resistance to
ampicillin (ApR) and tetracycline (TcR, cloning into the BamH1 site disrupts this
gene); the plasmid also contains the S. cerevisiae gene encoding IMsopropylmalate
dehydrogenase (LEU2, Andreadis et al., 1984) and an origin of replication taken
from the endogenous yeast 2p.m plasmid (Broach 1981), allowing it to be maintained
and selected for in S. cerevisiae strains. The plasmid is present in multicopy - an
approximate copy number of 50-70 plasmids per cell is usual. The LEU2 gene
allows transformed cells to be selected by growth on minimal medium in the absence
of leucine, after which these strains can be screened for the gene(s) of interest.
3.2 Isolation of a recombinant clone that can complement the sec1-1
mutation.
Approximately 10pg of the genomic library DNA was used to transform yeast strain
ABY12 ( sec1-1, Ieu2-3,112, his3-11,15 ) to leucine prototrophy. Transformed
cells were selected by growth on minimal medium, supplemented with histidine, at
26°C. Approximately 10,000 transformants were recovered after 48hr of growth
under these conditions. The transformants were washed off the plates, with sterile
SD, to form a suspension with an approximate cell density of 5x108 cells/ml. Cells
were subsequently plated onto complete medium and incubated at 37°C for 20hr in
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order to select for temperature resistant strains. Many colonies were recovered, ten
of which were picked for further analysis. The cosegregation of the LEU2 gene and
the sec1-1 complementing gene was tested by growth, through several generations on
complex medium at 26°C; all colonies that had lost the ability to grow in the absence
of leucine had also lost the ability to grow at 37°C, demonstrating complete linkage of
the two markers. Total DNA was prepared from temperature resistant yeast cells and
used to transform E.coli 5K to ApR. Individual bacterial transformants were
screened for the nature of the plasmid they contained; only one species of plasmid was
observed, which has been termed pEDB1. When reintroduced into ABY12, this
plasmid rendered the host cells temperature resistant. Evidence is presented in
section 3.4 and chapter 5 that the gene responsible for sec1-1 complementation is
the authentic SEC1 gene, and therefore for ease of writing the "cloned gene" is
referred to as the SEC1 gene from now on.
3.3 Subclonina of the SEC1 aene.
A restriction map of the genomic fragment of DNA present in pEDB1 for the enzymes
BamYW, EcoRI, Hind\\\, and Pst\ has been compiled and is shown in figure 3.2. The
DNA fragment is 10.6kb in length and contains numerous recognition sites for the
enzymes mentioned above. The pattern of Hind\\\ cleavage sites immediately
suggested a strategy for subcloning the SEC1 gene. Plasmid pEDB1 was cleaved with
Hind\\\ and the resulting mixture of fragments used in a ligation reaction. A number
of pEDB1 derivatives were obtained (pEDB14, pEDB15, pEDB16, and pEDB18),
which as detailed in figure 3.3. All the plasmids carry the 4.3kb Hind\\\-BamH\
fragment, either alone (pEDB16) or in combination with a second Hind\\\ fragment.
The four derivatives were tested for the ability to complement the sec1-1 lesion in
ABY12 following a similiar protocol to that described above. All four plasmids were
observed to support growth of ABY12 at 37°C indicating that the gene responsible for
complementation is located within the 4.3kb Hind\\\-BamH\ fragment.
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The restriction map for this region has been extended to include cleavage sites for
many more common enzymes, and is shown in Fig 3.4. The Xho\ site is unique within
this region and lies towards the centre of the fragment. To determine if the SEC1
gene spanned this site, the 4.3kbH/r7cflll-Bar77HI fragment was cloned into YEp213
(Broach 1983), to form pEDB213 thereby making the Xho\ site unique, after which
it was disrupted by insertion of a 1.2kb Sa/I fragment carrying a KmR gene. This had
no effect on the capability of the fragment to complement the sec1-1 mutation (data
not presented), consistent with the SEC1 gene lying to one side of the Xho\ site.
3.4 Demonstration that the cloned aene can complement the sec1-1
mutation when present in single copy only.
The strategy of isolating S. cerevisiae genes from genomic libraries made in
multicopy vectors has proven successful on many occasions (e.g see Nasmyth and
Reed 1980, Nasmyth and Tatchell 1980, Dietzal and Kurjan 1987). However, any
positive results have to be treated with caution because on numerous occasions genes
have been isolated, other than the wild type gene, that are capable of rescuing the
mutant strain - a phenomenon termed "mass action suppression" (e.g. see Dietzal and
Kurjan 1987). The final experiment presented in this section provides preliminary
evidence that the cloned gene is the authentic SEC1 gene. I have utilised a second class
of E.coli / S. cerevisiae shuttle vector, termed a Yip plasmid, which lacks the
elements of yeast DNA which would allow it to replicate independently of the genome.
This type of plasmid transforms yeast cells by integrating into the host genome, via
homologous recombination, so that it can be replicated during host DNA synthesis.
Such integration events are infrequent, resulting in the plasmid being present in
transformed cells at low copy number. Using this approach it has been possible to
demonstrate that the cloned gene is capable of complementing the sec1-1 mutation
when present in single copy only.
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The 4.3kb H/'ndlll-SamHI fragment was cloned into the respective sites of Ylp5 (see
figure 3.5, Struhl et at., 1979), to form plasmid pYI51. This plasmid carries the
yeast URA3 gene as a selectable marker (Rose et at., 1984), so that when pYI51 is
used to transform yeast cells it is possible for the plasmid to integrate into the
genome, via homologous recombination, at either the URA3 locus or the locus
represented by the 4.3kb Hind\\\-BamH\ fragment. Integration can be targeted,
however, by cleavage of the plasmid within one of the yeast sequences, to produce a
linear molecule whose ends are highly recombinogenic. To direct integration to the
chromosomal locus corresponding to the 4.3kb Hind\\\-BamH\ fragment,
approximately 10pg of pYI51 was linearised by cleavage at the Xho\ site, and used to
transform MEY12 to uracil prototrophy. Following 48hr growth on minimal
medium at 26°C more than 200 transformants were obtained of which fifteen were
taken for further analysis. The transformants were patched onto selective medium
and grown at 26°C for 48hr, after which they were replica plated onto complete
medium and grown at 37°C. All fifteen transformants grew at this temperature
during overnight incubations, confirming that the cloned gene is capable of
complementing the sec1-1 mutation even at low copy number.
From this sample of fifteen transformants, five strains (designated MEY12X1
through to MEY12X5) were taken for further analysis. Initially, the co-segregation
of the URA+ and SEC+ phenotypes was followed through several generations of growth
on complex medium - integrated plasmids are observed to be 100% stable. The five
strains were plated onto complete medium and grown at 26°C until visible colonies
appeared (48hr), and then replica plated onto selective and non-selective media. All
five strains showed 100% stability of the URA+, SEC+ phenotypes. It is possible
however, for a cell to possess more than one copy of pYI51, brought about by
multiple integration events (see fig 3.6). It was essential, therefore, to identify a
strain which had received only a single copy of the plasmid. Integration of a plasmid
at an homologous chromosomal locus results in an altered pattern of restriction
fragments within that region: it is possible to utilise this characteristic and in
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conjunction with Southern hybridisation experiments, determine the copy number of
the integrated plasmid.
To demonstrate integration at the chromosomal locus that is homologous to the 4.3kb
Hind\\\-BamY\\ fragment, genomic DNA was prepared from the five strains
(MEY12X1 through to MEY12X5), and following cleavage with Hind\\\, probed with
the 4.3kb Hind\\\-BamH\ fragment. The model predicts two fragments will hybridise
to this probe: a 9.5kb fragment corresponding to the integrated plasmid; and a
fragment of at least 4.3kb corresponding to the chromosomal Hind\\\ fragment
carrying the SEC1 gene. The results are shown in fig 3.7; two bands can clearly be
seen on the autoradiograph, which are judged to be 9.5kb and 4.6kb respectively by
extrapolation to size markers on the original agarose gel (data not shown). This
indicates that the right hand flanking genomic Hind\\\ site, as drawn on the map, lies
approximately 300bp from the BamH\ site.
The plasmid copy number of the MEY12 integrants was determined by probing
genomic DNA, digested with PvuW, with the purified 1.1 kb Hind\\\ fragment from
Ylp30, which carries the URA3 gene. A strain which has experienced a single
integration event would be expected to produce two fragments that would hybridise to
this probe: a fragment corresponding to the chromosomal PvuW fragment carrying
theURA3 gene (of unknown size at this point); and a fragment of at least 7kb,
corresponding to the distance from the plasmid PvuW site to the nearest chromosomal
PvuW site on the left as shown in Fig 3.6. Strains that possess tandem integrants
will produce both of these fragments, along with a third fragment of 9.5kb,
corresponding to pYI51. The results are shown in Fig 3.8: all strains produce two
bands of 3.5kb and at least 15kb; the smaller band is also present in DBY746 and
therefore represents the genomic PvuW fragment carrying the URA3 gene, whereas
the large band represents the hybrid plasmid - genomic DNA fragment. In addition
three strains (MEY12X1, X3, and X5) produce a third band of 9.5kb, and thus
present multiple integrants. MEY12X2 and MEY12X4 are therefore strains in which
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the cloned gene complements the sec1-1 mutation when present as a single copy
integrant.
3.5 Summary
In this chapter I have described the isolation of a recombinant plasmid (pEDB1), that
carries a 10.6kb fragment of yeast genomic DNA, capable of complementing the
sec1-1 mutation. Analysis by subcloning has localised the gene responsible for this
complementation to within a 4.3kb Hind III-Bam HI fragment. The genomic library
from which this clone was isolated was, however, constructed in a vector that is
maintained in multi-copy; it is possible therefore that pEDB1 contains a mass action
suppressor of the sec1-1 mutation. To demonstrate that this is not the case I have
shown that the 4.3kb Hind\\\-BamH\ fragment can complement the sec1-1 mutation
even when it is integrated into the genome at single copy. This evidence alone does not
eliminate the possibility that a gene has been isolated that can suppress the sec1-1
mutation when it is duplicated - this has been recently demonstrated for the sec15-1
mutation which can be suppressed by duplication of the SEC4 gene (Salminen and
Novick 1987). Further genetic evidence has therefore been sought to confirm that
the 4.3kb Hind\\\-BamH\ fragment carries the authentic SEC1 gene (see chapter 5)
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Figure 3.1 Map of YEp13.
YEp13 carries the genes conferring resistance to ampicillin (ApR) and tetracycline
(Tcr), and the origin of replication from pBR322 (Bolivar et a/.,1977), which
allow the plasmid to be maintained in E. coli. The plasmid also carries the S.
cerevisaie LEU2 gene and elements of the endogenous 2pm plasmid which allow it to
be maintained and selected for in yeast cells. See text for further details. B
(BamHI), H{Hind\\\), P (Pst\), R (EcoRI), S (Sa/I).
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Figure 3.2 Fragment of veast genomic DNA carried bv pEDB1.
By restriction mapping pEDB1 contains a 10.6kb fragment of yeast genomic DNA,
that was generated as a partial Sau3A fragment and cloned into the BamHI site of
YEp13. During this experiment the BamHI site at the right hand insert/vector DNA
junction was recreated, although this does not mean that a BamHI site appears in the
genome at this position. The location of several restriction sites are shown: B





Figure 3.3 Derivatives of pEDB1.
A. Shows a restriction map of the 10.6kb genomic fragment of DNA from pEDB16,
with the Hind\\\ (H) and BamHI (B) restriction sites, and the size of expected
fragments marked. The left Hind\\\ site is actually located in YEp13 vector sequences
(---)■
B. Approximately 1pg of pEDB1 was cleaved with Hind\II to release a large fragment
of 10.6kb (a hybrid fragment containg YEp13 vector sequences and'the 4.3 kb
Hind\\\-BamU\ fragment), and three smaller fragments of 2.9kb, 2.4kb, and "I.Okb;
all of which originate from the genomic fragment of DNA. These fragments were
religated together and plasmids isolated which carried the 4.3kb Hind\\\-BamH\
fragment, either alone (pEDB16), or in association with a second Hind\II fragment
(PEDB14, pEDB15, and pEDB18). Each plasmid was introduced into ABY12 and then
tested for its ability to complement the sec1-1 mutation; all four plasmids supported
growth of ABY12 at 37°C, indicating that the gene responsible for complementation
was located in the 4.3kb Hind\\\-BamH\ fragment.
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Figure 3.4 Restriction map of the 4.3kb Hind\\\-BamH\ fragment.
The restriction map of this region has been extended to include restriction sites for
several more common enzymes. B (BarnHI), C (C/al), H (Hind\\\), He (HincW), Hp
(Hpa\), Pv (Pvu\), R (EcoRI), Rv (EcoRV), X (Xho\), Xb (Xba\). The Xho\ site is






Figure 3.5 Map of YId5.
Ylp5 carries the ApR and TcR resistance genes and the origin of replication (ori)
from pBR322, which allow the vector to be maintained and selected in E. coli. In
addition the plasmid also carries the URA3 gene of S. cerevisiae which can be used as
a selectable marker in yeast strains defective for this gene. The plasmid cannot
replicate episomally in yeast but can become established by recombination into the
host genome. Plasmid pYI51 was formed by cloning the 4.3kb Hind\\\-BamH\




Figure 3.6 Schematic representation of integration of PYI51 into the
host q<?n<?me.
In order to become established in the cell plasmid pYI51 must integrate into the host
genome by homologous recombination; in this experiment, integration was targetted
to the genomic locus corresponding to the 4.3kb Hind\\\-BamH\ fragment, by
linearisation of pYI51 with Xho\ (A). This event was confirmed by Southern
hybridisation using the 4.3kb Hind\\\-BamH\ fragment to probe a genomic DNA
digested with Hind\\\ (see text for details and fig 3.7). Multiple integration events
are possible, resulting in strains with tandem integrated copies of pYI51 (B); such
strains were diagnosed by probing genomic DNA, digested with PvuW, with the 1.1 kb
Hind\\\ fragment of Ylp30 which carries the URA3 gene (see text for details and fig
3.8). Numerous restriction sites are shown, B (BamH\), H (HindIII), and P
(Pvu\\)\ those sites which are bracketed represent genomic restriction sites whose
exact location is not known. ApR and TcR - genes conferring resistance to ampicillin
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Figure 3.7 Integration of pYI51 into the genome.
Genomic DNA was prepared from strains MEY12X1-MEY12X5 (lanes 1 to 5
respectively), cleaved with Hind\\\ and the resulting fragments separated by gel
electrophoresis. DNA was transferred to nitrocellulose as described in chapter 2,
and probed with the 4.3kb Hind\\\-BamH\ fragment. In each integrant two fragments
hybridise with this probe: a fragment of approximately 9.5kb corresponding to
pYI51; and a fragment of 4.6kb representing the genomic Hind\\\ fragment which
carries the SEC1 gene.
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Figure 3.8 Copy number of integrated pY!51 molecules.
Genomic DNA was cleaved with PvuW, separated by gel electrophoresis, and
transferred to nitrocellulose. The filter was probed with the 1.1 kb Hind\\\ fragment







The control strain, DBY746, has only one DNA fragment that hybridises with this
probe; this represents the genomic PvuW fragment carrying the URA3 gene. A
maximum of three bands are seen with the strains carrying integrated copies of
pYI51, whose origin is described in the text and depicted in fig 3.6. Strains
MEY12X1, X3, and X5 possess all three bands and therefore have multiple copies of
pYI51 integrated into the genome, whereas MEY12X2 and MEY12X4 have only two of











Mapping of the SEC1 gene by transposon mutagenesis
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4.1 Introduction.
In the previous chapter I have described the isolation of a 10.6kb fragment of
genomic DNA that is capable of complementing the sec1-1 mutation. Subcloning
experiments have localised the gene responsible for this complementation to within
a 4.3kb region of the insert. One of the main aims in this thesis was to determine
the nucleotide sequence of the SEC1 gene (described in detail in chapter 6), and
therefore I set out to define the limits of the SEC1 gene more accurately.
I chose transposon mutagenesis as the most convenient method for this mapping
project. Transposons are found in both eukaryotic and prokaryotic systems. They
can simply be defined as segments of DNA, that have the ability to insert into the
genome of a host organism (for review see Kleckner 1981). Each transposon is a
self-contained unit which encodes one or more functions that are required, in
conjunction with functions specific to the host, to promote transposition. A review
of the mechanism of transposition is outside the scope of this thesis, but for more
detail the reader is referred to Derbyshire and Grindley (1986). The
characteristics described above have been harnessed to provide a powerful
experimental tool. The rationale of this study was to expose the 4.3kb
Hind\\\-BamH\ fragment, the insert of pEDB16, to a transposon under conditions
that would promote "hopping" of the transposon into this fragment. Transposition
into the SEC1 gene would abolish its ability to complement the sec1-1 mutation,
whereas transposition into regions outside the SEC1 gene would have no such effect.
The location of these two classes of insertion within the fragment will therefore
mark the position of the SEC1 gene.
In this study I have used the transposon Tn5, which is capable of inserting at high
frequency into the chromosome, plasmids, and temperate phages of gram negative
bacteria (for review see Berg and Berg 1983). A schematic representation of the
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Tn5 molecule is shown in Fig 4.1; the molecule is 5.7kb in length, and can be
roughly divided into three areas - a central region of 2.7kb which is flanked by two
regions of 1.5kb. The two flanking regions, termed IS50L and IS50R, are in fact
inverted repeats, of slightly different sequence, whose structure is thought to be
fundamental to the mechanism of transposition (Berg et at., 1980, 1982). The
IS50R region also encodes two proteins: the transposase and its regulator, which are
thought to catalyse the transposition event (Rothstein and Reznikoff 1981). The
central region of the molecule houses the gene encoding neomycin
phosphotransferase type II, which confers resistance to aminoglycoside antibiotics
(Berg et at., 1975); cells harboring a Tn5 molecule are therefore resistant to
kanamycin and neomycin. Since the Tn5 molecule is specific to gram negative
bacteria, mutagenesis of pEDB16 was carried out in E. coli , after which
mutagenised plasmids were recovered, analysed for the nature of the insertion they
contained, and then introduced into a suitable yeast strain to determine the effect of
the insertion upon ability to complement the sec1-1 mutation.
As a means of introducing the Tn5 molecule into bacterial cells, I have used a strain
of phage lambda that carries the transposon. This phage also carries mutations in
the cl gene (cl857), and the O and P genes (amber nonsense) such that following
infection, into a suitable host under the correct experimental conditions, the phage
lies dormant since the lysogenic and lytic life cycles are blocked - stable KmR
colonies can therefore only arise as a result of transposition. The Tn5 molecule has
stringent control mechanisms however (for review see Reznikoff 1982), which
permit only a single transposition event to occur within the recipient cell.
Therefore the appearance of a bacterial colony that is resistant to kanamycin is
thought to represent a unique transposition event, thereby allowing the easy
identification of many different insertions.
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4.2 Tn5 mutagenesis of the 4.3kb Hind\\\-BamH\ fragment.
E. coli strain 159 (sup0) was transformed to ApR with pEDB16. Transformed cells
were used to inoculate a 5ml culture which was grown, under selection in 0.2%
maltose (inducer of the lambda receptor), to mid-log phase (A600-0.5). Cells
were harvested and resuspended in 2.5ml of phage buffer, 1 ml of which was mixed
with 1 ml of a phage X::Tn5 lysate (titre of at least 1010pfu/ml). The infection
was allowed to proceed at room temperature for 10min, after which 4ml LB was
added and the mixture incubated at 42°C for a further 10min. The cells were
harvested by centrifugation and plated onto LB agar containing kanamycin and
ampicillin, to select for mutagenised derivatives of pEDB16. Many colonies were
observed following overnight incubation at 37°C; these were washed off the plates
and the resultant cell suspension used to inoculate a larger scale culture from which
plasmid DNA was prepared (this procedure segregates Tn5 insertions into plasmid
DNA from insertions in the host chromosomal DNA) . Approximately 1p.g of this
preparation was used to transform E. coli strain 5K to ApR/KmR and the resultant
transformants were screened for the nature of the insertion they contained.
The insertion of a Tn5 molecule into pEDB16 results in drastic changes in the
restriction pattern around the point of insertion. It is therefore possible to
determine the position of the Tn5 molecule by restriction digest analysis. In this
study I have used three enzymes, namely BamHI, EcoRI, and Hind\\\, for this
purpose. In total I have analysed plasmids from 67 ApR, KmR bacterial colonies.
Plasmids were first digested with EcoRI; when this enzyme is used to cleave
pEDB16, a characteristic profile of restriction fragments is produced, see fig 4.2.
The position of insertion of a Tn5 molecule can be easily localised since the
transposon does not possess any EcoRI cleavage sites, and thus the pEDB16 EcoRI
fragment housing the Tn5 molecule is observed to increase in size by 5.7kb (eg. see
fig 4.2). Of the 67 plasmids analysed in this way, 12 were found to possess Tn5
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insertions within the 2.5kb or 1.2kb EcoRI fragments of pEDB16. These plasmids
(pTN) were taken for further analysis.
The precise position at which the transposon had inserted into pEDB16 was
determined by further restriction analysis using the enzymes BamH\ and Hind\\\.
For both of these enzymes there is only a single cleavage site in pEDB16, while Tn5
has one BamH\ site and two Hind\\\ sites (see fig 4.1). In the mutagenised plasmids
novel restriction fragments are therefore produced, the size of which can be used to
accurately map the site of Tn5 insertion. I have presented the raw restriction data
for only one Tn5 insertion (pTN64, see fig 4.3 and the corresponding legend for full
description), as an example of the procedure that was used to map all twelve
insertions. Having mapped the position of the Tn5 insertions in this way, I
determined the ability of each plasmid to complement the sec1-1 mutation (see fig
4.4). Each pTN plasmid was introduced into ABY12; by transformation, with
selection for growth, at 26°C, on minimal medium in the absence of leucine.
Wherever it was possible ten transformants for each plasmid were taken for
further analysis; in those cases where plasmids transformed poorly the maximum
number of colonies possible were analysed. Each colony was patched onto selective
medium and grown at 26°C for at least 20hr, and then replica plated onto complete
medium and grown at either 26°C or 37°C overnight. The results are presented in
fig 4.5; of the twelve plasmids, four had lost the ability to complement the sec1-1
mutation (pTN18, pTN26, pTN57, and pTN64). In the cases of pTN18, pTN57, and
pTN64 all the transformants tested were unable to grow at 37°C; in the case of
pTN26 however, three of ten transformants were viable at the restrictive
temperature. This viability may be a result of recombination between the sec1-1
chromosomal gene and the Tn5 mutagenised SEC1 gene thereby producing a
functional SEC1 gene. These four insertions can therefore be used to mark the
position of the SEC1 gene within the 4.3kb Hind\\\-BamH\ fragment. In addition,
the Tn5 insertions present in pTN2 and pTN7 are located no more than 200bp
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outside this region and yet still retain the ability to complement sec1-1 mutation,
and thus it was possible to map the SEC1 gene within a 1.8kb region of DNA (Fig
4.4).
4.3 Summary.
I have used the transposon Tn5 to mutagenise plasmid pEDB16 - a derivative of
pEDB1 which carries only the 4.3kb Hind III-Bam HI fragment. In total I have
screened 67 pEDB16-derived plasmids which contain Tn5 insertions. By
restriction analysis, twelve plasmids were found to contain insertions within the
4.3kb Hind\\\-BamH\ fragment. When these plasmids were subsequently tested for
their ability to complement the sec1-1 mutation, four plasmids (pTN18, pTN26,
pTN57, and pTN64) were observed to be incapable of supporting the growth of
ABY12 at 37°C. These four plasmids harbor Tn5 insertions within the SEC1 gene;
restriction mapping has shown that these insertions span a region of 1.6kb to the
left of the Xho\ site. Other plasmids, namely pTN2 and pTN7, harbour Tn5
insertions that lie no more than 200bp outside this region yet still retain the
ability to complement sec1-1 mutation. The SEC1 gene has therefore been located
to a 1.8kb region of DNA, located to the right of the Xho\ site. It is possible
however, for the SEC1 ORF to extend outside this region since the insertion of a Tn5
molecule into a region of the gene that encodes a dispensable portion of the protein,
would not have any effect on its ability to support growth of a sec1-1 mutant at
37°C.
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Figure 4.1 Organisation of the transposon Tn5.
Diagram A is a schematic representation of the Tn5 molecule. The shaded regions
(IS50L and IS50R) are inverted repeat segments. The positions of the three open
reading frames encoding the transposase, the transposase regulator, and the
neomycin phosphotransferase are indicated. Diagram B shows a simple restriction
map of the Tn5 molecule, with several restriction sites marked: B (BamHI), H























Figure 4.2 Localisation of Tn5 insertions in dEDB16 mutaaenised
plasmids.
The transposon Tn5 does not have any EcoRI cleavage sites, and therefore insertion
of Tn5 into pEDB16 results in one of the EcoRI fragments increasing in size by
5.7kb. Shown in diagram A are EcoRI restriction digests of plasmids pEDB16 and
pTN64.
Lane 1 phage Xdigested with EcoRI and HincflW
Lane 2 pEDB16 digested with EcoRI
Lane 3 pTN64 digested with EcoRI.
Cleavage of pEDB16 with EcoRI releases five fragments of approximately 4.6, 4.2,
2.5, 2.2 and 1.2kb, four of these fragments are also seen when pTN64 is cleaved
with EcoRI, but the 2.5kb fragment is replaced by a larger fragment of
approximately 6kb; the Tn5 molecule present in pTN64 is therefore inserted into
the 2.5kb EcoRI fragment. Diagram B is a map of pEDB16 with the EcoRI
restriction sites and the size of the predicted fragments marked; only Tn5
insertions into the 1.2kb and 2.5kb EcoRI fragments (fragments A and B
respectively) were taken for further analysis.
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Fragment A - 1.2 kb
B - 2.5 kb
C - 4.2 kb
D - 22 kb
E - 4.6 kb
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Figure 4.3 BamHI and Hind\\\ digests to accurately map the position
of Tn5 insertions.
A. Restriction digests of pEDB16 (14.6kb) and pTN64 (20.3kb).
Lanel X EcoRI, HindW
Lane 2 pEDB16 BamHI
Lane 3 pEDB16 EcoRI
Lane 4 pEDB16 Hind\\\
Lane 5 pTN64 BamHI
Lane 6 pTN64 EcoRI
Lane 7 pTN64 Hind\\\
B. An EcoRI digest of pTN64 (lane 6, and as in fig 4.2) confirms that the Tn5
molecule has inserted into the 2.5kb EcoRI fragment. BamHI and Hind\\\ digests
were used to determine the exact position of insertion; pEDB16 contains only a
single site for each of these enzymes (lanes 1 and 3 respectively). Cleavage of
pTN64 with BamHI produces two fragments: a large fragment that cannot be sized
accurately, but is deduced to be 14.6kb, since the smaller fragment is 5.7kb. The
5.7kb fragment (fragment B) contains 2.6kb of Tn5 DNA, indicating that the
transposon must have inserted 3.1 kb away from the BamHI site of pEDB16. This
conclusion is confirmed by the Hind\\\ digest, which releases three fragments: a
large fragment deduced to be 14.6kb, and two smaller fragments of 3.3kb and
2.4kb; the 3.3kb fragment is an internal Tn5 fragment. The 2.4kb fragment
(fragment A) contains 1.2kb of Tn5 DNA, indicating that the transposon inserted
1.2kb away from the Hind\\\ site of pEDB16. The position of insertion deduced from





Figure 4.4 Afril'ty Qi In5 mutaqenised pEPB1? Plasmids la
complement the sec1-1 mutation.
A. Each pTN plasmid was introduced into ABY12 and then tested for the ability to
complement the sec1-1 mutation at 37°C as described in the text. Complementation
is denoted as (+), and failure to complement as (-).
B. Shows the position of the twelve different Tn5 insertions analysed, and their
effects on the sec1-1 complementing activity of pEDB16. Those insertions that had
no effect on the ability of pEDB16 to complement the sec1-1 mutation are shown as
Y. whereas those insertion that abolished sec1-1 complementing activity are
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Gene disruption: proof that the cloned fragment of yeast
genomic DNA carries the authentic SEC1 gene.
1 21
5.1 Introduction.
In chapter three I demonstrated that the gene which has been isolated from the
Nasmyth library can complement the sec1-1 mutation when it is integrated into the
genome at single copy. This is strong circumstantial evidence that the gene is the
authentic SEC1 gene, but formal genetic proof of this point is still required. A gene
disruption experiment proves that a cloned fragment carries the gene in question
(Rotstein 1983). The results described in chapters three and four provide all the
information that is required to undertake such an experiment: the gene has been
accurately mapped by Tn5 mutagenesis and has been found to span a region containing
some useful restriction sites. In this chapter I describe disruption of the SEC1 gene,
by insertion of the URA3 gene, and demonstrate that this construct integrates into
the chromosome at the SEC1 locus.
5.2 insertion of the URA3 gene into the SEC1 gene and disruption of
the chromosomal SEC1 oene.
A 1.1kb Hind\\\ fragment, carrying the URA3 gene, was taken from YEp24 (Botstein
at a/., 1979) and ligated into the Hind\\\ site of pK19 - a derivative of pUC19 that
confers KmR instead of ApR (Pridmore 1987). A recombinant plasmid was isolated
that actually contains two 1.1kb Hind\\\ fragments, and has been termed pK19URA3
(see fig 5.1). The URA3 gene was excised from pK19URA3 on a 1.1 kb Sma\ fragment
and ligated into the HincW site of pMEAO, which by restriction mapping and
transposon mutagenesis is deduced to be in the SEC1 gene, to form plasmid pSKOI.
It was thought likely that the SEC1 gene would encode an essential function, in which
case disruption of the SEC1 gene in a haploid strain would be a lethal event; all
experiments were therefore undertaken using a diploid strain. Approximately 10jxg
pSKOI was digested with ClaI and then used to transform MEY121
(ura3-52/ura3-52, SEC1/sec 1 -1 diploid) to uracil prototrophy. The C/al
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fragment which carries the URA3 gene (see fig 5.2) has SEC1 sequences at both its
termini; integration will therefore occur either at the wild type SEC1 locus or the
sec1-1 mutant allele. This will give rise to temperature sensitive and temperature
resistant diploid transformant strains respectively, at approximately equal
frequencies. If integration were to occur at some other undefined locus, all
transformants would be temperature resistant. Transformants were selected by
growth on minimal medium in the absence of uracil, at 26°C: fifty of these
transformants were patched onto a minimal medium, incubated at 26°C for 24hr, and
then replica plated onto complete medium and incubated at either 26°C or 37°C.
Eighteen transformants failed to grow at 37°C consistent with integration at the SEC1
locus.
Integration has also been investigated by Southern hybridisation. Genomic DNA was
prepared from the diploid strain MEY121, from the parents of this strain (MEY1 and
MEY12), and from five URA+ transformants (MEY121K1-MEY121K5) that were
either temperature sensitive (MEY121K2, K4, and K5) or temperature resistant
(MEY121K1 and K3). DNA was cleaved with Hind\\\, separated by gel electrophoresis
and transferred to nitrocellulose, and then probed with pHX18 (see fig 5.3). The
diploid strain, and its parents, contain only a single fragment, of 4.6kb, that
hybridises with this probe; this fragment will be present in two copies in the diploid
strain. The URA+ transformants however, each contain three fragments: a fragment
of 4.6kb representing the non-disrupted SEC1 allele, and fragments of 3.4kb and
2.5kb produced by insertion of the URA3 gene into the other SEC1 allele. It is
important to note that disrupted temperature resistant and temperature sensitive
diploid strains give exactly the same band pattern in this experiment, confirming
that integration has occured at one locus. It is also of interest that in all five URA+
strains only one chromosome has experienced integration, suggesting that disruption
of both SEC1 alleles in MEY121 is a lethal event. This question is further
investigated in section 5.3.
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5.3 Spoliation and tetrad dissection of a temperature resistant and a
temperature sensitive URA+ diploid strain.
The diploid strains MEY121K1 (temperature resistant) and MEY121K4
(temperature sensitive) were patched onto minimal medium, incubated at 26°C for
36hr, and then replica plated onto sporulation medium. After four days incubation at
26°C, approximately 60% of cells had undergone sporulation events. Twelve
four-spored asci derived from each diploid were dissected and the spores picked onto
complete medium and incubated at 26°C. Every ascus except one gave rise to two
viable strains and two non-viable strains (see fig 5.4); in the case of MEY121K1
(integration into the sec1-1 allele) the viable spores gave rise to temperature
resistant clonies which were ura", whereas MEY121K4 gave rise to temperature
sensitive ura" colonies. Other nutritional markers that were analysed (his3-11,
trp 1-289) segregated randomly (data not shown). These characteristics confirm
that the cloned gene maps to the SEC1 locus and establishes SEC1 as a gene essential
for cell viability. Microscopic examination of spores containing a disrupted SEC1
gene revealed that they had germinated and had passed through a few rounds of cell
division (data not shown). These spores presumably contained enough residual SEC1
gene product to support germination and growth for this period.
5.4 Summary
I have used a gene disruption experiment to demonstrate conclusively that the gene
which has been isolated by its ability to complement the sec 1-1 mutation is the
authentic SEC1 gene. The URA3 gene was used to disrupt the SEC1 gene and a linear
DNA fragment, with SEC1 coding sequences at it termini, used to transform a
SEC 1lsec1 -1, ura3-52/ura3-52 diploid strain to uracil prototrophy. Some 36%
URA+ transformants simultaneously became temperature sensitive. Dissection of
tetrads from a temperature sensitive URA+ diploid transformant produced a
segregation of 2 sed-1 ,ura3-52 : non viable (inferred to be URA+) strains, and
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similiarily a temperature resistant URA+ diploid transformant gave 2
SEC1/ura3-52 : 2 non viable (inferred to be URA+) strains; the tight linkage
between the temperature sensitive/resistant and ura" phenotypes confirms
integration at the SEC1 locus. The fact that only two spores per tetrad were viable
demonstrates that the SEC1 gene product is essential for cell viability even at 26°C,
removing the possibility that it could be required only at 37°C; or that temperature
sensitivity is due to an effect of a defective protein rather than absence of function.
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Figure 5.1 Formation of pKl9URA3.
Plasmids YEp24 and pK19 were cleaved with Hind\\\ and the resulting fragments
introduced into a ligation reaction. DNA molecules were used to transform E. coli
NM522 to KmR, in the presence of IPTG and X-GAL, allowing strains carrying
regenerated pK19 to be distinguished from strains carrying recombinant plasmids.
Recombinant plasmids were screened for those which contained the 1.1 kb Hind\\\
fragment of YEp24 which carries the URA3 gene; one plasmid, termed pK19URA3,
was identified that has two tandem copies of this fragment.
126
1 27
Figure 5.2 Insertion of the URA3 oene into the SEC1 gene.
Plasmid pK19URA3 was cleaved with Sma\, releasing the URA3 gene on a 1.1 kb
fragment of DNA. pK19URA3 Smal fragments were introduced into a ligation reaction
with pMEAO that had been linearised with HincW. Ligated DNA was used to transform
E. coli NM522 cells to ApR, which were then screened for a derivative of pMEAO that
had the 1.1 kb Smal fragment inserted into the HincW site. The photograph shows
restriction digests of such a derivative, alongside the same digests of pMEAO for
comparison







Insertion of the 1.1 kb Smal fragment introduces additional Hmdlll and EcoRV
restriction sites to produce fragments of 2.5kb and 1.6kb respectively, and
increases the size of the largest fragment of pMEAO in an EcoRI digest; these
characteristics were used to identify pSKOI. Single lines represent vector sequences,
and blocks represent cloned DNA fragments. Some restriction sites are shown for




Figure 5.3 Disruption of the chromosomal SEC1 oene.
A. A schematic diagram of the integration event. Plasmid pSKOI was cleaved with
C/al and then used to transform MEY121 to uracil prototrophy. The C/al fragment
that carries the URA3 gene becomes established by homologous recombination into
the host chromosome; integration will therefore be targetted to the SEC1 locus. B
(BamH\), C (C/al), H (Hind\\\), He (HincW), X {Xho\).
B. Southern hybridisation was used to confirm the nature of integration events.
Genomic DNA was cleaved with Hind\\\ and, after electrophoresis and transfer to









The observed band patterns agree exactly with the predictions made in diagam A. In
the three untransformed strains (MEY1, MEY12, and MEY121) only fragments of
4.6kb hybridise with the probe, whereas the URA+ transformants have three
fragments: the 4.6kb fragment as above, and fragments of 3.4kb and 2.5kb which are
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Figure 5.4 Dissection of tetrads from a temperature resistant and a
temperature sensitive ura+ diploid.
Twelve four-spored asci from a temperature resistant URA+ diploid (top panel) and
a temperature sensitive URA+ diploid (bottom panel) were dissected. Spores were
grown at 25°C on complete medium for three days and then photographed. See text
for further details. Many thanks are due to Dr. Ian Dawes (Dept. Microbiol., Univ.




Characterisation of the SEC1 gene and its product:




In previous chapters I have described the isolation of the SEC1 gene by its ability to
complement the sec1-1 mutation. In this chapter I describe further studies that I
have undertaken, including Northern hybridisation experiments, in vitro
transcription and translation of SEC1 mRNA, and nucleotide sequencing, which have
further characterised the SEC1 gene and its product (Seclp).
6.2 The SEC1 oene encodes a transcript of 2.5kb.
Northern hybridisation experiments have confirmed that the SEC1 gene, identified by
subcloning and transposon mutagenesis is expressed in actively growing yeast cells.
Total RNA was prepared from DBY746 that had been transformed to leucine
prototrophy with either pEDB16 or YEp13. RNA was separated by gel
electrophoresis, transferred to a nylon membrane, and probed with the 4.3kb
Hind\\\-BamH\ fragment. Two transcripts of approximately 2.5kb and 5.0kb were
detected in RNA prepared from DBY746 transformed with pEDB16, both of which are
sufficent in size to be transcribed from an open reading frame of 1.8kb (see fig.
6.1). The 2.5kb transcript was also observed in RNA prepared from DBY746
transformed with YEp13 on prolonged exposure of the filters (data not shown), and
thus is a candidate for the SEC1 mRNA.
To confirm that this transcript represents SEC1 mRNA, and to determine the
orientation of the SEC1 gene, RNA was probed with a smaller fragment of DNA from
the 4.3kb Hind\\\-BamH\ fragment. The 2.9kb Hindl\\-Xho\ fragment, which houses
the complete SEC1 gene, was ligated into the H/'ncflll-Sa/l restriction sites of
bacteriophages M13mp18 and mp19, to form pHX18 and pHX19 respectively (see
chapter 2). Single stranded pHX18 and pHX19 DNAs were harvested and used to
probe similiar blots to the one described above. Due to the opposite orientation of the
cloning sites in mp18 and mp19, pHX18 and pHX19 contain opposite strands of the
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Hindi\\-Xho\ fragment, ie either the SEC1 coding or non-coding strand, but only the
coding strand will hybridise to the mRNA. A single transcript is detected using
pHX18 as a probe (see fig. 6.2); this is the same size as the major transcript, shown
in fig. 6.1, detected when the 4.3kb H/ndlll-SamHI fragment was used as a probe. It
is most likely therefore that this transcript is derived from the SEC1 gene.
Conversely, no transcript was detected using pHX19 as a probe, suggesting that
pHX19 contains the non-coding strand of the SEC1 gene. This result therefore
establishes the orientation of the SEC1 gene in the H/ndlll-Xhol fragment: the 5' end
of the gene is towards the Hind\\\ restriction site and the 3' end towards the Xho\
restriction site, as depicted in fig. 6.2. The origin of the larger transcript shown in
fig. 6.1 is unknown; but it is probably due to spurious initiation of transcription in
YEp13 sequences.
6.3 Coupled in vitro transcription-translation of the SEC1 gene.
The potential for the SEC1 gene to encode a polypeptide was tested by in vitro
transcription-translation using a prokaryotic cell free system (De Vries and Zubay
1967, Zubay 1973). This system contains a crude preparation from E. coli which
contains all the necessary enzymes and factors required for transcription and
translation, which is supplemented with amino acids, an energy regenerating system
and certain co-factors; all that is required to program the reaction is plasmid DNA.
Newly synthesised proteins are radiolabeled by incorporation of [35S]- methionine,
and then visualised by SDS-PAGE with subsequent fluorography.
Eukaryotic genes can be expressed in this system provided they posses prokaryotic
expression signals and do not contain an intron(s), although the difference in codon
useage between prokaryotes and eukaryotes may lead to spurious products being
synthesised due to premature termination of translation etc. Despite these potential
problems however, yeast myosin (a protein of approximate molecular weight 200K)
has been expressed from its gene (MY01) in the Zubay system (Eli Orr, personal
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communication).
Figure 6.3 shows the polypeptide profiles obtained when numerous plasmids were
introduced into a Zubay system. All the plasmids analysed in this experiment were
derivatives of YEp13 which when used to program transcription and translation
directs expression of three predominant polypeptides of molecular weight 55K, 44K,
and 30K, and many other minor species which are probably spurious. The larger
polypeptide of approximate molecular weight 55K is even produced in a mock
reaction containing no DNA (fig. 6.3, lane 6), and must therefore be expressed from
contaminating DNA. The polypeptides of molecular weight 44K and 30K are seen in
all the lanes in fig. 6.3 (except the mock reaction, lane 6); this distribution and the
size of the two proteins are consistent with them being 6-IPM dehydrogenase
(product of the LEU2 gene, Andreadis et al., 1984) and 6-lactamase (product of the
ApR gene, Bolivar et al., 1977) respectively.
In addition to the three polypeptides described above, pEDB1 directs the expression
of several more polypeptides of approximate molecular weight 26K, 35K, 46K, and
five polypeptides of molecular weight 69-74K. It is not possible to say whether
these are all derived from separate open reading frames, or if they are the result of
spurious translation. Four of the polypeptides, of molecular weight 69-72K, are
also produced when pEDB16 is used to program the Zubay system, and are therefore
likely candidates for the SEC1 gene product. To determine which of these polypeptides
is derived from the SEC1 ORF, two mutagenised derivatives of pEDB16, pTN18 and
pTN64 (see section 4.2), were analysed. Both of these plasmids have Tn5 insertions
into the SEC1 gene, which completely abolish the ability of the plasmids to
complement the sec1-1 mutation at 37°C. No polypeptides of approximate molecular
weight 69-72K are expressed from these plasmids, consistent with each polypeptide
being derived from the SEC1 gene; presumeably the largest polypeptide (72K)
represents the full length product. Interestingly, two unique polypeptides of
approximate molecular weight 26K and 28K are seen in the profiles of pTN18 and
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pTN64 respectively. The size of these polypeptides is consistent with them being
truncated SEC1 polypeptides: pTN18 is distal to the 5' end of the gene and directs the
expression of a larger protein than pTN64, which is proximal.
6.4 Determination of the nucleotide sequence of the SEC1 aene.
To gain more information about the SEC1 gene and the protein it encodes, I have
determined the nucleotide sequence of the SEC1 gene. The 2.9kb H/'ndlll-X/7ol
fragment has been completely sequenced, on both strands, following the strategy
outlined in fig. 6.4 All six possible reading frames have been analysed, but only a
single open reading frame of significant length has been identified (fig. 6.5). This
ORF is 1828bp long, which could encode a polypeptide of 626 residues, and is likely
to be the SEC1 coding sequence for two reasons. First, the location of the ORF
corresponds to that region defined by transposon mutagenesis to be essential for
complementation of the sec1-1 mutation; and second, the ORF is in the same
orientation to that determined by the Northern hybridisation experiments described
above (section 6.2).
6.4A Analysis of the SEC1 open reading frame.
The ORF identified by nucleotide sequencing could encode a polypeptide of 626 amino
acids. This polypeptide (Seclp) has a predicted molecular weight of 72 936,
consistent with the size of the candidate Seclp seen in the in vitro transcription -
translation experiment.
The amino-terminal residues of Seclp do not bear any resemblance to a typical
amino-terminal signal sequence: this region contains only nine hydrophobic amino
acids in the first twenty residues (scoring Ala, Cys, Leu, lie, Met, Val, Trp, and Phe
as hydrophobic residues). Furthermore, analysis of the hydropathy of Seclp using
the method of Kyte and Doolittle (1982) reveals that there are no candidate internal
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hydrophobic domains that could direct translocation into a membrane (data not
shown). Two other proteins thought to play a role in secretion, Yptlp and Sec4p, are
peripherally bound to membranes (see sections 1.4.1 and 1.4.2). It has been
demonstrated for Yptlp that attachment is accomplished by palmityolation of cysteine
residues in the sequence GlyGlyCysCys, which forms the carboxy-terminus of the
protein. In contrast to Yptlp, the carboxy-terminus of Seclp is AlaThrArgTyr,
suggesting that it is not a substrate for palmityolation; therefore in all probability
Seclp will be found in the cytosolic fraction of the cell.
The second codon of Seclp is UCU, encoding a serine residue. Bachmair et at.,
(1986) have demonstrated that in yeast, the second position of E. coli
(3-galactosidase has a great effect on the stability of the protein; they further infer
that this is likely to be true for all unblocked non-compartmentalised proteins.
Serine, along with methionine, alanine, glycine, threonine and valine have been
categorised as stabilising amino acid residues, and are found to occupy the second
position in a protein in 63% of all yeast proteins (Bachmair et at., 1986). This
could imply that Seclp is a particularly stable protein; consistent with this, is the
observation that haploid strains in which the SEC1 gene has been disrupted can
germinate and undergo one to three rounds of cell division. Alternatively, the
presence of UCU in the second codon position may effect translation of mRNA. This
has been demonstrated for E. coli mRNA, where UCU is the second most frequently
used codon at this position. A mutational analysis of the second codon in the lacZ
mRNA demonstrated that the nature of the second codon affects expression over a
twenty fold range (Looman et at., 1987).
6.4B Codon useaoe in the SEC1 oene.
Genes that are highly expressed in S.cerevisiae show a distinct preference for the
possible coding triplets, in extreme cases only 22-26 of the possible 61 constitute
93% of all the triplets. Preferred codons are thought to reflect the major species of
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tRNA in S. cerevisiae. The codon bias index (CBI) is a measure of the fraction of
codon choices which is biased to 22 preferred triplets, a value of one indicates that
for all of the triplets in the mRNA only preferred codons are used, whereas a value of
zero reflects total random choice. Using the method of Bennetzen and Hall (1982a) I
have determined the CBI of the SEC1 gene to be 0.305. Highly expressed genes, such
as those encoding glyceraldehyde-3-phosphate dehydrogenase and alcohol
dehydrogenase isozyme 1 have reported CBI values greater than 0.9; whereas the
iso-2 cytochrome c gene, which is expressed at low levels, has a CBI value of 0.15
(Bennetzen and Hall 1982a). In comparison therefore, a CBI value of 0.305
predicts that the SEC1 gene will only be expressed at moderately low levels.
6.4C Analysis of the non-coding 5' and 3' flanking regions.
Specific sequence motifs exist in the 5' untranslated region of eukaryotic genes that
are thought to play a significant role in initiation and regulation of mRNA
transcription. The TATA element (consensus sequence 5TATAA3') is an essential
component of many promoters; its function is not completely understood but it is
believed to to be involved in positioning of RNA polymerase II transcription start
sites (for review see Breathneach and Chambon 1985). In higher eukaryotes the
TATA sequence is almost invariably located 25-30bp upstream from the mRNA
initiation site (Gannon et a!., 1979), but in yeast it can be found up to 150bp
upstream of the ATG codon, and many promoters contain more than one TATA element
(Hahn et al., 1985). In contrast, the sequence 5TATAA3' is not found in the SEC1
promoter, but the sequences 5TGTAA3' and 5'AATAA3' which resemble the consensus
are located at -73 to -69 and -59 to -55 respectively, although it has not been
determined if these are functional. The absence of a consensus TATA element is
consistent with the hypothesis that the SEC1 gene is expressed at low levels. The
CDC37 and CDC39 are two other examples of genes that do not have a TATA element in
their promoter and are also expressed at low levels: both genes encode approximately
five mRNA molecules per haploid cell and have codon bias index values of below 0.15
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(Ferguson et al., 1986).
Dobson et al., (1982) have reported a correlation between highly expressed genes of
S. cerevisiae and a pyrimidine rich region, in 5' flanking sequences, followed ten
nucleotides downstream by the sequence 5' CAAG 3'; initiation of transcription is
thought to occur in the latter sequence (Kingsman et al., 1985). A block of
pyrimidine residues is found in the SEC1 promoter between -132 and -119 but this
does not precede the tetranucleotide sequence 5' CAAG 3'; between nucleotide position
-119 and the ATG codon however, the related sequence 5' TAAG 3' (PyAAG) occurs
three times. One of these three sequences could provide the start site for the SEC1
transcript, although this is yet to be determined.
Numerous sequences have been associated with transcriptional termination in S.
cerevisiae, but a general consensus sequence has yet to be recognised. In several
genes, termination occurs in the sequence 5' TAAATAAG 3' (Bennetzen and Hall
1982b); no example of this sequence is found in the 3' flanking regions of the SEC1
gene. Alternatively, termination in the CYC1 gene is dependent upon the sequence
5'TAG...TAGT...(A/T rich)TTT3' which has since been found in a similiar position in
other yeast genes (Zaret and Sherman 1982). Again, no example of this sequence can
be found downstream of the SEC1 termination codon; termination of transcription,
therefore either occurs at these sequences downstream of the Xho\ site (this sequence
has not been determined), or at some other undefined sequence.
6.4D Context of the intiation codon.
In animal cells it is generally accepted that after the 40S ribosomal subunit has
bound to the 5' Cap-site, the subunit scans the leader until the first AUG codon is
encountered, at which point translation initiation occurs (Kozak 1981). The context
of the AUG, however, acts as an important signal to trigger initiation events.
Hamilton et a!., (1987) compared the DNA sequences around the ATG start codon of
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96 genes from S. cerevisiae; they found that 81% of these ATG codons were preceded
by an A residue at position -3, and 61% by an A residue at -1: the SEC1 ATG is
preceded by an A residue at position -3 but by a G residue at -1. In those genes
studied by Hamilton et al., (1987) only 9% were found to have a G residue at
position -1; in fact, G residues were rare throughout the leader, especially in the
five positions immediately preceding the ATG codon. The SEC1 transcript however,
has eight G residues between -1 and -30, two of which occur between -1 and -5.
A strong bias also exists for the first three bases downstream of the start codon. The
+4 and +6 positions are occupied by a T residue in 38% and 57% of those genes
studied by Hamilton et al., (1987) respectively; and a C residue is found at +5 in
52% of the cases. Thus, the first codon after the initiating ATG is usually TCT; this
is true of the SEC1 gene. In summary, the studies of Hamilton et al., (1987) reveal
the consensus DNA sequence 5' A/TAA/CAA/CA ATGTCT/C 3', whereas the equivalent
sequence in the SEC1 transcript is 5' GGAACGATGTCT 3', reinforcing the hypothesis
that the SEC1 gene will be poorly expressed.
The ATG which forms the start of the SEC1 ORF is preceded by an out of phase ATG at
-20, which is followed by an ORF of only ten codons. This ATG, however, is not
found in a favourable environment: the -3, -1, and +4 positions are occupied by C
residues, only the +6 position, which is a U, is favourable. It is therefore uncertain
whether this ATG would act as initiating signal for some fraction of the ribosomes
scanning the SEC1 mRNA molecule.
6.4E Analysis of potential splicing sites.
Splicing of mRNA molecules in S.cerevisiae is rare, only nine genes have been
identified that are synthesised as pre-mRNA, and subsequently matured by removal
of an intron. As in higher eukaryotes there are stringent sequence requirements at
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the 5' and 3' exon/intron boundaries (for review see Breathneach and Chambon
1981). The 5' donor site has been defined by the consensus sequence 5'GTATGT3' and
the 3' acceptor site by the sequence 5'C/UAG3\ In S. cerevisiae however, there is
also an absolute requirement for the sequence 5TACTAAC3' which is found 16-64
nucleotides upstream of the 3' acceptor site (Langford and Gallwitz 1983). Analysis
of the SEC1 nucleotide sequence revealed the presence of possible splicing sequences
within the large ORF described above: the sequence 5TACTAAC3' is found at
495-501, which is preceded by a candidate 5' donor site, sequence 5'GTATCG3', at
251-256; and followed by numerous 3' acceptor sites between 504-530.
To determine if the SEC1 transcript is spliced I have analysed mRNA prepared from a
wild type strain and a mutant strain that is defective in splicing. The rna2 mutation
is temperature sensitive, such that at 37°C, rna2 mutants accumulate unspliced
transcripts at the expense of mature mRNA molecules (Hartwell 1967, Roshbash et
at., 1981, Fried et at., 1981). Unspliced and mature mRNA molecules can be
distinguished by Northern hybridisation, since removal of an intron leads to a
reduction in the size of the mRNA. A nylon membrane, onto which RNA extracted
from a wild type strain and an rna2 mutant strain had been blotted, was the kind gift
of Drs. Derek Jamieson and Jean Beggs (Dept. Mol. Biol., Univ. of Edinburgh). This
membrane was probed with plasmid pMEAO (see chapter 2) that had been linearised
by cleavage with Hind\\\. The results are shown in fig. 6.6: in the wild type strain,
at both 26°C and 37°C, a single transcript of approximately 2.5kb was detected; the
same transcript is also detected in RNA extracted from the rna2 mutant at 26°C. No
difference however, can be detected between the size of this transcript and that
detected in an rna2 mutant at 37°C; therefore either the SEC1 mRNA is not subject to
splicing, or the number of spliced mRNA molecules is so low they cannot be detected
in this experiment.
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6.4F Comparison of the SEC1 aene product with proteins in the NBRF
database.
The polypeptide sequence of Seclp was compared to entries in the NBRF database
(version 16), using the Lipmann and Pearson FASTP program in KTUP1 mode
(Lipman and Pearson 1985). Of the proteins that showed some similarity to Seclp,
the most significant was the product of the Schizosaccharomyces pombe nim1+ gene.
This gene was identified by its ability, when cloned on a multi-copy plasmid, to
suppress a cdc25ts mutation, and has therefore been implicated in the control of cell
division (Russell and Nurse 1987). The nucleotide sequence of nim1+ reveals that it
could encode a polypeptide of 370 residues (Nimlp), of molecular weight 50 000,
that could be a protein kinase since it was found to be 20-35% identical to the
catalytic domains of a family of protein kinases, including cAMP-dependent protein
kinase and the v-src oncogene product. The similarities are concentrated in the
regions of the ATP binding site, and in the region where it is known that in certain
protein kinases a tyrosine or threonine residue is phosphorylated.
Figure 6.7 shows a comparison of Seclp and (Nimlp) protein: in this configuration
the two proteins show 25% identity over a region of 136 amino acids, but this
similarity does not suggest Seclp to be a protein kinase, since none of the residues
that are absolutely conserved in twelve protein kinase sequences (Hunter and Cooper
1985) are represented in Seclp.
6.5 Summary.
In this chapter I have described Northern hybridisation experiments that have
enabled SEC1 mRNA to be detected in wild type cells. This transcript is
approximately 2.5kb long, consistent with the size of the SEC1 gene as defined by
transposon mutagenesis. Using strand specific probes I have also demonstrated that
the SEC1 gene is orientated with its 5' terminus proximal to the H/'ndlll site, and
144
runs 5' to 3' towards the Xho\ site. To confirm that the SEC1 gene has the potential to
encode a polypeptide, I have expressed the gene using a prokaryotic in vitro coupled
transcription and translation system. A polypeptide of approximate molecular
weight 72K is expressed from pEDB16 in this system, but is not detected when two
derivatives of this plasmid (pTN18 and pTN64), containing Tn5 insertions into the
SEC1 gene, are analysed.
To gain more information about the SEC1 gene and its product (Seclp), I have
determined the nucleotide sequence of the 2.9kb Hind\\\-Xho\ fragment. Only a single
ORF has been identified which, by the following criteria, is likely to be the SEC1
coding sequence: it is the only ORF that begins with an ATG codon and continues for a
significant length; it is in the correct orientation as elucidated by Northern
hybridisation; and the ORF is located in the same region identified by transposon
mutagenesis to be essential for sec1-1 complementing activity. The SEC1 ORF is
1828bp long, and could encode a polypeptide of molecular weight 72 936; this is
consistent with the size of Seclp observed in the prokaryotic coupled in vitro
transcription-translation system. Two characteristics of the SEC1 gene suggest that
it is expressed at low levels only: analysis of 5' flanking sequences reveal that the
SEC1 promoter has very few of the sequence motifs that correlate with high levels of
gene expression; and the codon bias index for the SEC1 ORF is 0.305, indicating that
there is no tendency for preferred codons to be used. The amino acid sequence of
Seclp has been used to search the NBRF database to discover if it bears any
resemblance to other proteins of known function. Using the Lipman and Pearson
FASTP program, Seclp was found to be similiar to the nim1+ protein kinase of
Schizosaccharomyces pombe, although this resemblance does not imply Seclp to be a
protein kinase. The possible implications of this similarity will be discussed in
chapter 9.
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Figure 6.1 Northern hybridisation to detect the SEC1 transcript.
Total RNA was extracted from DBY746 that had been transformed to leucine
prototrophy with either pEDB16 or YEp13. Approximately 15pg of RNA was
separated by gel electrophoresis and then blotted onto Genescreen hybridisation
membrane. This filter was then probed with the 4.3kb Hind\\\-BamH\ fragment
using stringent hybridisation conditions.
Lanel. RNA from DBY746 transformed with pEDB16




Figure 6.2 Northern hybridisation experiments using strand specific
probes to detect the SEC1 transcript and determine the QrientgtiQn <?f
the SEC1 aene.
Single stranded pHX18 and pHX19 DNAs were prepared (see chapter 2) and used to
probe blots of RNA prepared from DBY746 transformed with pEDB16.
Panel A probe: pHX18 DNA.
Panel B probe: pHX19 DNA.
A transcript was detected only when pHX18 DNA was used as a probe. This clone must
therefore contain the coding strand of the SEC1 gene, enabling the orientation of the




Figure 6.3 Coupled in vitro transcription and translation of the SEC1
gene using a prokarvotic expression system.
Plasmids that were to be analysed in the Zubay system were first purified from
caesium chloride gradients. Approximately 5pg of each plasmid was mixed with the
constituents of the Zubay reaction. During a 1 hr incubation at 37°C newly
synthesised proteins were radiolabeled by incorporation of [35S]- methionine and
visualised by SDS-PAGE (using a 10% w/v polyacrylamide gel) with subsequent
fluorography.







Standard proteins: Myosin (200K), Phosphorylase b (92.5K), BSA (69K),
Ovalbumin (46K), Carbonic anhydrase (30K), Lysozyme (14.3K).
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Figure 6.4 Sequencing strategy-
The arrows indicate the direction and extent of sequence determination. Template
DNA consisted of either defined restriction fragments or Bal31 generated deletions
cloned into the polylinker of M13mp19 ( ► ); or synthetic oligonucleotides were
used to prime DNA synthesis with either pHX18 or pHX19 (i >). The SEC1 coding
sequence is marked by the large arrow at the top of the diagram. H {Hind\\\), C


















Figure 6.5 Nucleotide sequence of the SEC1 aene.
The complete sequence of the SEC1 gene is shown as well as 5' and 3' flanking
sequences. The sequence is only shown for the coding strand; the single letter amino
acid code is shown below the DNA sequence. The nucleotides underlined in the 5'
flanking region resemble some sequence motifs found in yeast promoters, whereas
those nucleotides underlined in the open reading frame represent potential splice























































































Figure 6.6 Northern hybridisation to test for splicing of the SEC1
transcript.
5jag of mRNA prepared from a wild type strain (FL100) at 26°C and 37°C, and from
an rna2 mutant strain (RY26) at 26°C and 37°C, was separated by gel
electrophoresis and then blotted onto nylon membrane. This filter was then probed







Figure 6.7 Comparison of Seclp and Nimlp.
This figure was composed using the BESTFIT program of the UWGCG molecular
biology software package. The alignment between residues 309 and 313 of Seclp was
done manually to give maximum similarity;^)denotes identity and(*)a conservative
change. In the region between the asparagine at position 239 of Seclp and the valine
at position 375 the two proteins share 25% identity. Those residues underlined in
the Nimlp sequences are highly conserved in some protein kinases (Hunter and
Cooper 1985); very few of these are present in Seclp suggesting that Seclp is not a
protein kinase.
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Seclp 236 PPQNTERPRSILIITDRTLEPFAPILHDFSYQAMAYDLVANVDTQKDIYH 285
II :: ::I I: : :| MM I
Nimlp 4 RHKNTIGVWRL GKTLGTGSTSCVRLAKHAKTGDL.AAIKIIPIRYA 48
286 YSAENEAGEQEEKVSKLVDLYDPSWIDLKHQHIMDANEYI.QGRIKELIA 334
: : : -III II MM I IM M : I
49 SIGMEILMMRLLRHPNILRLYDV.WTD..HQHMYLALEYVPDGELFHYIR 95
335 KNPLLVDRSNVKNTTDLLSWAHLKDFDEERRRLILHKTLVDECLGENAE 384







Fusion of SEC1 coding sequences to the 3' terminus of the
lacZgene: purification of a B-galactosidase-Secl p fusion
protein and its use as an immunogen.
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7.1 introduction-
The nucleotide sequence of the SEC1 gene predicts Seclp to have an molecular weight
of approximately 73K, and to be a resident of the cytoplasm (see chapter 6). In
order to confirm these characteristics and further investigate the function of Seclp a
biochemical investigation of the protein itself is required. For example,
immunoprecipitation of Seclp from wild type yeast cells will confirm the molecular
weight of the protein, whereas immunofluorescence or immunoprecipitation in
conjunction with subcellular fractionation will reveal the intracellular distribution
of Seclp; these techniques however, require an antibody that will specifically
recognise Seclp in a crude mixture of yeast proteins.
The first step in raising an antibody is to purify the target protein so that it can be
used as an immunogen, but since no characteristic of Seclp, other than its predicted
molecular weight, are known it is not feasible to purify the protein by classic
biochemical techniques. Recombinant DNA technology provides an excellent
alternative: foreign genes can be fused in-frame to the 3' terminus of a gene from E.
coli (e.g lacZ) which can be induced to high levels of expression, and the resultant
fusion protein purified from bacterial cells and used as an immunogen (for review
see Schoner et at., 1985). This strategy has several advantages: the fusion protein
can be made in large amounts - usually between 25-40% total cellular protein;
fusion proteins are usually insoluble and invariably aggregate together to form
inclusion bodies, which are easy to purify and also offer some protection against
proteolysis.
In this chapter I will describe the construction and purification of a
8-galactosidase-Sec1p fusion protein. Stanley and Luzio (1984) have designed
vectors specificaly for this purpose: the pEX vectors (see fig. 7.1) harbour a gene
fusion of the cro gene of bacteriophage lambda and the lacZ gene of E. coli (see fig.
7.1), that directs the production of a cro-R-galactosidase hybrid protein of
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molecular weight 117K. The three alternative plasmids (pEX1, pEX2, or PEX3)
each contain an MCS that has been placed at the 3" end of the lacZ gene, in different
reading frames, effectively allowing any open reading frame to be fused in frame to
the 3' terminus of lacZ. Transcription of the gene fusion is under control of the PR
promoter from bacteriophage lambda, regulated expression is therefore achieved by
introducing the plasmid into a host that harbours a lysogenised phage lambda
carrying the thermosensitive cl857 allele. At 30°C cl857 repressor is functional
and prevents expression of fusion protein, but a shift to 42°C inactivates the
repressor, allowing fusion protein to be produced up to 30-40% total cellular
protein (Stanley and Luzio 1984).
7.2 Fusion of the SEC1 oene to the 3' terminus of the lacZ gene.
The HincW restriction site within the coding sequence of the SEC1 gene is unique and
is compatible with the restriction sites in the MCS of the pEX vectors. The 1.5kb
H/V7cll-X/7ol fragment encodes the carboxy-terminal 418 amino acids of Seclp
(approximate molecular weight 58K), in addition to the 3' flanking sequences; this
fragment was cloned into the Sma\ and Sa/I restrictiion sites of pEX3, resulting in an
in-frame fusion between the SEC1 coding sequence and the 3' terminus of lacZ. This
plasmid has been called pEXS1. A 10ml culture of E. coli NF1 (a phage lambda
lysogen), transformed to ApR with pEXS1, was grown at 30°C under selection to
early exponential phase; the culture was then divided into two 5ml aliquots which
were incubated for a further 90min at either 42°C (to induce expression of the
fusion protein) or 30°C (control). Examination of the cultures by light microcopy
revealed the presence of numerous inclusion bodies inside induced cells (usually 2-3
per cell), which were completely absent from cells grown at 30°C (data not shown).
Bacterial cells were harvested by centrifugation and resuspended in 200|j.l water.
An equal volume of sample buffer (2x) was added along with solid urea to 8M, and
the cells lysed by boiling for 5min. Aliquots (40pl) from these samples were then
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analysed by SDS-PAGE using a 10% (w/v) acrylamide gel (see fig. 7.2). A protein
of approximate molecular weight 175K is clearly present in the induced samples,
that is completely absent from the extracts of cells grown at 30°C. The size of this
protein is entirely consistent with the predicted size of the
cro-13-galactosidase-Seclp fusion protein. The amount of fusion protein observed in
this experiment however, is an order of magnitude below that reported by Stanley
and Luzio (1984), who observed expression upto 30% total cell protein. To increase
total expression of fusion protein I extended the time of incubation at 42°C. Figure
7.3 shows the results of a time course experiment in which induction was carried out
for a maximum of 6hr. The amount of fusion protein produced was seen to increase
during the first four hours of induction but still not to a level equivalent to 30% of
total cell protein. This may be due to the large size of the open reading frame fused to
the 3' terminus of the lacZ gene - Stanley and Luzio (1984) observed optimal
expression when DNA fragments of only 400bp were cloned into the pEX plasmids.
7.3 Large scale production and purification of fusion protein.
A 11 culture of E. coli NF1 (pEXS1) was grown at 30°C under selection to early
exponential phase. Expression of fusion protein was induced by shifting the culture
to 42°C for a further 4hr of growth. The cells were then harvested, lysed, and the
inclusion bodies purified as described in chapter 2. A 1ml aliquot of purified
inclusion body was applied to a 100ml G150 Sephadex column, to remove residual
low molecular weight proteins and detergents prior to injection into rabbits.
Fractions were collected from the column and the A28o determined as an estimation of
protein content (fig. 7.4A). Samples were taken from fractions 12 to 17 and
analysed by SDS-PAGE using a 10% acylamide gel (fig. 7.4B). The
cro-R-galactosidase-Sec1p hybrid protein is the most prominent species of protein
in all four fractions; there is no evidence of contaminating proteins below molecular
weight 60K, although numerous species of higher molecular weight can be seen -
this is probably due to overloading of the column. Since the contaminating proteins
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are of bacterial origin and are therefore unlikely to initiate production of antibodies
that recognise proteins in yeast cells this purification was considered adequate.
7.4 Immunisation of rabbits with purified fusion protein.
Two female New Zealand White rabbits were each immunised with approximate
300|ig of purified fusion protein. Prior to injection the immunogen was mixed with
an equal volume of Freund's complete adjuvant to optimise presentation of the antigen
to the rabbit immune system. The mixture was injected subcutaneously, into at least
ten different positions over the back of the rabbit. Both rabbits were left untreated
for a period of five weeks, after which they received further injections of material to
stimulate a secondary immune response. Approximately 250pg of purified fusion
protein was mixed with an equal volume of Freund's incomplete adjuvant, and
injected into the rabbits using the same method described above. This treatment was
repeated three times, with fourteen day intervals between each injection. Blood
samples (50ml) were collected seven days after each injection and the serum tested
for the presence of antibodies that recognised the fusion protein. Preliminary
experiments, in which the serum obtained after the third boost has been used in a
Western blot, indicate that antibodies are present that specifically recognise
B-galactosidase in a mixture of proteins (data not shown). Both rabbits have
undergone another round of immunisation, the serum from this boost will shortly be
tested for antibodies that recognise Seclp in a mixture of yeast proteins.
7.5 Summary-
l have described the construction of a gene fusion in which a large portion of the SEC1
gene has been placed at the 3' terminus of a cro-lacZ hybrid gene. In bacterial cells,
this gene fusion directs the expression of a 175K cro-l3-galactosidase-Sec1p fusion
protein to about 10-20% total cellular protein. Most of the fusion protein was
insoluble and aggregated to form inclusion bodies. I have used differential
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centrifugation and gel filtration techniques to partially purify then hybrid protein,
which has been used to immunise rabbits in an attempt to raise antibodies against the
SEC1 gene product.
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Figure 7.1 Map of the dEX plasmids.
Diagram A illustrates the salient features of the pEX vectors. The cro-lacZ gene
fusion directs the expression of a 117K hybrid protein. A polylinker is located at the
3' terminus of the lacZ gene which can be used to insert foreign DNA fragments in
frame with B-galactosidase. Immediately 3' to the polylinker is a synthetic
oligonucleotide (STOP) containing stop codons in all open reading frames, and a
transcription termination fragment (Tfd) taken from phage Tfd. See Stanley and
Luzio (1984) for more details.
Diagram B shows the polylinker of the three pEX vectors, with the lacZ reading
frame and restriction sites in the polylinker marked. Plasmid pEXS1 was formed by
cloning the 1.5kb Hinc\\-Xho\ fragment, carrying SEC1 coding sequences into the
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Figure 7.2 Expression gi liifi cro-B-aalactosidase-Sec1 p fusion
protein in E. coli.
E. coli strain NF1 was transformed to ApR with pEXS1 and grown at 30°C to early
exponential phase (A600=0.3). To induce expression of fusion protein, cultures
were shifted to 42°C and incubated for a further 40min; cells were harvested, lysed
and prepared for SDS-PAGE analysis as described elsewhere. Proteins were
visualised by staining with Coomassie blue.
Lane 1 Standard proteins
Lane 2 Extract from E. coli NF1 grown at 42°C.
Lane 3 Extract from E. coli NF1 transformed to ApR with pEXS1
Standard proteins: Myosin (200K), B-galactosidase (116K), Phosphorylase b





Figure 7.3 Improved expression of cro-B-aalactosidase-Sec1 d fusion
protein in E. coli.
A 50ml culture of E. coli NF1 transformed to ApR with pEXS1 was grown at 30°C to
early exponential phase (A600=0.3), at which point the culture was shifted to 42°C.
Aliquots of 5ml were removed at T= 0,1,2,3,4,5, and 6 hours and processed for
SDS-PAGE as described elsewhere. Proteins were visualised by staining with
Coomassie blue.
Lane 1 Standard proteins (as in fig. 7.4)
Lane 2 6 hr induction at 42°C
Lane 3 5 hr induction at 42°C
Lane 4 4 hr induction at 42°C
Lane 5 3 hr induction at 42°C
Lane 6 2 hr induction at 42°C
Lane 7 1 hr induction at 42°C














Figure 7.4 Purification of cro-B-aalactosidase-Secl p fusion protein.
A. Inclusion bodies containing the fusion protein were first partially purified from
bacterial cells by differential centrifugation. Approximately one third of this
material was applied to a G150 Sephadex gel filtration chromatography column.
Fractions of 0.7ml were collected every two minutes and the A280 determined as an
estimation of the protein concentration. In total, thirty seven fractions were
collected.
B. Aliquots (40pl) from column fractions 12 to 17 were analysed by SDS-PAGE
using a 10% acrylamide gel. Proteins were visualised by staing with coomassie blue.
Lane 1 Standard proteins (as in fig. 7.4)
Lane 2 Extract from E. coli NF1 grown at 42°C.
Lane 3 Extract from E. coli NF1 transformed with pEXS1 grown at
42°C.
Lane 4 cro-S-galactosidase fusion protein purified by differential
centrifugation.
Lane 5 Column fraction 12 (40|il)
Lane 6 Column fraction 13 (40jxl)
Lane 7 Column fraction 14 (40|il)
Lane 8 Column fraction 15 (40pl)
Lane 9 Column fraction 16 (40pl)









The cloned fragment of genomic DNA also carries
the SEC5 gene: mapping of the SEC5 gene and investigation
of its relationship with the SEC1 gene.
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8.1 Introduction.
The SEC1 gene is located on the long arm of chromosome IV, in a tightly linked cluster
of genes including CDC37, SEC5, and SEC7. Previous genetic analysis has determined
the arrangement of these genes within the cluster (see Mortimer and Schild 1985);
the SEC5 gene has been found to lie adjacent to the SEC1 gene. In this chapter I will
demonstrate that the genomic fragment of pEDB1 also carries a second gene,
independent of the SEC1 gene, that can complement the sec5-24 mutation.
Mutations in the SEC5 gene result in a phenotype similiar to that displayed by a
sec1-1 mutant, ie: a late block of the secretion pathway, characterised by an
intracellular accumulation of secretory vesicles, and a cessation of endocytosis at
37°C. It is possible that this is a reflection of some overlap of function between the
SEC1 and SEC5 gene products, perhaps because the two genes have evolved from a
common ancestral sequence. I will describe experiments to demonstrate genetic
interaction between the SEC1 and SEC5 genes, suggesting functional overlap between
Seclp and Sec5p, but I also show that this relationship is not due to similarities in
the sequence (and therefore the products) of the SEC1 and SEC5 genes.
8.2 The 10.6kb oenomic fragment of dEDB1 carries a gene that can
complement the sec5-24 mutation.
MEY511 (sec5-24, Ieu2-3,112) was transformed to leucine prototrophy with
pEDB1, and tested for the ability to grow at 37°C. All transformants tested grew at
37°C, indicating that pEDB1 carries a gene that can complement the sec5-24
mutation. Plasmid pEDB16, which carries the SEC1 gene could not support growth of
MEY511 at 37°C. This clearly demonstrates the presence of a second gene,
distinguishable from the SEC1 gene, in the genomic fragment of pEDB1 that can
complement the sec5-24 mutation. Since the SEC1 and SEC5 genes have been shown
to be tightly linked in this fashion this gene is almost certainly the authentic SEC5
175
gene, although formal genetic proof of this is yet to be obtained. Further
complementation experiments revealed that none of the pEDB1 derivatives described
in chapter 3, namely: pEDB14, pEDB15, and pEDB18, were capable of supporting
growth of MEY511 at 37°C, thereby suggesting that the SEC5 gene could not be
subcloned on a single Hind\\\ fragment.
8.3 Mapping of the SEC5 oene bv Tn5 mutagenesis: and subclonina of
the gene.
In order to locate the SEC5 gene within the 10.6kb genomic fragment, pEDB1 was
analysed by Tn5 mutagenesis in exactly the same way as described in chapter 2. This
project was carried out in collaboration with Dr Alan Boyd, but for completeness I
have presented these results in fig 8.1. Of the 8 insertions analysed one, p3-11,
was observed to completely abolish the ability of pEDB1 to complement the sec5-24
mutation, and is therefore presumably within the SEC5 gene. This insertion is at
least 3.5kb away from the SEC1 gene, and thus confirms the existence of two
independent genes.
I have used one of the Tn5 derivatives described above to subclone the SEC5 gene. As
described in chapter 2 the insertion of the Tn5 molecule into pEDB1 results in the
introduction of new restriction sites. Plasmid p3-2 contains a transposon insertion
to the right of the SEC5 gene (in between SEC5 and SEC1); using the BamH\ site of
the Tn5 molecule and the BamH\ site at the junction of the genomic DNA and vector
DNA sequences, all the yeast genomic DNA to the right of the transposon was deleted
(see fig 8.1). The resulting plasmid has been termed pEDB32, and when introduced
into MEY511 can fully support its growth at 37°C.
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8.4 Genetic interaction between the SEC1 and SEC5 genes.
The suggestion that the SEC1 and SEC5 genes might have arisen from a common
ancestral sequence also implies that the respective polypeptides will be similiar in
sequence and perhaps function. The experiment described in section 8.2 however,
demonstrates that the SEC1 gene cannot support the growth of a sec5-24 mutant at
37°C, even when present in multicopy. The same question was asked of the SEC5
gene, ie. could it suppress the sec1-1 mutation at 37°C. In summary, ABY12 cells
transformed to leucine prototrophy by pEDB32 were found to be incapable of growth
at 37°C, indicating that the SEC5 gene cannot suppress mutations in the SEC1 gene.
As described in the Introduction, Salminen and Novick (1987) observed that
duplication of the SEC4 gene suppressed numerous late acting sec mutations at
33.5°C (an intermediate temperature that is lethal for the parental strains) but not
at 37°C. I therefore proceeded to test whether at 33.5°C, the sec1-1 mutation could
be suppressed by multiple copies of the SEC5 gene and similarly, if the sec5-24
mutation could be suppressed by multiple copies of the SEC1 gene. The results are
summarised in table 8.1. Considering complementation of sec5-24 by SEC1 first:
the recipient strain (MEY511) is incapable of growth at 33.5°C; growth is
completely restored when MEY511 is transformed with pEDB1 or pEDB32 (positive
controls) but not with YEp13 (negative control). However, MEY511 cells
transformed with pEDB16 (the SEC1 gene) also grew at 33.5°C, and moreover, did
not appear significantly different from MEY511 cells transformed with pEDB32, as
judged by colony size. To confirm that this effect was due to the SEC1 gene, the Tn5
mutagenised derivatives of pEDB16 (pTN, see chapter 4) were tested for the ability
to complement the sec5-24 mutation at 33.5°C: the four plasmids which contain
Tn5 insertions within the SEC1 gene (pTN18, pTN26, pTN57, and pTN64) did not
allow growth of MEY511 at 33.5°C (data not shown). Multiple copies of the SEC1
gene therefore cannot suppress mutations in the SEC5 gene at 37°C but can do so at
33.5°C. In direct contrast, it was found that increasing the number of copies of the
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SEC5 gene had no effect upon the growth of a sec1-1 mutant at either 37°C or
33.5°C. The functional relationship that exists between SEC1 and SEC5 is therefore
unidirectional.
8.5 Southern hybridisation experiments Ifl further examine the
relationship between SEC1 and SEC5.
One possible explanation for the genetic interaction between the SEC1 and SEC5
genes is a similarity in the sequences of the two genes. I have used Southern
hybridisation experiments to test this hypothesis; if SEC1 and SEC5 do have related
sequences then a DNA fragment carrying the SEC1 gene will hybridise to both SEC1
and SEC5 sequences in pEDB1.
Plasmid pEDB1 was cleaved with EcoRI, the fragments separated by gel
electrophoresis, transferred to nitrocellulose, and then probed with pHX18. Two
EcoRI fragments of 3.2kb and 1.2kb should hybridise to this probe since they have
identical sequences. If the SEC5 gene has any sequence similarity to the SEC1 gene,
additional fragments would also be detected. The hybridisation reaction was carried
out under conditions of reduced stringency (6xSSC, 50°C) thereby allowing
approximately 25% mismatch between sequences. The results are presented in fig
8.2: the fragments of 3.2kb and 1.2kb are clearly visible but there is no evidence for
any additional fragments hybridising to the probe, even following prolonged exposure
(data not shown). If the two genes do share related sequences therefore, they are not
detectable by this method. I have almost completed sequencing the SEC5gene: to date
an incomplete open reading frame of 1560bp, sufficient to encode a polypeptide of
520 residues has been identified; no similarities between this sequence and the SEC1
sequence have been found (data not shown).
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8.6 Genetic interactions between the SEC1 and /or the SEC5 genes and
other late-actina SEC genes.
I have extended the genetic analysis described in section 8.4 to include many of the
other late acting sec mutations. Plasmids pEDB1, pEDB16, and pEDB32 were tested
for the ability to complement the sec2-56, sec3-2, sec6-4, sec8-6, sec9-4,
sec10-2, and sec15-1 mutations at either 33.5°C or 37°C; complementation was
scored by the ability of transformed strains to form single colonies under restrictive
conditions (see table 8.2). Increasing the number of copies of the SEC1 gene was
found to suppress the sec3-2, sec9-4, and sec15-1 mutations at 33.5°C, whereas
multiple copies of the SEC5 gene suppressed the sec3-2, sec8-4, and sec10-2
mutations at 33.5°C. Complementation of the sec10-2 mutant is of particular
interest: at 33.5°C, increased copies of the SEC1 gene alone (pEDB16) cannot
suppress the sec10-2 mutation, but increase copies of the SEC5 gene alone
(pEDB32) can; however, when the copy number of both the SEC5 and SEC1 genes is
increased (pEDB1) the sec10-2 mutant cannot grow at 33.5°C. In this experiment
therefore, Seclp must somehow modulate the activity of Sec5p.
One mutation, sec3-2, can also be complemented at 37°C when pEDB1 is introduced
into the mutant strain but not when pEDB16 or pEDB32 are tested, suggesting that
under full restrictive conditions multiple copies of both the SEC1 and SEC5 genes are
required to support growth of a sec3-2 mutant. To confirm that this effect was
indeed due to the SEC1 and SEC5 genes, and not some other unidentified gene present
on the genomic fragment of pEDB1, four of the Tn5 derivatives described in section
8.2 were tested for the ability to complement the sec3-2 mutation at 37°C. The four
derivatives chosen (see fig 8.1) contained a Tn5 molecule inserted into the SEC1 gene
(p2-6), or the SEC5 gene (p3-11), or the region lying between the SEC1 and SEC5
genes (p1 -6, p3-11). As predicted the latter two derivatives still retained the
ability to complement the sec3-2 mutation at 37°C and the Tn5 insertion into the
SEC5 gene abolished the complementing activity of pEDB1. Surprisingly, the Tn5
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insertion into the SEC1 gene, that abolishes the ability of pEDB1 to complement the
sec1-1 mutation at 37°C, had no effect on complementation of the sec3-2 mutation.
However, this Tn5 insertion is positioned towards the 3' terminus of the SEC1 gene,
and thus a large truncated SEC1 polypeptide could be produced; but since this has
lost its biological activity (as defined by complementation of the sec1-1 mutation at
37°C) the most probable way in which it could exert this effect on complementation
of the sec3-2 mutation is by interaction with a second protein, possibly Sec5p.
Further analysis of Tn5 insertions into 5' regions of the SEC1 gene are required to
confirm this hypothesis, and rule out the formal possibility that there is a further
gene, carried on the genomic fragment of pEDB1, that is in part responsible for
complementation of the sec3-2 mutation.
8.8 Summary-
Previous genetic analysis has mapped the SEC1 gene adjacent to the SEC5 gene on the
long arm of chromosome IV. I have demonstrated that pEDB1, isolated from the
Nasmyth library by its ability to complement the sec1-1 mutation at 37°C, is also
capable of complementing the sec5-24 mutation at 37°C. The region of DNA that
confers this ability has been located by Tn5 mutagenesis and has been found to lie
approximately 3.5kb away from the SEC1 gene. Formal genetic proof that this gene
is the authentic SEC5 gene is currently being obtained.
Complementation analysis has revealed a genetic relationship between the SEC1 and
the SEC5 genes: at a restrictive temperature of 33.5°C multiple copies of the SEC1
gene can suppress the sec5-24 mutation, but this relationship is unidirectional
since increasing the number of SEC5 genes does not suppress the sec1-1 mutation.
The biochemical basis for this interaction is not known, although Southern
hybridisation experiments and partial sequence analysis make it very unlikely that
it reflects similarity in the sequences of the SEC1 and SEC5 genes.
180
I have extended the genetic interaction described above to include other late-acting
sec mutations, and have demonstrated that increasing the number of the SEC1 and/or
the SEC5 genes can suppress the sec3-2, sec8-6, sec9-4, sec10-2, and sec15-1
mutations at 33.5°C and also the sec3-2 mutation at 37°C. Circumstantial evidence
has also been obtained which suggests that Seclp may interact directly with Sec5p.
This confirms and extends the observations of Salminen and Novick (1987), who
described similiar genetic interaction between the SEC4 gene and other late acting
sec mutations. The possible implications of this type of interaction are discussed in
chapter 9.
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Figure 8.1 Localisation of the SEC5 gene.
Plasmid pEDB1 was mutagenised with the transposon Tn5 as described in chapter 2;
the position of Tn5 insertion was determined by restriction mapping and then several
derivatives were tested for the ability to complement the sec5-24 mutation at 37°C.
MEY511 was transformed to leucine prototrophy with the mutagenised plasmids, and
then tested for the ability to form single colonies at 37°C. One insertion was
identified ) that completely abolished the complementing activity of pEDB1; this
was flanked by numerous insertions that had no effect Cy7).
Insertion of a Tn5 molecule introduces new restriction sites, the BamHI site of one
Tn5 derivative (p3-2) was used in conjunction with the BamHI site at the righthand
boundary of the insert and vector sequences, to delete all the DNA to the right of the
SEC5 gene. The resulting plasmid, pEDB32, still retains the ability to complement
the sec5-24 mutation at 37°C.









Table 8.1 Genetic interaction between the SEC1 and SEC5 genes.
Plasmids pEDB1, pEDB16, pEDB32, and YEp13 were used to transform ABY12 and
MEY511 to leucine prototrophy. Transformants were selected at 26°C by growth on
minimal medium in the absence of leucine. Four transformants were then streaked
onto fresh minimal medium and incubated at 26°C, 33.5°C, and 37°C for 48hrs
-72hrs. Complementation was scored by the ability to form single colonies; (+)
represents complementation and, (-) no complementation.





























Figure 8.2 Southern hybridisation experiment to test for sequence
similiarities between the SEC1 and SEC5 genes.
Plasmid pEDB1 was cleaved with EcoRI, to produce 8 fragments of 0.65, 1.2, 1.3,
2.4, 3.2, 3.25, 4.2, and 4.3kb (data not shown). The fragments were separated by
gel electrophoresis and transferred to a nitrocellulose filter. This was probed, under
conditions of low stringency (6xSSC, 50°C) with pHX18 that had been radiolabeled
with [a32]P-dATP. Under these conditions only two fragments were seen to hybridise
to the probe, and both correspond to EcoRI fragments which carry SEC1 sequences.





Table 8.2 Genetic interactions between the SEC1 and/or SEC5 genes
and other late-actina SEC aenes.
Plasmids pEDB1, pEDB16, pEDB32, and YEp13 were introduced into numerous
strains. Transformants were selected by growth on minimal medium, in the absence
of leucine, at 26°C. Four transformants were then streaked onto fresh selective
medium and tested for the ability to form single colonies at 26°C, 33.5°C, and 37°C.





































































Transport of proteins from the endoplasmic reticulum to the cell surface in S.
cerevisae requires at least 23 SEC gene products. In this thesis I have described the
isolation of a fragment of genomic DNA which carries both the SEC1 and SEC5 genes
both of which are thought to encode proteins that function during the late stages of the
secretory pathway, where secretory vesicles fuse with the plasma membrane. In a
previous report, Salminen and Novick (1987) demonstrated extensive genetic
interaction between those SEC genes whose products function in this area of the
pathway: duplication of the SEC4 gene can suppress mutations in six other late acting
SEC genes, including the sec1-1 and sec5-24 mutations. In this thesis I have
demonstrated further genetic interactions which extend these observations: at 33.5°C
multiple copies of the SEC1 gene can suppress the sec3-2, sec5-24, sec9-4, and
sec15-1 mutations, whereas increasing the number of copies of the SEC5 gene can
suppress the sec3-2, sec8-2, and sec10-2 mutations; one mutation, sec3-2 was
also suppressed at 37°C when the copy number of both genes was increased. It is
important to emphasise that the genetic interactions described by Salminen and
Novick (1987) and in this thesis result from overexpression of SEC gene products.
Suppression of this type can reflect a similarity in the structure and function of the
gene products. Thus, S. cerevisiae has two genes that encode a-tubulin, TUB1 and
TUB3; the TUB1 gene is essential for cell viability but can be dispensed with if the
TUB3 gene is present in multiple copies (Schatz et a/.,1986a,b). It seems unlikely
however, that so many SEC genes will encode proteins so closely related in structure
and function. In fact the observation that the SEC1 and SEC4 genes are each essential
in their own right suggests that they do not have overlapping functions, but moreover
I have demonstrated that there is no sequence similarity between the SEC1, SEC5 or
SEC4 genes, despite the observed interactions.
In order to explain the interactions that they observed, Salminen and Novick (1987)
proposed that there may be multiple pathways in secretion and that Sec4p may
1 91
function on a pathway that is parallel to that one on which the interacting SEC gene
products function. In this model overexpression of Sec4p would compensate for a
partial defect on an alternative pathway, while defects on both pathways would be
synergistically deleterious and therefore lethal at all temperatures. This model is
not consistent with the genetic interactions described in this thesis. As an
alternative hypothesis, I propose that genetic interactions of this type are observed
where the activity of one SEC gene product is dependent upon the activity of another;
in this view the late acting SEC gene products therefore only acquire function if they
either form a complex with or are otherwise activated by another SEC protein(s)
(see fig. 9.1 and legend for full description).
A clue to what Seclp may be interacting with is provided by its resemblance to the
nim1+ gene product (Nimlp) of Schizosaccharomyce pombe. By sequence homology
Nimlp is proposed to be a protein kinase. Residues 239 to 375 of Seclp share 25%
identity with residues 7 to 136 of Nimlp; this region of Nimlp also contains
sequence motifs that correlate with protein kinase activity, but very few of these are
present in Seclp indicating that Seclp is not a protein kinase. Nimlp is thought to
participate in the control of cell division since the nim1+ gene was isolated by its
ability to suppress cdc25+ mutations when present in multiple copies. Russell and
Nurse (1987) postulate that Nimlp i§ a member of a regulatory network that
controls cell division (fig. 9.2); in this model the cdc2+ gene product (Cdc2p) is a
master regulator of mitosis whose function is rate limiting. The cdc25+ and wee1+
gene products (Cdc25p and Weelp respectively) exert control over the activity of
Cdc2p: Cdc25p stimulates Cdc2p mitotic function and is therefore an inducer of
mitosis, whereas Weelp counteracts Cdc2p mitotic function and is thus an inhibitor
of mitosis - the balance of Cdc25p and Weelp is therefore an important control
element of mitosis. Because the nim1+ gene can compensate for mutations in the
cdc25+ gene, Nimlp is therefore thought to be an inducer of mitosis and could
function as a negative regulator of Weelp or by modification of Cdc2p to prevent it
responding to Weelp.
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The similarity of the two proteins could indicate that Seclp is able to bind a
substrate protein(s) which is also recognised by a Nim1p-like protein. I have
presented two hypotheses to describe such an interaction (fig. 9.3): model A suggests
'
that Nimlp recognises a substrate and subsequently phosphorylates it, resulting in a
slight conformational change of the substrate which allows recognition and binding by
Seclp; model B implies that the substrate can interact with Seclp without prior
phosphorylation, so that competition for substrate would exist between Nimlp and
Seclp. Two predictions made by both models are that S. cerevisiae will possess a
homologue of the S. pombe nim1+ gene, and that Seclp will interact directly with
other proteins. It is likely that S. cerevisiae will indeed have a nim1+ homologue
since genetic analysis has demonstrated that the CDC28 gene of S. cerevisiae is
homologous to the cdc2+ gene of S. pombe, in fact the two genes can substitute for
each other implying that the two yeasts have similiar cell cycle control mechanisms
(Beach et al., 1982). In support of the second prediction I have demonstrated
extensive genetic interaction between the SEC1 gene and other SEC genes, which are
most readily explained by interaction of Seclp with other SEC gene products.
The similarity between Seclp and Nimlp provides a connection, albeit tenuous,
between a cell cycle control circuit and secretion; there are clear indications that
some such connection must exist. Cell division in S. cerevisiae is asymmetrical,
such that newly formed daughter cells are smaller in size and take longer to divide
than the parental cells they originated from (Hartwell and Unger 1977). It has been
proposed that there is a critical size which must be achieved prior to initiation of a
division cycle, ie. daughter cells are required to be of similar size to the parental
cell before division. During this period of growth there is no bud development and
new material is probably deposited over the whole of the cell surface. On reaching
the critical size cells enter into a division cycle and develop a bud. The onset of
budding is anticipated by the appearance of vesicles below the plasma membrane, and
an array of microtubules extending from the spindle pole body on the nucleus to the
presumptive site of bud emergence (for review see Wheals 1987). Throughout the
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subsequent budding phase of the cell cycle all secretion and membrane expansion are
restricted to the developing bud. Control systems must therefore exist which enable
the cell to regulate fusion of secretory vesicles with the plasma membrane in both a
spatial and temporal manner. The late acting SEC gene products may be elements of
such regulatory mechanisms.
The biochemical mechanism that underlies the switch from de-localised to polarised
membrane expansion is unknown, but ultimately it must involve an efficient
cytoskeletal system for targetted transport of secretory vesicles to a specific region
of the plasma membrane that is competent for membrane fusion. Evidence for a
relationship between late-acting SEC gene products and the cytoskeleton is beginning
to emerge. Thus, two SEC gene products have been visualised in cells by
immunofluorescence techniques. The SEC4 gene product is observed in association
with both secretory vesicles and the plasma membrane (Goud et at., 1988). The
SEC 15 gene product displays a intracellular distribution similar to that of actin, that
is, it is observed in patches at the periphery of the cell with several cables extending
from these patches to the interior of the cell and through the neck of the bud (Antti
Salminen, personal communication). The cytoskeleton has previously been
implicated to function in the late stages of the secretion pathway from the phenotype
of the act1-1 and act2-1 mutations (temperature sensitive actin mutations): under
restrictive conditions mutant cells exhibit an intracellular accumulation of
invertase and secretory vesicles in similar fashion to late-blocking sec mutants. It is
possible that the interacting group of late-acting SEC genes encode proteins which
are cytoskeletal elements or which promote association of secretory vesicles with the
cytoskeletal network.
In relation to this, a further clue to the function of Seclp may be provided by
erythrocytes, which also have an extensive cytoskeletal network that forms a shell
under the entire plasma membrane (for review see Backman 1988, fig. 9.4).
Many of the interactions shown in fig. 9.4 are influenced by
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phosphorylation/dephosphorylation reactions. For example, protein 4.9 has the
ability to bundle actin microfilaments into filaments but this ability is lost when
protein 4.9 is phosphorylated (Husain-Chisti et al., 1988). Alternatively, ankyrin
is proposed to anchor the cytoskeleton to the plasma membrane by interaction with
band 3; phosphorylation of ankyrin reduces its affinity for band 3 (Cianci et al.,
1988). Thus the integrity of the cytoskeletal network breaks down when certain of
its components are phosphorylated. Many of the proteins shown in fig. 9.3, including
band 4.9 and ankyrin have been identified in several non-erythrocyte cells (e.g see
Anderson et al., 1988), and one protein, spectrin, has been identified in S. cerevisae
(Eli Orr, personal communication). Phosphorylation of these and other proteins
could therefore be a general mechanism by which bundling of actin microfilaments
and their association with the plasma membrane is controlled. It is interesting to
speculate that Seclp could block phosphorylation of a cytoskeletal protein, such as a
protein similar to protein 4.9, thereby maintaining the integrity and organisation of
the actin cytoskeleton. Clearly, most of the interesting questions about Seclp
function remain to be answered but these speculative ideas provide a framework for
the design of future experiments.
9.2 Conclusions-
The sec mutants have provided an invaluable tool for investigations of protein
secretion from S. cerevisae-, they have allowed the secretory pathway to be
genetically dissected and biochemically characterised. The fact that only 23
complementation groups have been identified however, many of which have only one
member, suggests that this is not a complete representation of the gene products
required for transport of proteins from the ER to the cell surface. This is
particulary true of the Golgi complex where only two genes have been identified
whose products directly affect transport through the organelle, yet it is perhaps the
most intricate component of the secretory pathway. Further mutants could no doubt
be isolated by extending the mutant hunt of Novick and Schekman (1980), but it is
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likely that many genes will remain elusive because of the characteristics of the
mutant selection protocol. The proceedures employed by Novick and Schekman
(1980) necessitate that mutant strains remain viable at 37°C for up to three hours;
for many mutants this may not be realistic. Actin has been implicated in secretion
by the fact that mutations in the actin gene lead to a phenotype similiar to that of a
late sec mutant and one would therefore predict that the actin gene could have been
isolated in the sec mutant hunt. However, at 37°C the two actin mutations result in
an 88% loss in viability after four hours of incubation, suggesting that such mutants
would not have survived the mutant selection protocol. It was anticipated that
analysis of the late acting SEC genes and their products would provide an insight into
some of the mechanisms employed during fusion of secretory vesicles with the
plasma membrane. But what is beginning to emerge from preliminary investigations
is that these genes encode proteins which facilitate intracellular transport of
secretory vesicles. It may be necessary therefore to resort to more conventional
biochemical techniques to uncover such proteins before the genetic techniques
available with S. cerevisae realise their true potential.
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Figure 9.1 Interaction between the late-actina SEC aene products.
In this model the activity of one SEC protein is dependent upon another SEC protein.
Protein B is a substrate for protein A, which functions to either activate protein B to
B' or associates with B to form an AB complex. Activated B' or the AB complex
subsequently interacts with protein C to produce activated C' or an ABC complex. In
similar fashion C' or ABC acts upon D to produce either D' or an ABCD complex.
Removal of any component in this pathway, e.g by a temperature sensitive mutation,
would interrupt the chain of events and ultimately result in loss of function. Many of
the genetic interactions described in this thesis and by Salminen and Novick (1987)
are observed at 33.5°C. At this temperature, proteins encoded by mutant sec alleles
may retain activity, but at reduced levels. Such deficiencies could be compensated
for by overexpression of an interacting protein e.g defects in protein A could be
overcome by overexpression of protein B, thereby favouring the formation of either
B' or the AB complex. A similar argument can be used to explain some of the genetic
interactions observed at 37°C. It is known that the sec4-8 mutant gene encodes a
temperature sensitive protein that retains activity at 37°C, since overexpression of







Figure 9.2 Control of mitosis in Schizosaccharomvces dombe.
This model has been proposed by Russell and Nurse (1987). Three elements of this
control circuit are proposed to be protein kinases (P.K.); for the wee1+ and nim1 +
gene products, this is based upon sequence similarities with other protein kinases,
but biochemical evidence has been obtained in support of the cdc2+ gene product
being a protein kinase (Simanis and Nurse 1986). See text for further discussion.
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Figure 9.3 Functional relationship between Seclp and Nimlp.
Model A suggests that Nimlp and Seclp sequentially interact with protein X, and that
interaction of Seclp with protein X is dependent upon the phosphorylation state of
protein X. In this view, Nimlp binds to protein X and phosphorylates it;
phosphorylation results in a conformational change of protein X, allowing interaction
with Seclp.
Model B indicates that Seclp can interact with protein X without prior
phosphorylation of the substrate. In this view competition for protein X would exist
between Seclp and Nimlp. Formation of a Seclp-protein X complex would block







Figure 9.4 The erythrocyte cvtoskelton.
This diagram is a schematic illustration of the erythrocyte cytoskeleton. Proteins
which are known to be phosphorylated are in bold text. Those proteins that interact
with each other are connected by lines, and arrowheads indicate those interactions
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